<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Home parenteral nutrition for people with inoperable malignant bowel obstruction - Sowerbutts, AM - 2018 | Cochrane Library</title> <meta content="Home parenteral nutrition for people with inoperable malignant bowel obstruction - Sowerbutts, AM - 2018 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012812.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Home parenteral nutrition for people with inoperable malignant bowel obstruction - Sowerbutts, AM - 2018 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012812.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD012812.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Home parenteral nutrition for people with inoperable malignant bowel obstruction" name="citation_title"/> <meta content="Anne Marie Sowerbutts" name="citation_author"/> <meta content="The University of Manchester, and Manchester Academic Health Science Centre" name="citation_author_institution"/> <meta content="annemarie.sowerbutts@manchester.ac.uk" name="citation_author_email"/> <meta content="Simon Lal" name="citation_author"/> <meta content="Salford Royal Foundation Trust" name="citation_author_institution"/> <meta content="Jana Sremanakova" name="citation_author"/> <meta content="The University of Manchester, and Manchester Academic Health Science Centre" name="citation_author_institution"/> <meta content="Andrew Clamp" name="citation_author"/> <meta content="The Christie NHS Foundation Trust and University of Manchester" name="citation_author_institution"/> <meta content="Chris Todd" name="citation_author"/> <meta content="The University of Manchester, and Manchester Academic Health Science Centre" name="citation_author_institution"/> <meta content="Gordon C Jayson" name="citation_author"/> <meta content="The Christie NHS Foundation Trust and University of Manchester" name="citation_author_institution"/> <meta content="Antje Teubner" name="citation_author"/> <meta content="Salford Royal Foundation Trust" name="citation_author_institution"/> <meta content="Anne‐Marie Raftery" name="citation_author"/> <meta content="The Christie NHS Foundation Trust" name="citation_author_institution"/> <meta content="Eileen J Sutton" name="citation_author"/> <meta content="University of Bristol" name="citation_author_institution"/> <meta content="Lisa Hardy" name="citation_author"/> <meta content="Manchester University NHS Foundation Trust" name="citation_author_institution"/> <meta content="Sorrel Burden" name="citation_author"/> <meta content="The University of Manchester, and Manchester Academic Health Science Centre" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="8" name="citation_issue"/> <meta content="10.1002/14651858.CD012812.pub2" name="citation_doi"/> <meta content="2018" name="citation_date"/> <meta content="2018/08/10" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012812.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012812.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012812.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="*Parenteral Nutrition, Home [adverse effects, mortality]; Abdominal Neoplasms [complications]; Intestinal Obstruction [etiology, mortality, *therapy]; Observational Studies as Topic; Quality of Life" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012812.pub2&amp;doi=10.1002/14651858.CD012812.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012812.pub2&amp;doi=10.1002/14651858.CD012812.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012812.pub2&amp;doi=10.1002/14651858.CD012812.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012812.pub2&amp;doi=10.1002/14651858.CD012812.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012812.pub2&amp;doi=10.1002/14651858.CD012812.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012812.pub2&amp;doi=10.1002/14651858.CD012812.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012812.pub2&amp;doi=10.1002/14651858.CD012812.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012812.pub2&amp;doi=10.1002/14651858.CD012812.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012812.pub2&amp;doi=10.1002/14651858.CD012812.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012812.pub2&amp;doi=10.1002/14651858.CD012812.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012812.pub2&amp;doi=10.1002/14651858.CD012812.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012812.pub2&amp;doi=10.1002/14651858.CD012812.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012812.pub2&amp;doi=10.1002/14651858.CD012812.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012812.pub2&amp;doi=10.1002/14651858.CD012812.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012812.pub2&amp;doi=10.1002/14651858.CD012812.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012812.pub2&amp;doi=10.1002/14651858.CD012812.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012812.pub2&amp;doi=10.1002/14651858.CD012812.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012812.pub2&amp;doi=10.1002/14651858.CD012812.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012812.pub2&amp;doi=10.1002/14651858.CD012812.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012812.pub2&amp;doi=10.1002/14651858.CD012812.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012812.pub2&amp;doi=10.1002/14651858.CD012812.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012812.pub2&amp;doi=10.1002/14651858.CD012812.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012812.pub2&amp;doi=10.1002/14651858.CD012812.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774054000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774081000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000"}};Liferay.authToken="jU9oKp1Y";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD012812\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD012812\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012812\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012812\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1559916434000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","fa","zh_HANS","de","ru","ms","ja"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD012812.pub2",title:"Home parenteral nutrition for people with inoperable malignant bowel obstruction",firstPublishedDate:"Aug 10, 2018 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Gynaecological, Neuro‐oncology and Orphan Cancer Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738735355000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=jU9oKp1Y&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD012812.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD012812.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD012812.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD012812.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD012812.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD012812.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD012812.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD012812.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD012812.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD012812.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;Abstract&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Laienverständliche Zusammenfassung&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;一般語訳&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;Plain language summary&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD012812.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD012812.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD012812.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD012812.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>6420 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD012812.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012812.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012812.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012812.pub2/full#CD012812-abs-0004"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012812.pub2/full#CD012812-sec-0104"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012812.pub2/full#CD012812-sec-0022"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012812.pub2/full#CD012812-sec-0023"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012812.pub2/full#CD012812-sec-0028"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012812.pub2/full#CD012812-sec-0029"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012812.pub2/full#CD012812-sec-0061"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012812.pub2/full#CD012812-sec-0095"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD012812.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012812.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012812.pub2/appendices#CD012812-sec-0108"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012812.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012812.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012812.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012812.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD012812.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD012812.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD012812.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2018 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD012812.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Home parenteral nutrition for people with inoperable malignant bowel obstruction</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012812.pub2/information#CD012812-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Anne Marie Sowerbutts</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012812.pub2/information#CD012812-cr-0003">Simon Lal</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012812.pub2/information#CD012812-cr-0004">Jana Sremanakova</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012812.pub2/information#CD012812-cr-0005">Andrew Clamp</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012812.pub2/information#CD012812-cr-0006">Chris Todd</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012812.pub2/information#CD012812-cr-0007">Gordon C Jayson</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012812.pub2/information#CD012812-cr-0008">Antje Teubner</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012812.pub2/information#CD012812-cr-0009">Anne‐Marie Raftery</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012812.pub2/information#CD012812-cr-0010">Eileen J Sutton</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012812.pub2/information#CD012812-cr-0011">Lisa Hardy</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012812.pub2/information#CD012812-cr-0012">Sorrel Burden</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD012812.pub2/information/en#CD012812-sec-0113">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 10 August 2018 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD012812.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD012812.pub2">https://doi.org/10.1002/14651858.CD012812.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD012812-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD012812-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD012812-abs-0003">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD012812-abs-0011">فارسی</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD012812-abs-0002">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD012812-abs-0001" lang="en"> <section id="CD012812-sec-0001"> <h3 class="title" id="CD012812-sec-0001">Background</h3> <p>People with advanced ovarian or gastrointestinal cancer may develop malignant bowel obstruction (MBO). They are able to tolerate limited, if any, oral or enteral (via a tube directly into the gut) nutrition. Parenteral nutrition (PN) is the provision of macronutrients, micronutrients, electrolytes and fluid infused as an intravenous solution and provides a method for these people to receive nutrients. There are clinical and ethical arguments for and against the administration of PN to people receiving palliative care. </p> </section> <section id="CD012812-sec-0002"> <h3 class="title" id="CD012812-sec-0002">Objectives</h3> <p>To assess the effectiveness of home parenteral nutrition (HPN) in improving survival and quality of life in people with inoperable MBO. </p> </section> <section id="CD012812-sec-0003"> <h3 class="title" id="CD012812-sec-0003">Search methods</h3> <p>We searched the following electronic databases: Cochrane Central Register of Controlled Trials (CENTRAL; 2018, Issue 1), MEDLINE (Ovid), Embase (Ovid), BNI, CINAHL, Web of Science and NHS Economic Evaluation and Health Technology Assessment up to January 2018, ClinicalTrials.gov (<a href="http://clinicaltrials.gov/" target="_blank">http://clinicaltrials.gov/</a>) and in the World Health Organization (WHO) International Clinical Trials Registry Platform (ICTRP) search portal (<a href="http://apps.who.int/trialsearch/" target="_blank">http://apps.who.int/trialsearch/</a>). In addition, we handsearched included studies and used the ‘Similar articles’ feature on PubMed for included articles. </p> </section> <section id="CD012812-sec-0004"> <h3 class="title" id="CD012812-sec-0004">Selection criteria</h3> <p>We included any studies with more than five participants investigating HPN in people over 16 years of age with inoperable MBO. </p> </section> <section id="CD012812-sec-0005"> <h3 class="title" id="CD012812-sec-0005">Data collection and analysis</h3> <p>We extracted the data and assessed risk of bias for each study. We entered data into Review Manager 5 and used GRADEpro to assess the quality of the evidence. </p> </section> <section id="CD012812-sec-0006"> <h3 class="title" id="CD012812-sec-0006">Main results</h3> <p>We included 13 studies with a total of 721 participants in the review. The studies were observational, 12 studies had only one relevant treatment arm and no control and for the one study with a control arm, very few details were given. The risk of bias was high and the certainty of evidence was graded as very low for all outcomes. Due to heterogeneity of data, meta‐analysis was not performed and therefore the data were synthesised via a narrative summary. </p> <p>The evidence for benefit derived from PN was very low for survival and quality of life. All the studies measured overall survival and 636 (88%) of participants were deceased at the end of the study. However there were varying definitions of overall survival that yielded median survival intervals between 15 to 155 days (range three to 1278 days). Three studies used validated measures of quality of life. The results from assessment of quality of life were equivocal; one study reported improvements up until three months and two studies reported approximately similar numbers of participants with improvements and deterioration. Different quality of life scales were used in each of the studies and quality of life was measured at different time points. Due to the very low certainty of the evidence, we are very uncertain about the adverse events related to PN use. Adverse events were measured by nine studies and data for individual participants could be extracted from eight studies. This revealed that 32 of 260 (12%) patients developed a central venous catheter infection or were hospitalised because of complications related to PN. </p> </section> <section id="CD012812-sec-0007"> <h3 class="title" id="CD012812-sec-0007">Authors' conclusions</h3> <p>We are very uncertain whether HPN improves survival or quality of life in people with MBO as the certainty of evidence was very low for both outcomes. As the evidence base is limited and at high risk of bias, further higher‐quality prospective studies are required. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD012812-abs-0004" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD012812-abs-0004">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD012812-abs-0006">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD012812-abs-0010">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD012812-abs-0012">فارسی</a> </li> <li class="section-language"> <a class="" href="full/ja#CD012812-abs-0009">日本語</a> </li> <li class="section-language"> <a class="" href="full/ms#CD012812-abs-0008">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/ru#CD012812-abs-0007">Русский</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD012812-abs-0005">简体中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD012812-abs-0004" lang="en"> <h3>Home parenteral nutrition for people with bowel obstruction caused by cancer</h3> <p><b>What is the issue?</b><br/> People with advanced cancer within the abdominal cavity can develop blockages of the bowel that cannot be treated surgically. This may cause nausea and vomiting and an inability to absorb enough nutrition via the gut. An alternative to conventional feeding when the gut does not work, is feeding through a vein, known as parenteral nutrition (PN). This is often used in hospital to support patients when return of gut function is expected. However, it can also be considered as part of palliative treatment in advanced cancer when return of gut function is unlikely. </p> <p><b>Why is it important?</b><br/> PN in people with blockage of the bowel due to advanced, inoperable cancer is controversial. Treatments are largely limited to best supportive care and there are arguments for and against artificial feeding in this situation. There is some evidence that it may lengthen survival, but the treatment can be burdensome and risky for individuals where quality of life is a priority. </p> <p><b>We asked:</b><br/> Is PN effective in improving survival and quality of life in people with inoperable blockage of the bowel caused by advanced cancer? </p> <p><b>We found:</b><br/> The benefits of PN are uncertain as the evidence is of very low certainty, provided mainly by studies that only looked at people who received PN rather than comparing patients who received PN with those who did not. As we found no randomised controlled trials, we have included the results from 13 observational studies with a total of 721 participants. For 12 of the studies, there was only one relevant treatment group and no control group. Therefore, the results are only for people receiving PN and we have no information about those not receiving it. The average survival time for people on PN varied from three to 1278 days. Only three studies measured quality of life using a recognised measure. One study found quality of life improved and two studies found similar numbers of people both improved and deteriorated. However, the three studies monitored quality of life at different points in time and measured it in different ways. Side effects occurred in 12% of people in the eight studies that measured them. </p> <p><b>This means:</b><br/> Further research is needed to find out if PN is of benefit to people with an inoperable blockage of the bowel caused by advanced cancer. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD012812-sec-0104" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD012812-sec-0104"></div> <h3 class="title" id="CD012812-sec-0105">Implications for practice</h3> <section id="CD012812-sec-0105"> <p>Due to the very low certainty of evidence, we are very uncertain whether parenteral nutrition (PN) improves length and quality of life in people with malignant bowel obstruction (MBO). </p> </section> <h3 class="title" id="CD012812-sec-0106">Implications for research</h3> <section id="CD012812-sec-0106"> <p>The certainty of evidence in this review is very low and well‐designed prospective research is required. This is an area where it is considered ethically difficult to conduct randomised controlled trials, as noted above. However, it might be possible to randomise people with very short estimated survival intervals to simple intravenous fluid support (e.g. saline) or parenteral nutrition (PN). </p> <p>The majority of studies in this review were based on data from one centre and there was heterogeneity in the cancer diagnosis, and across the studies, in definitions of outcome measures. In order to gather sufficient data to answer the question regarding the impact of PN on survival and quality of life in MBO, prospective national or international cohort studies are required with centres working to the same protocol. Although, historically practice in the UK and other countries (e.g. Denmark) has differed from the practice in some countries such as USA and Italy in terms of percentage of patients receiving PN with advanced cancer, the UK has seen an increase use of PN in cases with advanced cancer (<a href="./references#CD012812-bbs2-0044" title="BrandtCF , HvistendahlM , NaimiRM , TriblerS , StaunM , BrøbechP , et al. Home parenteral nutrition in adult patients with chronic intestinal failure: the evolution over 4 decades in a tertiary referral center. Journal of Parenteral and Enteral Nutrition2017;41(7):1178‐87. ">Brandt 2017</a>; <a href="./references#CD012812-bbs2-0054" title="DibbM , SoopM , TeubnerA , ShafferJ , AbrahamA , CarlsonG , et al. Survival and nutritional dependence on home parenteral nutrition: three decades of experience from a single referral centre. Clinical Nutrition2017;36(2):570‐6. ">Dibb 2017</a>). Moreover, working from the same protocol would mitigate against differences across countries. To give a robust measure, survival could be measured from the time PN commences in addition to the time of discharge home. Investigation of quality of life would benefit from qualitative studies using robust methods, and quantitatively, the use of validated patient‐reported outcome measures and validated quality of life questionnaires (<a href="./references#CD012812-bbs2-0039" title="AaronsonNK , AhmedzaiS , BergmanB , BullingerM , CullA , DuezN J , et al. The European Organization for Research and Treatment of Cancer QLQ‐C30: a quality‐of‐life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute1993;85(5):365‐76. ">Aaronson 1993</a>; <a href="./references#CD012812-bbs2-0080" title="WilburnJ , McKennaSP , HeaneyA , RouseM , TaylorM , CulkinA , et al. Development and validation of the Parenteral Nutrition Impact Questionnaire (PNIQ), a patient‐centric outcome measure for Home Parenteral Nutrition. Clinical Nutrition2017;37:978‐83. ">Wilburn 2017</a>). It may be useful to investigate change in quality of life relative to baseline over the whole time period on PN, as it could produce an initial improvement which falls with advancing disease. In addition to investigating survival, there is a need to be able to assess prognosis in people with MBO. It could be argued that PN is adds little to patient survival if they succumb to their disease within two weeks of starting the treatment. However, most people could not survive without nutrition for more than 12 weeks and PN would seem beneficial in this instance. Currently, guidelines for the use of HPN are based on predicting survival (<a href="./references#CD012812-bbs2-0043" title="BozzettiF , ArendsJ , LundholmK , MicklewrightA , ZurcherG , MuscaritoliM . ESPEN Guidelines on parenteral nutrition: non‐surgical oncology. Clinical Nutrition2009;28:445‐54. ">Bozzetti 2009</a>). There is an urgent need to develop assessment tools to estimate prognosis in these patients to enable HPN to be offered to patients who are likely to live beyond the time required to organise home parenteral nutrition (HPN). </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD012812-sec-0022" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD012812-sec-0022"></div> <div class="table" id="CD012812-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Parenteral nutrition (PN) for inoperable malignant bowel obstruction (MBO)</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p><b>Home parenteral nutrition for people with inoperable bowel cancer</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p><b>Patient or population:</b> people with advanced cancer with inoperable malignant bowel obstruction (MBO)<br/> <b>Setting:</b> outpatient/home care<br/> <b>Intervention:</b> parenteral nutrition (PN) </p> </td> </tr> <tr class="table-header separated"> <td align="center" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Impact</b> </p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="center" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> </tr> <tr class="separated"> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Length of Survival</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>We are uncertain whether PN improves survival for patients with MBO receiving PN. It was not possible to combine data due to heterogeneity of cancer diagnosis and differing starting points for measuring survival.There was a wide variation of survival lengths reported in the studies, with median survival periods of 15 to 155 days (range 3 to 1278 days) and mean survival intervals of 85 to 164 days (range 8 to 1004 days). </p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>721</p> <p>(13 observational studies)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> Very Low <sup>1 2</sup> </p> </td> </tr> <tr class="separated"> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Quality of life</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>We are very uncertain if PN proves quality of life for patients with MBO receiving PN. Three studies used validated questionnaires. One of these studies found an improvement over three months for global quality of life. Two studies had a mixed picture; one measuring well‐being at one month and one overall quality of life at two months. Around half of participants showed no change, a quarter to a fifth deteriorated and a quarter to a third improved. </p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>188</p> <p>(3 observational studies)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> Very Low <sup>1 2</sup> </p> </td> </tr> <tr class="separated"> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adverse events</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>We are very uncertain about the impact of PN on adverse events of patients in MBO as the quality of the evidence was very low. There is limited evidence about adverse events. Although nine studies reported this outcome, data for individual patients could be extracted from eight studies and 32/260 (12%) patients developed a central venous catheter infection or were hospitalised for PN complications. </p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>280</p> <p>(9 observational studies)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> Very Low <sup>1 2</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate certainty:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low certainty:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low certainty:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="4"> <div class="table-footnote"> <p><sup>1</sup> The studies were down graded by three points as all of the studies were observational so patients were not allocated treatments at random and healthcare professionals and patients were not blinded to treatment received. Therefore, the studies are at very high risk of bias. </p> <p><sup>2</sup> Narrative synthesis conducted estimates not precise </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD012812-sec-0023" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD012812-sec-0023"></div> <section id="CD012812-sec-0024"> <h3 class="title" id="CD012812-sec-0024">Description of the condition</h3> <p>Malignant bowel obstruction (MBO) is caused by mechanical, vascular or neurological dysfunction of the small or large bowel (<a href="./references#CD012812-bbs2-0040" title="AnthonyT , BaronT , MercadanteS , GreenS , ChiD , CunninghamJ , et al. Report of the clinical protocol committee: development of randomized trials for malignant bowel obstruction. Journal of Pain and Symptom Management2007;34(1 Suppl):S49‐59. ">Anthony 2007</a>; <a href="./references#CD012812-bbs2-0073" title="RipamontiCI , EassonAM , GerdesH . Management of malignant bowel obstruction. European Journal of Cancer2008;44(8):1105‐15. ">Ripamonti 2008</a>). People with MBO experience symptoms such as nausea, vomiting, abdominal distention and pain (<a href="./references#CD012812-bbs2-0010" title="MercadanteS . Parenteral nutrition at home in advanced cancer patients. Journal of Pain and Symptom Management1995;10:476‐80. ">Mercadante 1995</a>). </p> <p>MBO occurs most often in people who have ovarian and gastrointestinal cancers. There is a wide variation in quoted incidence rates of MBO as data have been drawn from small retrospective and autopsy studies, with reported rates varying between 5% and 51% in women with ovarian cancer and 10% to 28% in people with gastrointestinal cancer (<a href="./references#CD012812-bbs2-0048" title="CousinsSE , TempestE , FeuerDJ . Surgery for the resolution of symptoms in malignant bowel obstruction in advanced gynaecological and gastrointestinal cancer. Cochrane Database of Systematic Reviews2016, Issue 1. [DOI: 10.1002/14651858.CD002764.pub2] ">Cousins 2016</a>). Other cancers that have been associated with MBO include bladder cancer (3% to 10%) and endometrial (womb) cancer (3% to 11%), as well as metastatic breast cancer and melanoma (<a href="./references#CD012812-bbs2-0055" title="FergusonHJ , FergusonCI , SpeakmanJ , IsmailT . Management of intestinal obstruction in advanced malignancy. Annals of Medicine and Surgery2015;4(3):264‐70. ">Ferguson 2015</a>). </p> <p>Some people with MBO have disease that is amenable to surgical treatment on first presentation (<a href="./references#CD012812-bbs2-0048" title="CousinsSE , TempestE , FeuerDJ . Surgery for the resolution of symptoms in malignant bowel obstruction in advanced gynaecological and gastrointestinal cancer. Cochrane Database of Systematic Reviews2016, Issue 1. [DOI: 10.1002/14651858.CD002764.pub2] ">Cousins 2016</a>; <a href="./references#CD012812-bbs2-0049" title="DanieleA , FerreroA , FusoL , MinecciaM , PorcellanaV , VassalloD , et al. Palliative care in patients with ovarian cancer and bowel obstruction. Supportive Care in Cancer2015;23(11):3157‐63. ">Daniele 2015</a>). However, people who experience recurrences of MBO are unlikely to benefit from further surgery, at which point they are deemed to have inoperable MBO (<a href="./references#CD012812-bbs2-0050" title="DeBernardo , R . Surgical management of malignant bowel obstruction: strategies toward palliation of patients with advanced cancer. Current Oncology Reports2009;11(4):287‐92. ">DeBernardo 2009</a>; <a href="./references#CD012812-bbs2-0068" title="MercadanteS , CasuccioA , MangioneS . Medical treatment for inoperable malignant bowel obstruction: a qualitative systematic review. Journal of Pain and Symptom Management2007;33(2):217‐23. ">Mercadante 2007</a>). Rates of survival in the literature for people with MBO range from less than a month to up to 12 months; this wide range is due to differences in patient selection and whether the MBO resolves, treatments and definitions of survival (<a href="./references#CD012812-bbs2-0010" title="MercadanteS . Parenteral nutrition at home in advanced cancer patients. Journal of Pain and Symptom Management1995;10:476‐80. ">Mercadante 1995</a>; <a href="./references#CD012812-bbs2-0071" title="PorzioG , AielliF , VernaL , GallettiB , RazaviGS , FicorellaC . Can malignant bowel obstruction in advanced cancer patients be treated at home?. Supportive Care in Cancer2011;19(3):431‐3. ">Porzio 2011</a>). However, some studies have quoted an average survival of between two and three months (<a href="./references#CD012812-bbs2-0058" title="HardyJ , LingJ , MansiJ , IsaacsR , BlissJ , A'HernR , et al. Pitfalls in placebo‐controlled trials in palliative care: dexamethasone for the palliation of malignant bowel obstruction. Palliative Medicine1998;12(6):437‐42. ">Hardy 1998</a>; <a href="./references#CD012812-bbs2-0066" title="LavalG , GirardierJ , LassauniereJM , LeducB , HaondC , Schaerer , R . The use of steroids in the management of inoperable intestinal obstruction in terminal cancer patients: do they remove the obstruction?. Palliative Medicine2000;14(1):3‐10. ">Laval 2000</a>). People with inoperable MBO are managed medically using corticosteroids, antiemetics and antisecretory agents (<a href="./references#CD012812-bbs2-0055" title="FergusonHJ , FergusonCI , SpeakmanJ , IsmailT . Management of intestinal obstruction in advanced malignancy. Annals of Medicine and Surgery2015;4(3):264‐70. ">Ferguson 2015</a>). For people with uncontrolled vomiting, a naso‐gastric tube or venting gastrostomy may be considered (<a href="./references#CD012812-bbs2-0045" title="GemloB , RaynerAA , LewisB , WongA , VieleCS , UngarettiJR , et al. Home support of patients with end‐stage malignant bowel obstruction using hydration and venting gastrostomy. American Journal of Surgery1986;152(1):100‐4. ">Brett 1986</a>). People with inoperable MBO are unable to maintain adequate oral intake and may benefit from parenteral nutrition (PN). </p> </section> <section id="CD012812-sec-0025"> <h3 class="title" id="CD012812-sec-0025">Description of the intervention</h3> <p>PN is the provision of macronutrients, micronutrients, electrolytes and fluid infused as an intravenous solution. Individuals are assessed for their energy, nutrient and fluid requirements and PN solutions are then tailored to these requirements (<a href="./references#CD012812-bbs2-0042" title="BielawskaB , AllardJP . Parenteral nutrition and intestinal failure. Nutrients2017;9(5):E446. ">Bielawska 2017</a>). This solution is usually administrated to a patient during the night, over 10 to 15 hours, depending on individual tolerance, nutrition and fluid requirements (<a href="./references#CD012812-bbs2-0079" title="WantenG , CalderPC , ForbesA . Managing adult patients who need home parenteral nutrition. BMJ2011;342:d1447. ">Wanten 2011</a>). Short‐term PN may be initially administrated via a peripheral or central vein. However, patients receive long‐term PN and home parenteral nutrition (HPN) via a central venous catheter (<a href="./references#CD012812-bbs2-0065" title="LaiNM , ChaiyakunaprukN , LaiNA , O'RiordanE , PauWSC , SaintS . Catheter impregnation, coating or bonding for reducing central venous catheter‐related infections in adults. Cochrane Database of Systematic Reviews2016, Issue 3. [DOI: 10.1002/14651858.CD007878.pub3] ">Lai 2016</a>; <a href="./references#CD012812-bbs2-0070" title="PittirutiM , HamiltonH , BiffiR , MacFieJ , PertkiewiczM , ESPEN . ESPEN guidelines on parenteral nutrition: central venous catheters (access, care, diagnosis and therapy of complications). Clinical Nutritrion2009;28(4):365‐77. ">Pittiruti 2009</a>). This Cochrane Review will focus on such nutritional support. </p> </section> <section id="CD012812-sec-0026"> <h3 class="title" id="CD012812-sec-0026">How the intervention might work</h3> <p>In PN, nutrients and fluids are delivered to patients via the venous route. People with MBO are able to tolerate limited, if any, oral or enteral nutrition (delivery of nutrients into the gastrointestinal tract by means of a tube), and thus are unable to meet their nutritional requirements orally. PN therefore provides a method for these patients to receive nutrients and fluid that otherwise would be inaccessible to them. PN may improve survival (<a href="./references#CD012812-bbs2-0016" title="BrardL , WeitzenS , Strubel‐LaganSL , SwamyN , GordinierME , MooreRG , et al. The effect of total parenteral nutrition on the survival of terminally ill ovarian cancer patients. Gynecologic Oncology2006;103:176‐80. ">Brard 2006</a>). Median survival in people with MBO who receive PN is around 80 days (<a href="./references#CD012812-bbs2-0001" title="Abu‐RustumNR , BarakatRR , VenkatramanE , SpriggsD . Chemotherapy and total parenteral nutrition for advanced ovarian cancer with bowel obstruction. Gynecologic Oncology1997;64:493‐5. ">Abu‐Rustum 1997</a>; <a href="./references#CD012812-bbs2-0029" title="NaghibiM , SmithTR , EliaM . A systematic review with meta‐analysis of survival, quality of life and cost‐effectiveness of home parenteral nutrition in patients with inoperable malignant bowel obstruction. Clinical Nutrition2015;34:825‐37. ">Naghibi 2015</a>). The treatment may also improve quality of life and there have been reports of symptomatic improvement after starting PN (<a href="./references#CD012812-bbs2-0010" title="MercadanteS . Parenteral nutrition at home in advanced cancer patients. Journal of Pain and Symptom Management1995;10:476‐80. ">Mercadante 1995</a>). </p> </section> <section id="CD012812-sec-0027"> <h3 class="title" id="CD012812-sec-0027">Why it is important to do this review</h3> <p>The provision of PN in patients undergoing palliative care is somewhat controversial. There is a fundamental human right to food, which has been recognised by the United Nations (UN) (<a href="./references#CD012812-bbs2-0077" title="United Nations GeneralAssembly . Universal Declaration of Human Rights. 1948. www.refworld.org/docid/3ae6b3712c.html (accessed 21 February 2017). ">UN 1948</a>). However, there are clinical and ethical arguments for and against the administration of PN, related to what the person wants, their symptoms and clinical evidence. There is some evidence of benefit in terms of survival, but the treatment is costly to the healthcare provider and may be burdensome for patients (<a href="./references#CD012812-bbs2-0001" title="Abu‐RustumNR , BarakatRR , VenkatramanE , SpriggsD . Chemotherapy and total parenteral nutrition for advanced ovarian cancer with bowel obstruction. Gynecologic Oncology1997;64:493‐5. ">Abu‐Rustum 1997</a>; <a href="./references#CD012812-bbs2-0016" title="BrardL , WeitzenS , Strubel‐LaganSL , SwamyN , GordinierME , MooreRG , et al. The effect of total parenteral nutrition on the survival of terminally ill ovarian cancer patients. Gynecologic Oncology2006;103:176‐80. ">Brard 2006</a>; <a href="./references#CD012812-bbs2-0053" title="DiBaiseJK , ScolapioJS . Home parenteral and enteral nutrition. Gastroenterology Clinics of North America2007;36(1):123‐44. ">DiBaise 2007</a>; <a href="./references#CD012812-bbs2-0026" title="HodaD , JatoiA , BurnesJ , LoprinziC , KellyD . Should patients with advanced, incurable cancers ever be sent home with total parenteral nutrition? A single institution's 20‐year experience. Cancer2005;103:863‐8. ">Hoda 2005</a>; <a href="./references#CD012812-bbs2-0029" title="NaghibiM , SmithTR , EliaM . A systematic review with meta‐analysis of survival, quality of life and cost‐effectiveness of home parenteral nutrition in patients with inoperable malignant bowel obstruction. Clinical Nutrition2015;34:825‐37. ">Naghibi 2015</a>; <a href="./references#CD012812-bbs2-0031" title="PasanisiF , OrbanA , ScalfiL , AlfonsiL , SantarpiaL , ZurloE , et al. Predictors of survival in terminal‐cancer patients with irreversible bowel obstruction receiving home parenteral nutrition. Nutrition2001;17:581‐4. ">Pasanisi 2001</a>). There is a lack of consensus on the role of PN in this patient group which is reflected in varying rates worldwide of people with active cancer receiving PN (<a href="./references#CD012812-bbs2-0061" title="HowardL , AmentM , FlemingCR , ShikeM , SteigerE . Current use and clinical outcome of home parenteral and enteral nutrition therapies in the United States. Gastroenterology1995;109(2):355‐65. ">Howard 1995</a>; <a href="./references#CD012812-bbs2-0075" title="SmithT , NaghibiM . BANS report 2016. Artificial nutrition support in the UK 2005–2015. Adult home parenteral nutrition and home intravenous fluids.. http://www.bapen.org.uk/images/pdfs/reports/bans‐report‐2016.pdf (accessed 06 Feb 2018). ">Smith 2016</a>). In the USA, people with cancer were the largest proportion (42%) of people receiving HPN from 1985 to 1992, although current data show that people with short‐bowel syndrome are now the largest group receiving HPN (<a href="./references#CD012812-bbs2-0062" title="HowardL . Home parenteral nutrition: survival, cost, and quality of life. Gastroenterology2006;130(2):S52‐9. ">Howard 2006</a>; <a href="./references#CD012812-bbs2-0081" title="WinklerMF , DiMaria‐GhaliliRA , GuenterP , ResnickHE , RobinsonL , LymanB , et al. Characteristics of a cohort of home parenteral nutrition patients at the time of enrollment in the Sustain Registry. Journal of Parenteral and Enteral Nutrition2016;40(8):1140‐9. ">Winkler 2016</a>). In Europe as a whole, cancer is the primary indication for HPN in 39% of cases, although there are variations in different European countries for example, Denmark 8%, Belgium 23%, Spain, 39% and the Netherlands 60% (<a href="./references#CD012812-bbs2-0041" title="BakkerH , BozzettiF , StaunM , Leon‐SanzM , HebuterneX , PertkiewiczM , et al. Home parenteral nutrition in adults: a European multicentre survey in 1997. ESPEN‐Home Artificial Nutrition Working Group. Clinical Nutrition1999;18(3):135‐40. ">Bakker 1999</a>). In the UK, this figure is 27% of patients (<a href="./references#CD012812-bbs2-0075" title="SmithT , NaghibiM . BANS report 2016. Artificial nutrition support in the UK 2005–2015. Adult home parenteral nutrition and home intravenous fluids.. http://www.bapen.org.uk/images/pdfs/reports/bans‐report‐2016.pdf (accessed 06 Feb 2018). ">Smith 2016</a>); all centres providing HPN to patients, including those with cancer, are expected to comply with the British Intestinal Failure Alliance Position statement (<a href="./references#CD012812-bbs2-0046" title="British Intestinal FailureAlliance . British Intestinal Failure Alliance (BIFA) position statement 2016: home parenteral nutrition. British Association of Parenteral and Enteral Nutrition2016; Vol. http://bit.ly/2qfFEbW (accessed 18 April 2018). ">British Intestinal Failure Alliance 2016</a>) . This Cochrane Review examines the potential benefits and disadvantages of PN for people with cancer focusing on benefits, including survival, quality of life or both, and disadvantages including any adverse events that result from the treatment. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD012812-sec-0028" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD012812-sec-0028"></div> <p>To assess the effectiveness of home parenteral nutrition (HPN) in improving survival and quality of life in people with inoperable MBO. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD012812-sec-0029" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD012812-sec-0029"></div> <section id="CD012812-sec-0030"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD012812-sec-0031"> <h4 class="title">Types of studies</h4> <section id="CD012812-sec-0032"> <h5 class="title">Quantitative</h5> <p>We did not envisage identification of randomised controlled trials (RCTs) due to sparse data and therefore we included non‐randomised studies,quasi‐RCTs, non‐randomised controlled trials, prospective and retrospective cohort studies, including single‐arm studies and case series of more than five participants. </p> <p>We excluded case series with less than five participants.</p> </section> <section id="CD012812-sec-0033"> <h5 class="title">Qualitative</h5> <p>We planned to include any qualitative studies (phenomenological, ethnographic or grounded theory) that used recognised methods of qualitative data collection (interview, observation, focus group) and analysis. </p> </section> </section> <section id="CD012812-sec-0034"> <h4 class="title">Types of participants</h4> <section id="CD012812-sec-0035"> <h5 class="title">Inclusion criteria</h5> <p>The participants fulfilled each of the following criteria.</p> <p> <ul id="CD012812-list-0001"> <li> <p>People over 16 years of age with inoperable MBO.</p> </li> <li> <p>Receiving PN via a central venous catheter.</p> </li> <li> <p>Receiving or planned to receive PN at home.</p> </li> <li> <p>No curative treatment: we deemed any chemotherapy or radiotherapy in this setting as palliative. </p> </li> </ul> </p> </section> <section id="CD012812-sec-0036"> <h5 class="title">Exclusion criteria</h5> <p> <ul id="CD012812-list-0002"> <li> <p>Bowel obstruction caused by pseudomyxoma peritonei and desmoid tumours as these tumours are slow growing and individuals have more favourable survival. </p> </li> <li> <p>Receiving PN through a peripheral vein.</p> </li> <li> <p>Receiving only intravenous fluids that lack protein and calories.</p> </li> <li> <p>Studies with &lt; 70% participants receiving PN for inoperable MBO, unless we could extract data on MBO participants. </p> </li> </ul> </p> <p>If it was unclear whether the participants met the inclusion criteria based on the published data, we contacted the study authors for further information. If we were still unable to establish if the study met the criteria, the study was excluded. </p> </section> </section> <section id="CD012812-sec-0037"> <h4 class="title">Types of interventions</h4> <section id="CD012812-sec-0038"> <h5 class="title">Intervention</h5> <p> <ul id="CD012812-list-0003"> <li> <p>Treatment with PN delivered through a central venous catheter.</p> </li> </ul> </p> </section> <section id="CD012812-sec-0039"> <h5 class="title">Control</h5> <p> <ul id="CD012812-list-0004"> <li> <p>No PN support.</p> </li> <li> <p>Other nutritional interventions, such as elemental diet or intravenous fluids alone.</p> </li> </ul> </p> </section> </section> <section id="CD012812-sec-0040"> <h4 class="title">Types of outcome measures</h4> <section id="CD012812-sec-0041"> <h5 class="title">Primary outcomes</h5> <p> <ul id="CD012812-list-0005"> <li> <p>Length of survival from diagnosis of MBO or, if not given, implementation of PN until death from any cause. </p> </li> <li> <p>Quality of life: any measure of quality of life completed by participants, carers or an independent rater. However, we gave preference to validated questionnaires, e.g. the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ‐C30). </p> </li> </ul> </p> </section> <section id="CD012812-sec-0042"> <h5 class="title">Secondary outcomes</h5> <p> <ul id="CD012812-list-0006"> <li> <p>Measurement of gastrointestinal symptoms e.g. nausea, vomiting, abdominal distention, diarrhoea, pain on eating using a validated questionnaire, or recorded in a dichotomous form i.e. present/absent. </p> </li> <li> <p>Any measure of nutritional status, such as anthropometry or validated measures e.g. subjective global assessment. </p> </li> <li> <p>Qualitative reports of quality of life or symptoms.</p> </li> <li> <p>Where multiple time points were recorded, we gave priority to baseline, one month, three months and six months observations. </p> </li> <li> <p>Adverse events: sepsis caused by central venous catheter infection/hospitalisation due to HPN complications (other catheter complications, fluid overload including peripheral oedema or ascites), were reported as present or absent. </p> </li> <li> <p>Adverse events if they occurred at any time point during the administration of PN.</p> </li> <li> <p>Health economic outcomes: cost of treatment, any measurement of cost‐effectiveness of treatment such as quality adjusted life year. </p> </li> </ul> </p> </section> </section> </section> <section id="CD012812-sec-0043"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD012812-sec-0044"> <h4 class="title">Electronic searches</h4> <p>We identified relevant studies by conducting searches (January 2018) of the following electronic databases. </p> <p> <ul id="CD012812-list-0007"> <li> <p>Cochrane Central Register of Controlled Trials (CENTRAL, 2018, Issue 1)</p> </li> <li> <p>Ovid MEDLINE (1946 to January 2018)</p> </li> <li> <p>Embase (1980 to January 2018)</p> </li> </ul> </p> <p>We also searched Bristish Nursing Index (BNI), Cumulative Index to Nursing and Allied Health Literature (CINAHL), Web of Science and NHS Economic Evaluation Database (NHS EED) and Health Technology Assessment (HTA) in January 2018. We conducted a generic search for malignant bowel obstruction (MBO) and parenteral nutrition (PN) which would include qualitative and quantitative studies. </p> <p>We searched for any currently recruiting trials in ClinicalTrials.gov (<a href="http://clinicaltrials.gov/" target="_blank">http://clinicaltrials.gov/</a>) and in the World Health Organization (WHO) International Clinical Trials Registry Platform (ICTRP) search portal (<a href="http://apps.who.int/trialsearch/" target="_blank">http://apps.who.int/trialsearch/</a>). We contacted the authors of any trials found which should have completed but for which the results were not published. </p> <p>The detailed search strategy for MEDLINE is in <a href="./appendices#CD012812-sec-0109">Appendix 1</a>, Embase in <a href="./appendices#CD012812-sec-0110">Appendix 2</a> and CENTRAL in <a href="./appendices#CD012812-sec-0111">Appendix 3</a>. </p> </section> <section id="CD012812-sec-0045"> <h4 class="title">Searching other resources</h4> <p>We handsearched selected articles to identify any other relevant articles. We also found all included articles on PubMed and searched for other pertinent articles using the ‘Similar articles’ feature. </p> </section> </section> <section id="CD012812-sec-0046"> <h3 class="title" id="CD012812-sec-0046">Data collection and analysis</h3> <p>We followed the guidance of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD012812-bbs2-0060" title="HigginsJP , GreenS , editor(s) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011</a>). We entered data into Review Manager (<a href="./references#CD012812-bbs2-0072" title="Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>). Although we planned to use SPSS (version 23) (<a href="./references#CD012812-bbs2-0064" title="IBMCorp . SPSS statistics for windows. version 23.0. Armonk, NY: IBM corp, 2015. ">IBM corp 2015</a>), statistical analysis was not feasible in view of the data set. </p> <section id="CD012812-sec-0047"> <h4 class="title">Selection of studies</h4> <p>We downloaded all titles and abstracts retrieved by electronic searching to EndNote and removed duplicates. Two review authors (AMS, JS, AC, SL or CT) independently examined the remaining references and excluded those studies that clearly did not meet the inclusion criteria. JS obtained copies of the full‐text of potentially relevant references. Independently, two review authors (AMS and JS) assessed the eligibility of the retrieved reports/publications. We resolved any disagreement through discussion. If it was unclear whether a study met the inclusion criteria, it was discussed with a third review author (SB). We identified and excluded duplicate reports and collated multiple reports of the same study so that each study rather than each report was the unit of interest in the review. We recorded the selection process in sufficient detail to complete a PRISMA flow diagram and a <a href="./references#CD012812-sec-0119" title="">Characteristics of included studies</a> table (<a href="./references#CD012812-bbs2-0067" title="LiberatiA , AltmanDG , TetzlaffJ , MulrowC , GøtzschePC , IoannidisJP , et al. The PRISMA statement for reporting systematic reviews and meta‐analyses of studies that evaluate health care interventions: explanation and elaboration. PLOS Medicine2009;6(7):e1000100. ">Liberati 2009</a>). </p> </section> <section id="CD012812-sec-0048"> <h4 class="title">Data extraction and management</h4> <p>Two review authors (AMS, JS or LH) independently extracted study characteristics and outcome data from included studies using a piloted data collection form. We noted in the <a href="./references#CD012812-sec-0119" title="">Characteristics of included studies</a> table if outcome data were not reported in a usable way. We resolved disagreements by consensus and did not need to involve a third review author (SB). One author (JS) transferred data to the RevMan 5 file (<a href="./references#CD012812-bbs2-0072" title="Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>). We double‐checked that data had been entered correctly by comparing the data presented in the systematic review with the study reports. A second review author (AMS) did a 'spot‐check' to assess the accuracy of the study characteristics against the study report. </p> <p>For included studies, we extracted the following data.</p> <p> <ul id="CD012812-list-0008"> <li> <p>Author, year of publication and journal citation (including language).</p> </li> <li> <p>Country.</p> </li> <li> <p>Setting.</p> </li> <li> <p>Inclusion and exclusion criteria.</p> </li> <li> <p>Study design, methodology.</p> </li> <li> <p>Source of funding.</p> </li> <li> <p>Study population:</p> <ul id="CD012812-list-0009"> <li> <p>total number enrolled;</p> </li> <li> <p>age;</p> </li> <li> <p>co‐morbidities;</p> </li> <li> <p>performance status at diagnosis of MBO;</p> </li> <li> <p>cancer diagnosis including, if indicated, staging, number and sites of metastasis and treatments received; </p> </li> <li> <p>any data on confounding factors which might improve a patient's symptoms of MBO such as administration of steroids, antisecretory medication or prokinetics. </p> </li> </ul> </li> <li> <p>Intervention details:</p> <ul id="CD012812-list-0010"> <li> <p>any details of nutrition received: PN nutritional content, number of times given in a week and whether any other oral intake was recorded; </p> </li> <li> <p><a href="#CD012812-sec-0041">Primary outcomes</a> and <a href="#CD012812-sec-0042">Secondary outcomes</a> as detailed above. </p> </li> </ul> </li> <li> <p>Comparison:</p> <ul id="CD012812-list-0011"> <li> <p>whether any oral intake was recorded or intravenous fluids administered;</p> </li> <li> <p><a href="#CD012812-sec-0041">Primary outcomes</a> and <a href="#CD012812-sec-0042">Secondary outcomes</a> as detailed above. </p> </li> </ul> </li> </ul> <ul id="CD012812-list-0012"> <li> <p>Risk of bias in study (see <a href="#CD012812-sec-0049">Assessment of risk of bias in included studies</a> section below). </p> </li> <li> <p>Duration of follow‐up.</p> </li> <li> <p>We noted the time points at which outcomes were collected and reported.</p> </li> </ul> </p> <p>We planned to extract results as follows.</p> <p> <ul id="CD012812-list-0013"> <li> <p>For time‐to‐event data (e.g. survival), we planned to extract the log of the hazard ratio [log(HR)] and its standard error (SE) from study reports. If these were not reported, we planned to estimate the log (HR) and its SE using the methods of <a href="./references#CD012812-bbs2-0069" title="ParmarMK , TorriV , StewartL . Extracting summary statistics to perform meta‐analyses of the published literature for survival endpoints. Statistics in Medicine1998;17(24):2815‐34. ">Parmar 1998</a>. </p> </li> <li> <p>For dichotomous outcomes (e.g. gastrointestinal symptoms) we planned to extract the number of participants in each treatment arm who experienced the outcome of interest and the number of participants assessed at the endpoint, in order to estimate a risk ratio (RR). </p> </li> <li> <p>For continuous outcomes (e.g. quality of life measures), we planned to extract the final value and standard deviation (SD) of the outcome of interest and the number of participants assessed at endpoint in each treatment arm at the end of follow‐up, in order to estimate the mean difference (MD) between treatment arms and its SE. </p> </li> </ul> </p> <p>However, it was not possible to conduct any of these analyses as most studies only had a treatment group and no control, and for the one study with a comparator insufficient details were given. </p> </section> <section id="CD012812-sec-0049"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>We assessed and reported on the methodological risk of bias of included studies in accordance with the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD012812-bbs2-0060" title="HigginsJP , GreenS , editor(s) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011</a>), which recommends the explicit reporting of the following individual elements. </p> <p> <ul id="CD012812-list-0014"> <li> <p>Selection bias: random sequence generation and allocation concealment.</p> </li> <li> <p>Performance bias: blinding of participants and personnel.</p> </li> <li> <p>Detection bias: blinding of outcome assessment.</p> </li> <li> <p>Attrition bias: incomplete outcome data, which is less than 80% reported for primary outcomes. </p> </li> <li> <p>Reporting bias: selective reporting of outcomes.</p> </li> <li> <p>Other: any other risk of bias.</p> </li> </ul> </p> <p>We assessed the risk of bias in non‐randomised controlled studies in accordance with the additional criteria below. </p> <p> <ul id="CD012812-list-0015"> <li> <p>Details of criteria for assignment of participants to treatments:</p> <ul id="CD012812-list-0016"> <li> <p>low risk of bias: yes;</p> </li> <li> <p>high risk of bias: no;</p> </li> <li> <p>unclear risk of bias: if no details provided.</p> </li> </ul> </li> <li> <p>Comparability of treatment groups: no differences between the two groups or differences controlled for, in particular with reference to age, performance status at diagnosis of MBO, cancer diagnosis, stage, grade, metastasis: </p> <ul id="CD012812-list-0017"> <li> <p>low risk of bias: if at least two of these characteristics were reported and any reported differences were controlled for; </p> </li> <li> <p>high risk of bias: if the two groups differed and differences were not controlled for; </p> </li> <li> <p>unclear risk of bias: if fewer than two of these characteristics were reported even if there were no other differences between the groups, and other characteristics had been controlled for. </p> </li> </ul> </li> </ul> </p> <p>We defined the following endpoint as a subjective outcome: quality of life.</p> <p>We defined the following endpoints as objective outcomes: survival and adverse events (hospitalisation due to PN).. </p> </section> <section id="CD012812-sec-0050"> <h4 class="title">Measures of treatment effect</h4> <p>We intended to use the following measures of the effect of treatment:</p> <p> <ul id="CD012812-list-0018"> <li> <p>For time‐to‐event data, we intended to use the HR.</p> </li> <li> <p>For dichotomous outcomes, we planned to analyse data based on the number of events and the number of participants assessed in the intervention and comparison groups. We planned to use these to calculate the RR and 95% confidence interval (CI). </p> </li> <li> <p>For continuous outcomes, we planned to analyse data based on the mean, SD and number of participants assessed for both the intervention and comparison groups to calculate MD between treatment arms with a 95% CI. If the MD was reported without individual group data, we intended to use this to report the study results. If more than one study measured the same outcome using different tools, we planned to calculate the standardised mean difference (SMD) and 95% CI using the inverse variance method in RevMan 5 (<a href="./references#CD012812-bbs2-0072" title="Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>). </p> </li> </ul> </p> <p>It was not possible to undertake these calculations as most studies only had a treatment group and no control, and for the one study with a comparator insufficient details were given. </p> </section> <section id="CD012812-sec-0051"> <h4 class="title">Unit of analysis issues</h4> <p>We used participants as the unit of analysis. In the case of repeated measurements, we recorded data at one month, three months and six months. </p> </section> <section id="CD012812-sec-0052"> <h4 class="title">Dealing with missing data</h4> <p>We contacted study authors to obtain missing data (participant, outcome or summary data). For participant data, we conducted evidence synthesis on an intention‐to‐treat basis. We reported on the levels of loss to follow‐up and assessed this as a source of potential bias. </p> <p>For missing outcome or summary data, we have not imputed missing data and we have reported any assumptions in the review. </p> </section> <section id="CD012812-sec-0053"> <h4 class="title">Assessment of heterogeneity</h4> <p>The studies included participants with a range of primary cancers so there was substantial clinical heterogeneity between included studies therefore meta‐analysis and a statistical assessment of heterogeneity were not possible. If studies had been similar enough based on consideration of primary cancer to allow pooling of data using meta‐analysis, we planned to assess the degree of heterogeneity by: </p> <p> <ul id="CD012812-list-0019"> <li> <p>visual inspection of forest plots;</p> </li> <li> <p>estimation of the percentage heterogeneity (I² statistic) between trials which cannot be ascribed to sampling variation (<a href="./references#CD012812-bbs2-0059" title="HigginsJPT , ThompsonSG , DeeksJJ , AltmanDG . Measuring inconsistency in meta‐analysis. BMJ2003;357(7414):557‐60. ">Higgins 2003</a>); </p> </li> <li> <p>formal statistical test of the significance of the heterogeneity (Chi² test) (<a href="./references#CD012812-bbs2-0051" title="DeeksJJ , AltmanDG , BradburnMJ . Statistical methods for examining heterogeneity and combining results from several studies in meta‐analysis. BMJ2001;323(7306):224‐8. ">Deeks 2001</a>). </p> </li> </ul> </p> <p>We intended to regard heterogeneity to be substantial if the I² statistic value was greater than 30% and either the T² value was greater than zero, or there was a low P value (&lt; 0.10) in the Chi² test for heterogeneity. </p> <p>Given the heterogeneity of the data, we used a narrative approach to synthesise the data. </p> </section> <section id="CD012812-sec-0054"> <h4 class="title">Assessment of reporting biases</h4> <p>It was not possible to explore publication bias using a funnel plot (<a href="./references#CD012812-bbs2-0060" title="HigginsJP , GreenS , editor(s) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011</a>). </p> </section> <section id="CD012812-sec-0055"> <h4 class="title">Data synthesis</h4> <section id="CD012812-sec-0056"> <h5 class="title">Quantitative synthesis</h5> <p>We intended to perform a meta‐analysis using the fixed‐effect model in RevMan 5 (<a href="./references#CD012812-bbs2-0072" title="Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>) if a sufficient number of clinically similar studies (in terms of primary cancer diagnosis) were available to ensure meaningful conclusions, and if statistical heterogeneity was low (I² statistic &lt; 30%). If there was variability in the primary cancer diagnosis of included studies, or if statistical heterogeneity was substantial (I² statistic &gt; 30%), we planned to use the random‐effects model with inverse variance for meta‐analysis (<a href="./references#CD012812-bbs2-0052" title="DerSimonianR , LairdN . Meta‐analysis in clinical trials. Controlled Clinical Trials1986;7(3):177‐88. ">DerSimonian 1986</a>). We planned to only include non‐randomised studies with two or more comparison groups if statistical adjustments were made for baseline imbalances. </p> <p> <ul id="CD012812-list-0020"> <li> <p>For time‐to‐event data, we planned to pool HRs using the generic inverse variance facility in RevMan 5 (<a href="./references#CD012812-bbs2-0072" title="Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>). </p> </li> <li> <p>For any dichotomous outcomes, we intended to calculate the RR for each study and we would then have pooled these. </p> </li> <li> <p>For continuous outcomes, we planned to pool the MD between the treatment arms at the end of follow‐up, if all trials measured the outcome on the same scale; otherwise we intended to pool standard mean difference (SMD) values. </p> </li> </ul> </p> <p>However, we were unable to pool the data statistically using meta‐analysis, therefore we conducted a narrative synthesis of the results. </p> </section> <section id="CD012812-sec-0057"> <h5 class="title">Qualitative synthesis</h5> <p>It was not possible for us to undertake a meta‐synthesis as no qualitative studies were identified. </p> </section> </section> <section id="CD012812-sec-0058"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We reported on different lengths of survival of participants with different types of cancer where these data were available. </p> </section> <section id="CD012812-sec-0059"> <h4 class="title">Sensitivity analysis</h4> <p>Insufficient numbers of studies met the review inclusion criteria to undertake a sensitivity analysis to determine if the findings were altered by excluding trials of high risk of bias as determined by the Cochrane 'Risk of bias' tool (<a href="./references#CD012812-bbs2-0060" title="HigginsJP , GreenS , editor(s) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011</a>). </p> <p>We did not find any qualitative studies, therefore assessing whether any one article was adding disproportionately to the findings was not required. </p> <section id="CD012812-sec-0060"> <h5 class="title">'Summary of findings' table</h5> <p>To interpret the findings and to rate the certainty of the evidence, two review authors (AMS and JS) used the GRADE approach (<a href="./references#CD012812-bbs2-0057" title="GuyattG , OxmanAD , AklEA , KunzR , VistG , BrozekJ , et al. GRADE guidelines: 1 introduction ‐ GRADE evidence profiles and summary of findings tables. Journal of Clinical Epidemiology2011;64(4):383‐94. [DOI: 10.1016/j.jclinepi.2010.04.026] ">Guyatt 2011</a>) and the guidelines provided in Chapter 12.2 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD012812-bbs2-0074" title="SchünemannH , OxmanA , VistG , HigginsJ , DeeksJ , GlasziouP , GuyattG . Chapter 12: Interpreting results and drawing conclusions. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Schünemann 2011</a>). First, we analysed the overall certainty of evidence for each outcome individually, downgrading the evidence from 'low' as all the studies were observational to 'very low' depending on the risk of bias, indirectness of evidence, inconsistency, imprecision of effect estimates or potential publication bias. Afterwards, we took this into account to draft the review conclusions. We used the GRADEpro GDT software to produce a 'Summary of findings' table with the results of this analysis (<a href="./references#CD012812-bbs2-0056" title="EvidencePrime , Inc . GRADEpro Guideline Development Tool. Hamilton (ON): McMaster University, 2015. ">GRADEpro 2015</a>). We considered the following outcomes. </p> <p> <ul id="CD012812-list-0021"> <li> <p>Survival.</p> </li> <li> <p>Quality of life measured on a validated questionnaire.</p> </li> <li> <p>Adverse events of central venous catheter infection or hospitalisation due to PN.</p> </li> </ul> </p> <p>Meta‐analysis was not possible, so we have presented results in a narrative ‘Summary of findings’ table format, such as that used by <a href="./references#CD012812-bbs2-0047" title="ChanR , WebsterJ , MarquartL . Information interventions for orienting patients and their carers to cancer care facilities. Cochrane Database of Systematic Reviews2011, Issue 12. [DOI: 10.1002/14651858.CD008273.pub2] ">Chan 2011</a> (<a href="./full#CD012812-tbl-0001">summary of findings Table for the main comparison</a>). </p> </section> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD012812-sec-0061" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD012812-sec-0061"></div> <section id="CD012812-sec-0062"> <h3 class="title">Description of studies</h3> <section id="CD012812-sec-0063"> <h4 class="title">Results of the search</h4> <p>Combining the references and removing the duplicates produced a list of 3114 references. We conducted further electronic searches on BNI, CINAHL, Web of Science, NHS Economic Evaluation, Health Technology Assessment, ClinicalTrials.gov and the World Health Organization (WHO) International Clinical Trials Registry Platform. This uncovered a further 2120, which was reduced to 1876 once duplicates were removed. The resulting 4990 references were screened for relevance by two review authors. The following authors screened studies: AMS, JS, CT, AC and SL. This identified 146 references that were potentially eligible for inclusion in the review. Two review authors( AMS and JS) excluded 111 studies as not meeting the inclusion criteria on full‐text review; one study which should have completed could not be found in full text and we had no response from the contact author,further details can be found in <a href="./references#CD012812-sec-0121" title="">Characteristics of ongoing studies</a>. We excluded a further 24 studies following discussion with a third review author (SB). Two additional references were found; one from using the similar articles feature on Pubmed and one from screening the reference lists of other studies. A total of 13 studies with a total of 721 participants were included in the review. </p> <p>For further details, please see the PRISMA diagram <a href="#CD012812-fig-0001">Figure 1</a> </p> <div class="figure" id="CD012812-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD012812-fig-0001" src="/cdsr/doi/10.1002/14651858.CD012812.pub2/media/CDSR/CD012812/image_n/nCD012812-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> </section> <section id="CD012812-sec-0064"> <h4 class="title">Included studies</h4> <p>See <a href="./references#CD012812-sec-0119" title="">Characteristics of included studies</a> </p> <section id="CD012812-sec-0065"> <h5 class="title">Design</h5> <p>We included 13 studies in the review. Six studies were conducted prospectively (<a href="./references#CD012812-bbs2-0003" title="BozzettiF , CozzaglioL , BiganzoliE , ChiavennaG , DeCiccoM , DonatiD , et al. Quality of life and length of survival in advanced cancer patients on home parenteral nutrition. Clinical Nutrition2002;21:281‐8. ">Bozzetti 2002</a>; <a href="./references#CD012812-bbs2-0004" title="ChermeshI , MashiachT , AmitA , HaimN , PapierI , EferganR , et al. Home parenteral nutrition (HTPN) for incurable patients with cancer with gastrointestinal obstruction: do the benefits outweigh the risks?. Medical Oncology2011;28:83‐8. ">Chermesh 2011</a>; <a href="./references#CD012812-bbs2-0005" title="CotogniP , DeCarliL , PasseraR , AmerioML , AgnelloE , FaddaM , et al. Longitudinal study of quality of life in advanced cancer patients on home parenteral nutrition. Cancer Medicine2017;6:1799‐806. ">Cotogni 2017</a>; <a href="./references#CD012812-bbs2-0007" title="FinocchiaroC , GervasioS , AgnelloE , AppianoS , BertettoO , CiuffredaL , et al. Multicentric study on home parenteral nutrition in advanced cancer patients. Rivista italiana di Nutrizione Parenterale ed Enterale2002;20:98‐107. ">Finocchiaro 2002</a>; <a href="./references#CD012812-bbs2-0010" title="MercadanteS . Parenteral nutrition at home in advanced cancer patients. Journal of Pain and Symptom Management1995;10:476‐80. ">Mercadante 1995</a>; <a href="./references#CD012812-bbs2-0011" title="PironiL , RuggeriE , TannebergerS , GiordaniS , PannutiF , MiglioliM . Home artificial nutrition in advanced cancer. Journal of the Royal Society of Medicine1997;90(11):597‐603. ">Pironi 1997</a>), and seven retrospectively (<a href="./references#CD012812-bbs2-0001" title="Abu‐RustumNR , BarakatRR , VenkatramanE , SpriggsD . Chemotherapy and total parenteral nutrition for advanced ovarian cancer with bowel obstruction. Gynecologic Oncology1997;64:493‐5. ">Abu‐Rustum 1997</a>; <a href="./references#CD012812-bbs2-0002" title="AugustDA , ThornD , FisherRL , WelchekCM . Home parenteral nutrition for patients with inoperable malignant bowel obstruction. Journal of Parenteral and Enteral Nutrition1991;15:323‐7. ">August 1991</a>; <a href="./references#CD012812-bbs2-0006" title="DuerksenDR , TingE , ThomsonP , McCurdyK , LinscerJ , Larsen‐CelharS , et al. Is there a role for TPN in terminally ill patients with bowel obstruction?. Nutrition2004;20:760‐3. ">Duerksen 2004</a>; <a href="./references#CD012812-bbs2-0008" title="KeaneN , FragkosK , PatelP , BertschF , MehtaJ , DiCaroS , et al. Performance status, prognostic scoring, and parenteral nutrition requirements predict survival in patients with advanced cancer receiving home parenteral nutrition. Nutrition and Cancer2018;70(1):73‐82. ">Keane 2018</a>; <a href="./references#CD012812-bbs2-0009" title="KingLA , CarsonLF , KonstantinidesN , HouseMS , AdcockLL , PremKA , et al. Outcome assessment of home parenteral nutrition in patients with gynecologic malignancies: what have we learned in a decade of experience?. Gynecologic Oncology1993;51:377‐82. ">King 1993</a>; <a href="./references#CD012812-bbs2-0012" title="SantarpiaL , AlfonsiL , PasanisiF , DeCaprioC , ScalfiL , ContaldoF . Predictive factors of survival in patients with peritoneal carcinomatosis on home parenteral nutrition. Nutrition2006;22:355‐60. ">Santarpia 2006</a>; <a href="./references#CD012812-bbs2-0013" title="SooI , GramlichL . Use of parenteral nutrition in patients with advanced cancer. Applied Physiology, Nutrition, and Metabolism2008;33:102‐6. ">Soo 2008</a>). From the prospective studies two were cohort (<a href="./references#CD012812-bbs2-0004" title="ChermeshI , MashiachT , AmitA , HaimN , PapierI , EferganR , et al. Home parenteral nutrition (HTPN) for incurable patients with cancer with gastrointestinal obstruction: do the benefits outweigh the risks?. Medical Oncology2011;28:83‐8. ">Chermesh 2011</a>; <a href="./references#CD012812-bbs2-0005" title="CotogniP , DeCarliL , PasseraR , AmerioML , AgnelloE , FaddaM , et al. Longitudinal study of quality of life in advanced cancer patients on home parenteral nutrition. Cancer Medicine2017;6:1799‐806. ">Cotogni 2017</a>) and four were case series (<a href="./references#CD012812-bbs2-0003" title="BozzettiF , CozzaglioL , BiganzoliE , ChiavennaG , DeCiccoM , DonatiD , et al. Quality of life and length of survival in advanced cancer patients on home parenteral nutrition. Clinical Nutrition2002;21:281‐8. ">Bozzetti 2002</a>; <a href="./references#CD012812-bbs2-0007" title="FinocchiaroC , GervasioS , AgnelloE , AppianoS , BertettoO , CiuffredaL , et al. Multicentric study on home parenteral nutrition in advanced cancer patients. Rivista italiana di Nutrizione Parenterale ed Enterale2002;20:98‐107. ">Finocchiaro 2002</a>; <a href="./references#CD012812-bbs2-0010" title="MercadanteS . Parenteral nutrition at home in advanced cancer patients. Journal of Pain and Symptom Management1995;10:476‐80. ">Mercadante 1995</a>; <a href="./references#CD012812-bbs2-0011" title="PironiL , RuggeriE , TannebergerS , GiordaniS , PannutiF , MiglioliM . Home artificial nutrition in advanced cancer. Journal of the Royal Society of Medicine1997;90(11):597‐603. ">Pironi 1997</a>) and from the retrospective studies, six were case series (<a href="./references#CD012812-bbs2-0002" title="AugustDA , ThornD , FisherRL , WelchekCM . Home parenteral nutrition for patients with inoperable malignant bowel obstruction. Journal of Parenteral and Enteral Nutrition1991;15:323‐7. ">August 1991</a>; <a href="./references#CD012812-bbs2-0006" title="DuerksenDR , TingE , ThomsonP , McCurdyK , LinscerJ , Larsen‐CelharS , et al. Is there a role for TPN in terminally ill patients with bowel obstruction?. Nutrition2004;20:760‐3. ">Duerksen 2004</a>; <a href="./references#CD012812-bbs2-0008" title="KeaneN , FragkosK , PatelP , BertschF , MehtaJ , DiCaroS , et al. Performance status, prognostic scoring, and parenteral nutrition requirements predict survival in patients with advanced cancer receiving home parenteral nutrition. Nutrition and Cancer2018;70(1):73‐82. ">Keane 2018</a>; <a href="./references#CD012812-bbs2-0009" title="KingLA , CarsonLF , KonstantinidesN , HouseMS , AdcockLL , PremKA , et al. Outcome assessment of home parenteral nutrition in patients with gynecologic malignancies: what have we learned in a decade of experience?. Gynecologic Oncology1993;51:377‐82. ">King 1993</a>; <a href="./references#CD012812-bbs2-0012" title="SantarpiaL , AlfonsiL , PasanisiF , DeCaprioC , ScalfiL , ContaldoF . Predictive factors of survival in patients with peritoneal carcinomatosis on home parenteral nutrition. Nutrition2006;22:355‐60. ">Santarpia 2006</a>; <a href="./references#CD012812-bbs2-0013" title="SooI , GramlichL . Use of parenteral nutrition in patients with advanced cancer. Applied Physiology, Nutrition, and Metabolism2008;33:102‐6. ">Soo 2008</a>), and one was a cohort study (<a href="./references#CD012812-bbs2-0001" title="Abu‐RustumNR , BarakatRR , VenkatramanE , SpriggsD . Chemotherapy and total parenteral nutrition for advanced ovarian cancer with bowel obstruction. Gynecologic Oncology1997;64:493‐5. ">Abu‐Rustum 1997</a>). We contacted the authors of three included studies for more information on patient characteristics and received no further data from them ( <a href="./references#CD012812-bbs2-0001" title="Abu‐RustumNR , BarakatRR , VenkatramanE , SpriggsD . Chemotherapy and total parenteral nutrition for advanced ovarian cancer with bowel obstruction. Gynecologic Oncology1997;64:493‐5. ">Abu‐Rustum 1997</a>; <a href="./references#CD012812-bbs2-0003" title="BozzettiF , CozzaglioL , BiganzoliE , ChiavennaG , DeCiccoM , DonatiD , et al. Quality of life and length of survival in advanced cancer patients on home parenteral nutrition. Clinical Nutrition2002;21:281‐8. ">Bozzetti 2002</a>; <a href="./references#CD012812-bbs2-0011" title="PironiL , RuggeriE , TannebergerS , GiordaniS , PannutiF , MiglioliM . Home artificial nutrition in advanced cancer. Journal of the Royal Society of Medicine1997;90(11):597‐603. ">Pironi 1997</a>). </p> </section> <section id="CD012812-sec-0066"> <h5 class="title">Setting</h5> <p>Three included studies were conducted in the USA (<a href="./references#CD012812-bbs2-0001" title="Abu‐RustumNR , BarakatRR , VenkatramanE , SpriggsD . Chemotherapy and total parenteral nutrition for advanced ovarian cancer with bowel obstruction. Gynecologic Oncology1997;64:493‐5. ">Abu‐Rustum 1997</a>; <a href="./references#CD012812-bbs2-0002" title="AugustDA , ThornD , FisherRL , WelchekCM . Home parenteral nutrition for patients with inoperable malignant bowel obstruction. Journal of Parenteral and Enteral Nutrition1991;15:323‐7. ">August 1991</a>; <a href="./references#CD012812-bbs2-0009" title="KingLA , CarsonLF , KonstantinidesN , HouseMS , AdcockLL , PremKA , et al. Outcome assessment of home parenteral nutrition in patients with gynecologic malignancies: what have we learned in a decade of experience?. Gynecologic Oncology1993;51:377‐82. ">King 1993</a>), six in Italy (<a href="./references#CD012812-bbs2-0003" title="BozzettiF , CozzaglioL , BiganzoliE , ChiavennaG , DeCiccoM , DonatiD , et al. Quality of life and length of survival in advanced cancer patients on home parenteral nutrition. Clinical Nutrition2002;21:281‐8. ">Bozzetti 2002</a>; <a href="./references#CD012812-bbs2-0005" title="CotogniP , DeCarliL , PasseraR , AmerioML , AgnelloE , FaddaM , et al. Longitudinal study of quality of life in advanced cancer patients on home parenteral nutrition. Cancer Medicine2017;6:1799‐806. ">Cotogni 2017</a>; <a href="./references#CD012812-bbs2-0007" title="FinocchiaroC , GervasioS , AgnelloE , AppianoS , BertettoO , CiuffredaL , et al. Multicentric study on home parenteral nutrition in advanced cancer patients. Rivista italiana di Nutrizione Parenterale ed Enterale2002;20:98‐107. ">Finocchiaro 2002</a>; <a href="./references#CD012812-bbs2-0010" title="MercadanteS . Parenteral nutrition at home in advanced cancer patients. Journal of Pain and Symptom Management1995;10:476‐80. ">Mercadante 1995</a>; <a href="./references#CD012812-bbs2-0011" title="PironiL , RuggeriE , TannebergerS , GiordaniS , PannutiF , MiglioliM . Home artificial nutrition in advanced cancer. Journal of the Royal Society of Medicine1997;90(11):597‐603. ">Pironi 1997</a>;<a href="./references#CD012812-bbs2-0012" title="SantarpiaL , AlfonsiL , PasanisiF , DeCaprioC , ScalfiL , ContaldoF . Predictive factors of survival in patients with peritoneal carcinomatosis on home parenteral nutrition. Nutrition2006;22:355‐60. ">Santarpia 2006</a>), one in Israel (<a href="./references#CD012812-bbs2-0004" title="ChermeshI , MashiachT , AmitA , HaimN , PapierI , EferganR , et al. Home parenteral nutrition (HTPN) for incurable patients with cancer with gastrointestinal obstruction: do the benefits outweigh the risks?. Medical Oncology2011;28:83‐8. ">Chermesh 2011</a>), one in Canada (<a href="./references#CD012812-bbs2-0013" title="SooI , GramlichL . Use of parenteral nutrition in patients with advanced cancer. Applied Physiology, Nutrition, and Metabolism2008;33:102‐6. ">Soo 2008</a>), and one in England (<a href="./references#CD012812-bbs2-0008" title="KeaneN , FragkosK , PatelP , BertschF , MehtaJ , DiCaroS , et al. Performance status, prognostic scoring, and parenteral nutrition requirements predict survival in patients with advanced cancer receiving home parenteral nutrition. Nutrition and Cancer2018;70(1):73‐82. ">Keane 2018</a>). All the participants had parenteral nutrition (PN) at home. One study included participants who had PN in hospital and at home (<a href="./references#CD012812-bbs2-0006" title="DuerksenDR , TingE , ThomsonP , McCurdyK , LinscerJ , Larsen‐CelharS , et al. Is there a role for TPN in terminally ill patients with bowel obstruction?. Nutrition2004;20:760‐3. ">Duerksen 2004</a>), however, data were only extracted for participants at home. </p> </section> <section id="CD012812-sec-0067"> <h5 class="title">Participants</h5> <p>There were 721 participants considered in this review of which 308 were male and 384 female. We were unable to extract the gender for 29 participants. There was a wide age range; some studies gave age as median which varied between 54 to 62 years (range 32 to 79 years) and others as mean 48.76 (SD 13.8) to 60 (SD 28) years. </p> <p>There was a wide variety of cancer diagnoses in participants: 237 gynaecological (including ovarian, endometrial, cervical and peritoneal), 390 gastro‐intestinal (oesophagus, stomach, pancreas, colorectal and appendix), 14 lung,11 breast, five haematological, four kidney, three head‐neck, and 57 from other sites. </p> <p>Some of the participants received oncology treatment whilst on PN; 174 had chemotherapy, 20 had radiotherapy and 14 had surgery, with some participants receiving more than one treatment (<a href="./references#CD012812-bbs2-0001" title="Abu‐RustumNR , BarakatRR , VenkatramanE , SpriggsD . Chemotherapy and total parenteral nutrition for advanced ovarian cancer with bowel obstruction. Gynecologic Oncology1997;64:493‐5. ">Abu‐Rustum 1997</a>; <a href="./references#CD012812-bbs2-0003" title="BozzettiF , CozzaglioL , BiganzoliE , ChiavennaG , DeCiccoM , DonatiD , et al. Quality of life and length of survival in advanced cancer patients on home parenteral nutrition. Clinical Nutrition2002;21:281‐8. ">Bozzetti 2002</a>; <a href="./references#CD012812-bbs2-0005" title="CotogniP , DeCarliL , PasseraR , AmerioML , AgnelloE , FaddaM , et al. Longitudinal study of quality of life in advanced cancer patients on home parenteral nutrition. Cancer Medicine2017;6:1799‐806. ">Cotogni 2017</a>; <a href="./references#CD012812-bbs2-0009" title="KingLA , CarsonLF , KonstantinidesN , HouseMS , AdcockLL , PremKA , et al. Outcome assessment of home parenteral nutrition in patients with gynecologic malignancies: what have we learned in a decade of experience?. Gynecologic Oncology1993;51:377‐82. ">King 1993</a>; <a href="./references#CD012812-bbs2-0013" title="SooI , GramlichL . Use of parenteral nutrition in patients with advanced cancer. Applied Physiology, Nutrition, and Metabolism2008;33:102‐6. ">Soo 2008</a>). Five studies gave no details about whether participants were receiving any treatment (<a href="./references#CD012812-bbs2-0002" title="AugustDA , ThornD , FisherRL , WelchekCM . Home parenteral nutrition for patients with inoperable malignant bowel obstruction. Journal of Parenteral and Enteral Nutrition1991;15:323‐7. ">August 1991</a>; <a href="./references#CD012812-bbs2-0004" title="ChermeshI , MashiachT , AmitA , HaimN , PapierI , EferganR , et al. Home parenteral nutrition (HTPN) for incurable patients with cancer with gastrointestinal obstruction: do the benefits outweigh the risks?. Medical Oncology2011;28:83‐8. ">Chermesh 2011</a>; <a href="./references#CD012812-bbs2-0010" title="MercadanteS . Parenteral nutrition at home in advanced cancer patients. Journal of Pain and Symptom Management1995;10:476‐80. ">Mercadante 1995</a>; <a href="./references#CD012812-bbs2-0011" title="PironiL , RuggeriE , TannebergerS , GiordaniS , PannutiF , MiglioliM . Home artificial nutrition in advanced cancer. Journal of the Royal Society of Medicine1997;90(11):597‐603. ">Pironi 1997</a>; <a href="./references#CD012812-bbs2-0012" title="SantarpiaL , AlfonsiL , PasanisiF , DeCaprioC , ScalfiL , ContaldoF . Predictive factors of survival in patients with peritoneal carcinomatosis on home parenteral nutrition. Nutrition2006;22:355‐60. ">Santarpia 2006</a>). In one study, chemotherapy was given to some participants, but it is unclear whether this pertained to the participants included in this review (<a href="./references#CD012812-bbs2-0006" title="DuerksenDR , TingE , ThomsonP , McCurdyK , LinscerJ , Larsen‐CelharS , et al. Is there a role for TPN in terminally ill patients with bowel obstruction?. Nutrition2004;20:760‐3. ">Duerksen 2004</a>), and in two other studies the numbers receiving chemotherapy whilst on PN were unclear (<a href="./references#CD012812-bbs2-0007" title="FinocchiaroC , GervasioS , AgnelloE , AppianoS , BertettoO , CiuffredaL , et al. Multicentric study on home parenteral nutrition in advanced cancer patients. Rivista italiana di Nutrizione Parenterale ed Enterale2002;20:98‐107. ">Finocchiaro 2002</a>; <a href="./references#CD012812-bbs2-0008" title="KeaneN , FragkosK , PatelP , BertschF , MehtaJ , DiCaroS , et al. Performance status, prognostic scoring, and parenteral nutrition requirements predict survival in patients with advanced cancer receiving home parenteral nutrition. Nutrition and Cancer2018;70(1):73‐82. ">Keane 2018</a>). </p> <p>In most of the studies, there was no information about the oral intake of the participants (<a href="./references#CD012812-bbs2-0002" title="AugustDA , ThornD , FisherRL , WelchekCM . Home parenteral nutrition for patients with inoperable malignant bowel obstruction. Journal of Parenteral and Enteral Nutrition1991;15:323‐7. ">August 1991</a>; <a href="./references#CD012812-bbs2-0003" title="BozzettiF , CozzaglioL , BiganzoliE , ChiavennaG , DeCiccoM , DonatiD , et al. Quality of life and length of survival in advanced cancer patients on home parenteral nutrition. Clinical Nutrition2002;21:281‐8. ">Bozzetti 2002</a>; <a href="./references#CD012812-bbs2-0004" title="ChermeshI , MashiachT , AmitA , HaimN , PapierI , EferganR , et al. Home parenteral nutrition (HTPN) for incurable patients with cancer with gastrointestinal obstruction: do the benefits outweigh the risks?. Medical Oncology2011;28:83‐8. ">Chermesh 2011</a>; <a href="./references#CD012812-bbs2-0006" title="DuerksenDR , TingE , ThomsonP , McCurdyK , LinscerJ , Larsen‐CelharS , et al. Is there a role for TPN in terminally ill patients with bowel obstruction?. Nutrition2004;20:760‐3. ">Duerksen 2004</a>; <a href="./references#CD012812-bbs2-0008" title="KeaneN , FragkosK , PatelP , BertschF , MehtaJ , DiCaroS , et al. Performance status, prognostic scoring, and parenteral nutrition requirements predict survival in patients with advanced cancer receiving home parenteral nutrition. Nutrition and Cancer2018;70(1):73‐82. ">Keane 2018</a>; <a href="./references#CD012812-bbs2-0009" title="KingLA , CarsonLF , KonstantinidesN , HouseMS , AdcockLL , PremKA , et al. Outcome assessment of home parenteral nutrition in patients with gynecologic malignancies: what have we learned in a decade of experience?. Gynecologic Oncology1993;51:377‐82. ">King 1993</a>; <a href="./references#CD012812-bbs2-0010" title="MercadanteS . Parenteral nutrition at home in advanced cancer patients. Journal of Pain and Symptom Management1995;10:476‐80. ">Mercadante 1995</a>; <a href="./references#CD012812-bbs2-0011" title="PironiL , RuggeriE , TannebergerS , GiordaniS , PannutiF , MiglioliM . Home artificial nutrition in advanced cancer. Journal of the Royal Society of Medicine1997;90(11):597‐603. ">Pironi 1997</a>; <a href="./references#CD012812-bbs2-0012" title="SantarpiaL , AlfonsiL , PasanisiF , DeCaprioC , ScalfiL , ContaldoF . Predictive factors of survival in patients with peritoneal carcinomatosis on home parenteral nutrition. Nutrition2006;22:355‐60. ">Santarpia 2006</a>; <a href="./references#CD012812-bbs2-0013" title="SooI , GramlichL . Use of parenteral nutrition in patients with advanced cancer. Applied Physiology, Nutrition, and Metabolism2008;33:102‐6. ">Soo 2008</a>). <a href="./references#CD012812-bbs2-0007" title="FinocchiaroC , GervasioS , AgnelloE , AppianoS , BertettoO , CiuffredaL , et al. Multicentric study on home parenteral nutrition in advanced cancer patients. Rivista italiana di Nutrizione Parenterale ed Enterale2002;20:98‐107. ">Finocchiaro 2002</a> reported that 32 participants (46%) were taking oral nutrition, but gave no information as to calorie intake, and similarly. <a href="./references#CD012812-bbs2-0001" title="Abu‐RustumNR , BarakatRR , VenkatramanE , SpriggsD . Chemotherapy and total parenteral nutrition for advanced ovarian cancer with bowel obstruction. Gynecologic Oncology1997;64:493‐5. ">Abu‐Rustum 1997</a> commented that participants were taking a liquid diet, but gave no information on oral energy intake. <a href="./references#CD012812-bbs2-0005" title="CotogniP , DeCarliL , PasseraR , AmerioML , AgnelloE , FaddaM , et al. Longitudinal study of quality of life in advanced cancer patients on home parenteral nutrition. Cancer Medicine2017;6:1799‐806. ">Cotogni 2017</a> reported participants taking a median of 500 kcal per day. </p> <p>Baseline performance status was measured and reported in nine studies using Karnofsky performance status, where a higher score indicates better performance (<a href="./references#CD012812-bbs2-0003" title="BozzettiF , CozzaglioL , BiganzoliE , ChiavennaG , DeCiccoM , DonatiD , et al. Quality of life and length of survival in advanced cancer patients on home parenteral nutrition. Clinical Nutrition2002;21:281‐8. ">Bozzetti 2002</a>; <a href="./references#CD012812-bbs2-0005" title="CotogniP , DeCarliL , PasseraR , AmerioML , AgnelloE , FaddaM , et al. Longitudinal study of quality of life in advanced cancer patients on home parenteral nutrition. Cancer Medicine2017;6:1799‐806. ">Cotogni 2017</a>; <a href="./references#CD012812-bbs2-0006" title="DuerksenDR , TingE , ThomsonP , McCurdyK , LinscerJ , Larsen‐CelharS , et al. Is there a role for TPN in terminally ill patients with bowel obstruction?. Nutrition2004;20:760‐3. ">Duerksen 2004</a>; <a href="./references#CD012812-bbs2-0007" title="FinocchiaroC , GervasioS , AgnelloE , AppianoS , BertettoO , CiuffredaL , et al. Multicentric study on home parenteral nutrition in advanced cancer patients. Rivista italiana di Nutrizione Parenterale ed Enterale2002;20:98‐107. ">Finocchiaro 2002</a>; <a href="./references#CD012812-bbs2-0008" title="KeaneN , FragkosK , PatelP , BertschF , MehtaJ , DiCaroS , et al. Performance status, prognostic scoring, and parenteral nutrition requirements predict survival in patients with advanced cancer receiving home parenteral nutrition. Nutrition and Cancer2018;70(1):73‐82. ">Keane 2018</a>; <a href="./references#CD012812-bbs2-0009" title="KingLA , CarsonLF , KonstantinidesN , HouseMS , AdcockLL , PremKA , et al. Outcome assessment of home parenteral nutrition in patients with gynecologic malignancies: what have we learned in a decade of experience?. Gynecologic Oncology1993;51:377‐82. ">King 1993</a>; <a href="./references#CD012812-bbs2-0011" title="PironiL , RuggeriE , TannebergerS , GiordaniS , PannutiF , MiglioliM . Home artificial nutrition in advanced cancer. Journal of the Royal Society of Medicine1997;90(11):597‐603. ">Pironi 1997</a>; <a href="./references#CD012812-bbs2-0012" title="SantarpiaL , AlfonsiL , PasanisiF , DeCaprioC , ScalfiL , ContaldoF . Predictive factors of survival in patients with peritoneal carcinomatosis on home parenteral nutrition. Nutrition2006;22:355‐60. ">Santarpia 2006</a>; <a href="./references#CD012812-bbs2-0013" title="SooI , GramlichL . Use of parenteral nutrition in patients with advanced cancer. Applied Physiology, Nutrition, and Metabolism2008;33:102‐6. ">Soo 2008</a>). Four studies reported median Karnofsky performance status, which was 60 to 70 (range 40 to 90) (<a href="./references#CD012812-bbs2-0003" title="BozzettiF , CozzaglioL , BiganzoliE , ChiavennaG , DeCiccoM , DonatiD , et al. Quality of life and length of survival in advanced cancer patients on home parenteral nutrition. Clinical Nutrition2002;21:281‐8. ">Bozzetti 2002</a>; <a href="./references#CD012812-bbs2-0005" title="CotogniP , DeCarliL , PasseraR , AmerioML , AgnelloE , FaddaM , et al. Longitudinal study of quality of life in advanced cancer patients on home parenteral nutrition. Cancer Medicine2017;6:1799‐806. ">Cotogni 2017</a>; <a href="./references#CD012812-bbs2-0006" title="DuerksenDR , TingE , ThomsonP , McCurdyK , LinscerJ , Larsen‐CelharS , et al. Is there a role for TPN in terminally ill patients with bowel obstruction?. Nutrition2004;20:760‐3. ">Duerksen 2004</a>; <a href="./references#CD012812-bbs2-0007" title="FinocchiaroC , GervasioS , AgnelloE , AppianoS , BertettoO , CiuffredaL , et al. Multicentric study on home parenteral nutrition in advanced cancer patients. Rivista italiana di Nutrizione Parenterale ed Enterale2002;20:98‐107. ">Finocchiaro 2002</a>). <a href="./references#CD012812-bbs2-0008" title="KeaneN , FragkosK , PatelP , BertschF , MehtaJ , DiCaroS , et al. Performance status, prognostic scoring, and parenteral nutrition requirements predict survival in patients with advanced cancer receiving home parenteral nutrition. Nutrition and Cancer2018;70(1):73‐82. ">Keane 2018</a> and <a href="./references#CD012812-bbs2-0013" title="SooI , GramlichL . Use of parenteral nutrition in patients with advanced cancer. Applied Physiology, Nutrition, and Metabolism2008;33:102‐6. ">Soo 2008</a> reported mean Karnofsky performance status as 50 ± 16 and 62.7 (SD 18.52), respectively. <a href="./references#CD012812-bbs2-0009" title="KingLA , CarsonLF , KonstantinidesN , HouseMS , AdcockLL , PremKA , et al. Outcome assessment of home parenteral nutrition in patients with gynecologic malignancies: what have we learned in a decade of experience?. Gynecologic Oncology1993;51:377‐82. ">King 1993</a> reported Karnofsky performance status as 48, but it was unclear if this was mean or median and no range or standard deviation *SD) was given. <a href="./references#CD012812-bbs2-0011" title="PironiL , RuggeriE , TannebergerS , GiordaniS , PannutiF , MiglioliM . Home artificial nutrition in advanced cancer. Journal of the Royal Society of Medicine1997;90(11):597‐603. ">Pironi 1997</a> found Karnofsky performance status was 30 to 40 in 9 (31%) participants, 50 to 60 in 18 (62%) participants and 70 to 80 in 2 (7%) participants. <a href="./references#CD012812-bbs2-0012" title="SantarpiaL , AlfonsiL , PasanisiF , DeCaprioC , ScalfiL , ContaldoF . Predictive factors of survival in patients with peritoneal carcinomatosis on home parenteral nutrition. Nutrition2006;22:355‐60. ">Santarpia 2006</a> reported Karnofsky performance status as ≤ 40 in 12 participants and ≥ 50 in 52 participants. No measure of performance status was reported in four studies (<a href="./references#CD012812-bbs2-0001" title="Abu‐RustumNR , BarakatRR , VenkatramanE , SpriggsD . Chemotherapy and total parenteral nutrition for advanced ovarian cancer with bowel obstruction. Gynecologic Oncology1997;64:493‐5. ">Abu‐Rustum 1997</a>; <a href="./references#CD012812-bbs2-0002" title="AugustDA , ThornD , FisherRL , WelchekCM . Home parenteral nutrition for patients with inoperable malignant bowel obstruction. Journal of Parenteral and Enteral Nutrition1991;15:323‐7. ">August 1991</a>; <a href="./references#CD012812-bbs2-0010" title="MercadanteS . Parenteral nutrition at home in advanced cancer patients. Journal of Pain and Symptom Management1995;10:476‐80. ">Mercadante 1995</a>; <a href="./references#CD012812-bbs2-0004" title="ChermeshI , MashiachT , AmitA , HaimN , PapierI , EferganR , et al. Home parenteral nutrition (HTPN) for incurable patients with cancer with gastrointestinal obstruction: do the benefits outweigh the risks?. Medical Oncology2011;28:83‐8. ">Chermesh 2011</a>) </p> <p>No studies reported on confounding factors such as use of steroids, which may improve the symptoms of malignant bowel obstruction (MBO); neither did any studies comment on co‐morbidities in participants. </p> </section> <section id="CD012812-sec-0068"> <h5 class="title">Interventions</h5> <p>The intervention we considered was home parenteral nutrition (HPN) and all of the participants identified in included studies received PN at home. However, six of the studies gave no details about the nutritional composition of administrated solutions (<a href="./references#CD012812-bbs2-0001" title="Abu‐RustumNR , BarakatRR , VenkatramanE , SpriggsD . Chemotherapy and total parenteral nutrition for advanced ovarian cancer with bowel obstruction. Gynecologic Oncology1997;64:493‐5. ">Abu‐Rustum 1997</a>; <a href="./references#CD012812-bbs2-0004" title="ChermeshI , MashiachT , AmitA , HaimN , PapierI , EferganR , et al. Home parenteral nutrition (HTPN) for incurable patients with cancer with gastrointestinal obstruction: do the benefits outweigh the risks?. Medical Oncology2011;28:83‐8. ">Chermesh 2011</a>; <a href="./references#CD012812-bbs2-0005" title="CotogniP , DeCarliL , PasseraR , AmerioML , AgnelloE , FaddaM , et al. Longitudinal study of quality of life in advanced cancer patients on home parenteral nutrition. Cancer Medicine2017;6:1799‐806. ">Cotogni 2017</a>; <a href="./references#CD012812-bbs2-0006" title="DuerksenDR , TingE , ThomsonP , McCurdyK , LinscerJ , Larsen‐CelharS , et al. Is there a role for TPN in terminally ill patients with bowel obstruction?. Nutrition2004;20:760‐3. ">Duerksen 2004</a>; <a href="./references#CD012812-bbs2-0009" title="KingLA , CarsonLF , KonstantinidesN , HouseMS , AdcockLL , PremKA , et al. Outcome assessment of home parenteral nutrition in patients with gynecologic malignancies: what have we learned in a decade of experience?. Gynecologic Oncology1993;51:377‐82. ">King 1993</a>; <a href="./references#CD012812-bbs2-0011" title="PironiL , RuggeriE , TannebergerS , GiordaniS , PannutiF , MiglioliM . Home artificial nutrition in advanced cancer. Journal of the Royal Society of Medicine1997;90(11):597‐603. ">Pironi 1997</a>), whereas this information was available in the other studies. </p> <p>In <a href="./references#CD012812-bbs2-0002" title="AugustDA , ThornD , FisherRL , WelchekCM . Home parenteral nutrition for patients with inoperable malignant bowel obstruction. Journal of Parenteral and Enteral Nutrition1991;15:323‐7. ">August 1991</a>, solutions contained 1.0 L to 3.0 L of crystalline amino acid (4.25% or 5.0%), dextrose (25% to 35%), and appropriate electrolytes, vitamins and minerals. Most participants received lipid emulsion (250 mL of a 20% solution) weekly. Participants had individually‐tailored regimens, although no details were given. In <a href="./references#CD012812-bbs2-0003" title="BozzettiF , CozzaglioL , BiganzoliE , ChiavennaG , DeCiccoM , DonatiD , et al. Quality of life and length of survival in advanced cancer patients on home parenteral nutrition. Clinical Nutrition2002;21:281‐8. ">Bozzetti 2002</a>, the aim was 30 non‐protein kcal/kg/day for participants. The median values for the PN preparations were 300 g/day glucose (range 160 g to 500 g), 60 g/day lipid (range 42 g to 100 g) and 12 g/day nitrogen (range 6.2 g to 13.7 g). <a href="./references#CD012812-bbs2-0007" title="FinocchiaroC , GervasioS , AgnelloE , AppianoS , BertettoO , CiuffredaL , et al. Multicentric study on home parenteral nutrition in advanced cancer patients. Rivista italiana di Nutrizione Parenterale ed Enterale2002;20:98‐107. ">Finocchiaro 2002</a> aimed to match energy intake with nutritional guidelines for the Italian population multiplied by a specific illness factor (<a href="./references#CD012812-bbs2-0076" title="Società Italiana NutrizioneUmana . [Livelli di Assunzione Raccomandati di Energia e Nutrienti per la papolazione Italiana]. EDRA Medical Publisher Revisione, 1996. ">Società Italiana Nutrizione Umana 1996</a>), 1.2 g/kg/day protein and 30 mL to 35 mL/kg/day fluid. Initially, participants were given 1500 mL/day (750 mL to 2500 mL), 1400 kcal/day (600 kcal to 1900 kcal), 60 g/day (30 g to 85 g) of protein and added micronutrients, which gave them 27.8 mL/kg (13.3 mL to 52.6 mL) and 24.4 kcal/kg (8.5 kcal to 40 kcal). In <a href="./references#CD012812-bbs2-0010" title="MercadanteS . Parenteral nutrition at home in advanced cancer patients. Journal of Pain and Symptom Management1995;10:476‐80. ">Mercadante 1995</a>, solutions contained 1500 kcal to 2000 kcal, composed of dextrose (providing 60% to 70% of energy) and 10% fat emulsion (approximately 30% to 40% energy), essential amino acids enriched with branched‐chain L‐amino acids (approximately 17 g to 20 g), and electrolytes and vitamins as required. <a href="./references#CD012812-bbs2-0008" title="KeaneN , FragkosK , PatelP , BertschF , MehtaJ , DiCaroS , et al. Performance status, prognostic scoring, and parenteral nutrition requirements predict survival in patients with advanced cancer receiving home parenteral nutrition. Nutrition and Cancer2018;70(1):73‐82. ">Keane 2018</a> gave mean requirements for PN, which were volume 2251 mL ± 626 mL, 11 ± 3 g/day nitrogen, 911 ± 304 kcal/day glucose, 573 ± 262 kcal/day lipid, 112 ± mmol/day sodium, 57 ± 26 mmol/day potassium, 5 ± 2 mmol/day calcium, 10 ± 5 mmol/day magnesium and 21 ±10 mmol/day phosphate. <a href="./references#CD012812-bbs2-0012" title="SantarpiaL , AlfonsiL , PasanisiF , DeCaprioC , ScalfiL , ContaldoF . Predictive factors of survival in patients with peritoneal carcinomatosis on home parenteral nutrition. Nutrition2006;22:355‐60. ">Santarpia 2006</a> did not comment on solution composition, but aimed for individualised nutritional support providing 20 to 30 kcal/kg/day, 3 to 4 g/kg/day carbohydrate, 1 g/kg/day lipid and 1.0 to 1.5 g/kg/ day protein. Similarly, <a href="./references#CD012812-bbs2-0013" title="SooI , GramlichL . Use of parenteral nutrition in patients with advanced cancer. Applied Physiology, Nutrition, and Metabolism2008;33:102‐6. ">Soo 2008</a> did not comment on solution composition, but aimed for 25 kcal/kg, 1 g/kg protein and standard provision of micronutrients for participants. </p> </section> <section id="CD012812-sec-0069"> <h5 class="title">Comparators</h5> <p>Ten studies were case series that lacked comparator arms (<a href="./references#CD012812-bbs2-0002" title="AugustDA , ThornD , FisherRL , WelchekCM . Home parenteral nutrition for patients with inoperable malignant bowel obstruction. Journal of Parenteral and Enteral Nutrition1991;15:323‐7. ">August 1991</a>; <a href="./references#CD012812-bbs2-0003" title="BozzettiF , CozzaglioL , BiganzoliE , ChiavennaG , DeCiccoM , DonatiD , et al. Quality of life and length of survival in advanced cancer patients on home parenteral nutrition. Clinical Nutrition2002;21:281‐8. ">Bozzetti 2002</a>; <a href="./references#CD012812-bbs2-0006" title="DuerksenDR , TingE , ThomsonP , McCurdyK , LinscerJ , Larsen‐CelharS , et al. Is there a role for TPN in terminally ill patients with bowel obstruction?. Nutrition2004;20:760‐3. ">Duerksen 2004</a>; <a href="./references#CD012812-bbs2-0007" title="FinocchiaroC , GervasioS , AgnelloE , AppianoS , BertettoO , CiuffredaL , et al. Multicentric study on home parenteral nutrition in advanced cancer patients. Rivista italiana di Nutrizione Parenterale ed Enterale2002;20:98‐107. ">Finocchiaro 2002</a>; <a href="./references#CD012812-bbs2-0008" title="KeaneN , FragkosK , PatelP , BertschF , MehtaJ , DiCaroS , et al. Performance status, prognostic scoring, and parenteral nutrition requirements predict survival in patients with advanced cancer receiving home parenteral nutrition. Nutrition and Cancer2018;70(1):73‐82. ">Keane 2018</a>; <a href="./references#CD012812-bbs2-0009" title="KingLA , CarsonLF , KonstantinidesN , HouseMS , AdcockLL , PremKA , et al. Outcome assessment of home parenteral nutrition in patients with gynecologic malignancies: what have we learned in a decade of experience?. Gynecologic Oncology1993;51:377‐82. ">King 1993</a>; <a href="./references#CD012812-bbs2-0010" title="MercadanteS . Parenteral nutrition at home in advanced cancer patients. Journal of Pain and Symptom Management1995;10:476‐80. ">Mercadante 1995</a>; <a href="./references#CD012812-bbs2-0011" title="PironiL , RuggeriE , TannebergerS , GiordaniS , PannutiF , MiglioliM . Home artificial nutrition in advanced cancer. Journal of the Royal Society of Medicine1997;90(11):597‐603. ">Pironi 1997</a>; <a href="./references#CD012812-bbs2-0012" title="SantarpiaL , AlfonsiL , PasanisiF , DeCaprioC , ScalfiL , ContaldoF . Predictive factors of survival in patients with peritoneal carcinomatosis on home parenteral nutrition. Nutrition2006;22:355‐60. ">Santarpia 2006</a>; <a href="./references#CD012812-bbs2-0013" title="SooI , GramlichL . Use of parenteral nutrition in patients with advanced cancer. Applied Physiology, Nutrition, and Metabolism2008;33:102‐6. ">Soo 2008</a>). One study (<a href="./references#CD012812-bbs2-0001" title="Abu‐RustumNR , BarakatRR , VenkatramanE , SpriggsD . Chemotherapy and total parenteral nutrition for advanced ovarian cancer with bowel obstruction. Gynecologic Oncology1997;64:493‐5. ">Abu‐Rustum 1997</a>) compared chemotherapy and PN with chemotherapy alone and another (<a href="./references#CD012812-bbs2-0005" title="CotogniP , DeCarliL , PasseraR , AmerioML , AgnelloE , FaddaM , et al. Longitudinal study of quality of life in advanced cancer patients on home parenteral nutrition. Cancer Medicine2017;6:1799‐806. ">Cotogni 2017</a>) compared PN and treatment (chemotherapy, radiotherapy or a combination of both) with PN alone. One study had a comparator that was not relevant for this review (<a href="./references#CD012812-bbs2-0004" title="ChermeshI , MashiachT , AmitA , HaimN , PapierI , EferganR , et al. Home parenteral nutrition (HTPN) for incurable patients with cancer with gastrointestinal obstruction: do the benefits outweigh the risks?. Medical Oncology2011;28:83‐8. ">Chermesh 2011</a>), which compared PN in MBO with benign disease. However, data were only extracted for the MBO participants. </p> </section> <section id="CD012812-sec-0070"> <h5 class="title">Outcome</h5> <section id="CD012812-sec-0071"> <h6 class="title">Survival</h6> <p>All of the studies reported the overall survival of participants on PN. However, the definition of survival was inconsistent between the studies, and at times unclear. Some defined survival from the start of HPN (<a href="./references#CD012812-bbs2-0003" title="BozzettiF , CozzaglioL , BiganzoliE , ChiavennaG , DeCiccoM , DonatiD , et al. Quality of life and length of survival in advanced cancer patients on home parenteral nutrition. Clinical Nutrition2002;21:281‐8. ">Bozzetti 2002</a>; <a href="./references#CD012812-bbs2-0009" title="KingLA , CarsonLF , KonstantinidesN , HouseMS , AdcockLL , PremKA , et al. Outcome assessment of home parenteral nutrition in patients with gynecologic malignancies: what have we learned in a decade of experience?. Gynecologic Oncology1993;51:377‐82. ">King 1993</a>; <a href="./references#CD012812-bbs2-0012" title="SantarpiaL , AlfonsiL , PasanisiF , DeCaprioC , ScalfiL , ContaldoF . Predictive factors of survival in patients with peritoneal carcinomatosis on home parenteral nutrition. Nutrition2006;22:355‐60. ">Santarpia 2006</a>), which could be assumed to be from discharge, until death. Other studies explicitly stated that survival was measured from discharge until death (<a href="./references#CD012812-bbs2-0002" title="AugustDA , ThornD , FisherRL , WelchekCM . Home parenteral nutrition for patients with inoperable malignant bowel obstruction. Journal of Parenteral and Enteral Nutrition1991;15:323‐7. ">August 1991</a>; <a href="./references#CD012812-bbs2-0004" title="ChermeshI , MashiachT , AmitA , HaimN , PapierI , EferganR , et al. Home parenteral nutrition (HTPN) for incurable patients with cancer with gastrointestinal obstruction: do the benefits outweigh the risks?. Medical Oncology2011;28:83‐8. ">Chermesh 2011</a>; <a href="./references#CD012812-bbs2-0008" title="KeaneN , FragkosK , PatelP , BertschF , MehtaJ , DiCaroS , et al. Performance status, prognostic scoring, and parenteral nutrition requirements predict survival in patients with advanced cancer receiving home parenteral nutrition. Nutrition and Cancer2018;70(1):73‐82. ">Keane 2018</a>); whilst others were unclear, but it has been assumed by the review authors that the survival interval was calculated from discharge until death (<a href="./references#CD012812-bbs2-0005" title="CotogniP , DeCarliL , PasseraR , AmerioML , AgnelloE , FaddaM , et al. Longitudinal study of quality of life in advanced cancer patients on home parenteral nutrition. Cancer Medicine2017;6:1799‐806. ">Cotogni 2017</a>; <a href="./references#CD012812-bbs2-0007" title="FinocchiaroC , GervasioS , AgnelloE , AppianoS , BertettoO , CiuffredaL , et al. Multicentric study on home parenteral nutrition in advanced cancer patients. Rivista italiana di Nutrizione Parenterale ed Enterale2002;20:98‐107. ">Finocchiaro 2002</a>; <a href="./references#CD012812-bbs2-0011" title="PironiL , RuggeriE , TannebergerS , GiordaniS , PannutiF , MiglioliM . Home artificial nutrition in advanced cancer. Journal of the Royal Society of Medicine1997;90(11):597‐603. ">Pironi 1997</a>; <a href="./references#CD012812-bbs2-0013" title="SooI , GramlichL . Use of parenteral nutrition in patients with advanced cancer. Applied Physiology, Nutrition, and Metabolism2008;33:102‐6. ">Soo 2008</a>). <a href="./references#CD012812-bbs2-0001" title="Abu‐RustumNR , BarakatRR , VenkatramanE , SpriggsD . Chemotherapy and total parenteral nutrition for advanced ovarian cancer with bowel obstruction. Gynecologic Oncology1997;64:493‐5. ">Abu‐Rustum 1997</a> measured survival from venting gastrostomy placement. In <a href="./references#CD012812-bbs2-0010" title="MercadanteS . Parenteral nutrition at home in advanced cancer patients. Journal of Pain and Symptom Management1995;10:476‐80. ">Mercadante 1995</a> and <a href="./references#CD012812-bbs2-0006" title="DuerksenDR , TingE , ThomsonP , McCurdyK , LinscerJ , Larsen‐CelharS , et al. Is there a role for TPN in terminally ill patients with bowel obstruction?. Nutrition2004;20:760‐3. ">Duerksen 2004</a>, survival was measured from initiation of PN. Therefore, in these three studies (<a href="./references#CD012812-bbs2-0001" title="Abu‐RustumNR , BarakatRR , VenkatramanE , SpriggsD . Chemotherapy and total parenteral nutrition for advanced ovarian cancer with bowel obstruction. Gynecologic Oncology1997;64:493‐5. ">Abu‐Rustum 1997</a>; <a href="./references#CD012812-bbs2-0006" title="DuerksenDR , TingE , ThomsonP , McCurdyK , LinscerJ , Larsen‐CelharS , et al. Is there a role for TPN in terminally ill patients with bowel obstruction?. Nutrition2004;20:760‐3. ">Duerksen 2004</a>; <a href="./references#CD012812-bbs2-0010" title="MercadanteS . Parenteral nutrition at home in advanced cancer patients. Journal of Pain and Symptom Management1995;10:476‐80. ">Mercadante 1995</a>), survival was calculated over a longer time period as the measurement started whilst the patient was in hospital. </p> </section> <section id="CD012812-sec-0072"> <h6 class="title">Quality of life</h6> <p>Four of the studies described quality of life of participants receiving HPN (<a href="./references#CD012812-bbs2-0003" title="BozzettiF , CozzaglioL , BiganzoliE , ChiavennaG , DeCiccoM , DonatiD , et al. Quality of life and length of survival in advanced cancer patients on home parenteral nutrition. Clinical Nutrition2002;21:281‐8. ">Bozzetti 2002</a>; <a href="./references#CD012812-bbs2-0005" title="CotogniP , DeCarliL , PasseraR , AmerioML , AgnelloE , FaddaM , et al. Longitudinal study of quality of life in advanced cancer patients on home parenteral nutrition. Cancer Medicine2017;6:1799‐806. ">Cotogni 2017</a>; <a href="./references#CD012812-bbs2-0007" title="FinocchiaroC , GervasioS , AgnelloE , AppianoS , BertettoO , CiuffredaL , et al. Multicentric study on home parenteral nutrition in advanced cancer patients. Rivista italiana di Nutrizione Parenterale ed Enterale2002;20:98‐107. ">Finocchiaro 2002</a>; <a href="./references#CD012812-bbs2-0009" title="KingLA , CarsonLF , KonstantinidesN , HouseMS , AdcockLL , PremKA , et al. Outcome assessment of home parenteral nutrition in patients with gynecologic malignancies: what have we learned in a decade of experience?. Gynecologic Oncology1993;51:377‐82. ">King 1993</a>). Three of the studies used a validated instrument to measure quality of life (<a href="./references#CD012812-bbs2-0003" title="BozzettiF , CozzaglioL , BiganzoliE , ChiavennaG , DeCiccoM , DonatiD , et al. Quality of life and length of survival in advanced cancer patients on home parenteral nutrition. Clinical Nutrition2002;21:281‐8. ">Bozzetti 2002</a>; <a href="./references#CD012812-bbs2-0005" title="CotogniP , DeCarliL , PasseraR , AmerioML , AgnelloE , FaddaM , et al. Longitudinal study of quality of life in advanced cancer patients on home parenteral nutrition. Cancer Medicine2017;6:1799‐806. ">Cotogni 2017</a>; <a href="./references#CD012812-bbs2-0007" title="FinocchiaroC , GervasioS , AgnelloE , AppianoS , BertettoO , CiuffredaL , et al. Multicentric study on home parenteral nutrition in advanced cancer patients. Rivista italiana di Nutrizione Parenterale ed Enterale2002;20:98‐107. ">Finocchiaro 2002</a>): <a href="./references#CD012812-bbs2-0003" title="BozzettiF , CozzaglioL , BiganzoliE , ChiavennaG , DeCiccoM , DonatiD , et al. Quality of life and length of survival in advanced cancer patients on home parenteral nutrition. Clinical Nutrition2002;21:281‐8. ">Bozzetti 2002</a> used the Rotterdam Symptom Checklist, which participants filled in monthly, and presented detailed results from 64 participants after one month on PN; lower scores represent better quality of life. <a href="./references#CD012812-bbs2-0005" title="CotogniP , DeCarliL , PasseraR , AmerioML , AgnelloE , FaddaM , et al. Longitudinal study of quality of life in advanced cancer patients on home parenteral nutrition. Cancer Medicine2017;6:1799‐806. ">Cotogni 2017</a> used participant‐completed European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 Version 3.0 (EORTC QLQ‐C30). Scores ranged between zero and 100 with higher scores indicating better quality of life in the domains: global quality of life, physical functioning, role functioning, emotional functioning, cognitive functioning and social functioning. In the domains: appetite loss, fatigue, nausea and vomiting and financial impact, lower scores indicate a better quality of life. Participants completed the questionnaire before initiation of HPN in the presence of a healthcare professional and subsequently at home, monthly for four months. <a href="./references#CD012812-bbs2-0007" title="FinocchiaroC , GervasioS , AgnelloE , AppianoS , BertettoO , CiuffredaL , et al. Multicentric study on home parenteral nutrition in advanced cancer patients. Rivista italiana di Nutrizione Parenterale ed Enterale2002;20:98‐107. ">Finocchiaro 2002</a> used the Therapy Impact Questionnaire with 27 participants treated for more than two months, although it was unclear who completed the questionnaire; lower scores indicated a better quality of life. <a href="./references#CD012812-bbs2-0009" title="KingLA , CarsonLF , KonstantinidesN , HouseMS , AdcockLL , PremKA , et al. Outcome assessment of home parenteral nutrition in patients with gynecologic malignancies: what have we learned in a decade of experience?. Gynecologic Oncology1993;51:377‐82. ">King 1993</a> employed various criteria to assess quality of life. Physical and psychological well‐being were assessed by Karnofsky Performance Status, level of activity, morale and presence of pain, fatigue, gastrointestinal discomfort, nausea, vomiting and diarrhoea; apart from Karnofsky Performance Status, criteria were measured by a one (usual or best) to five (worse or never) scale. Social interactions with friends and family were also measured on the same one‐to‐five scale. <a href="./references#CD012812-bbs2-0009" title="KingLA , CarsonLF , KonstantinidesN , HouseMS , AdcockLL , PremKA , et al. Outcome assessment of home parenteral nutrition in patients with gynecologic malignancies: what have we learned in a decade of experience?. Gynecologic Oncology1993;51:377‐82. ">King 1993</a> also reported participant employment or recreational travel as present or absent. It was unclear in the <a href="./references#CD012812-bbs2-0009" title="KingLA , CarsonLF , KonstantinidesN , HouseMS , AdcockLL , PremKA , et al. Outcome assessment of home parenteral nutrition in patients with gynecologic malignancies: what have we learned in a decade of experience?. Gynecologic Oncology1993;51:377‐82. ">King 1993</a> study who was assessing participant quality of life, but they gathered the information from medical records, interviews with participants and family, and from healthcare professionals. </p> </section> <section id="CD012812-sec-0073"> <h6 class="title">Measurement of gastrointestinal symptoms</h6> <p>Most studies did not monitor gastrointestinal symptoms. However in some studies gastrointestinal symptoms were measured in combination with other symptoms and could not be abstracted separately (<a href="./references#CD012812-bbs2-0003" title="BozzettiF , CozzaglioL , BiganzoliE , ChiavennaG , DeCiccoM , DonatiD , et al. Quality of life and length of survival in advanced cancer patients on home parenteral nutrition. Clinical Nutrition2002;21:281‐8. ">Bozzetti 2002</a>; <a href="./references#CD012812-bbs2-0005" title="CotogniP , DeCarliL , PasseraR , AmerioML , AgnelloE , FaddaM , et al. Longitudinal study of quality of life in advanced cancer patients on home parenteral nutrition. Cancer Medicine2017;6:1799‐806. ">Cotogni 2017</a>). <a href="./references#CD012812-bbs2-0009" title="KingLA , CarsonLF , KonstantinidesN , HouseMS , AdcockLL , PremKA , et al. Outcome assessment of home parenteral nutrition in patients with gynecologic malignancies: what have we learned in a decade of experience?. Gynecologic Oncology1993;51:377‐82. ">King 1993</a> investigated gastrointestinal discomfort, nausea and vomiting and diarrhoea using a scale of one (usual or best) to five (worst or never) prior to PN and at one‐month intervals. <a href="./references#CD012812-bbs2-0007" title="FinocchiaroC , GervasioS , AgnelloE , AppianoS , BertettoO , CiuffredaL , et al. Multicentric study on home parenteral nutrition in advanced cancer patients. Rivista italiana di Nutrizione Parenterale ed Enterale2002;20:98‐107. ">Finocchiaro 2002</a> presented symptoms of nausea and vomiting in 27 participants treated for longer than two months on HPN; these were measured as part of the Therapy Impact Questionnaire where a lower score indicates a better outcome. </p> </section> <section id="CD012812-sec-0074"> <h6 class="title">Measurement of nutritional status</h6> <p>Four studies (<a href="./references#CD012812-bbs2-0003" title="BozzettiF , CozzaglioL , BiganzoliE , ChiavennaG , DeCiccoM , DonatiD , et al. Quality of life and length of survival in advanced cancer patients on home parenteral nutrition. Clinical Nutrition2002;21:281‐8. ">Bozzetti 2002</a>; <a href="./references#CD012812-bbs2-0007" title="FinocchiaroC , GervasioS , AgnelloE , AppianoS , BertettoO , CiuffredaL , et al. Multicentric study on home parenteral nutrition in advanced cancer patients. Rivista italiana di Nutrizione Parenterale ed Enterale2002;20:98‐107. ">Finocchiaro 2002</a>; <a href="./references#CD012812-bbs2-0009" title="KingLA , CarsonLF , KonstantinidesN , HouseMS , AdcockLL , PremKA , et al. Outcome assessment of home parenteral nutrition in patients with gynecologic malignancies: what have we learned in a decade of experience?. Gynecologic Oncology1993;51:377‐82. ">King 1993</a>; <a href="./references#CD012812-bbs2-0012" title="SantarpiaL , AlfonsiL , PasanisiF , DeCaprioC , ScalfiL , ContaldoF . Predictive factors of survival in patients with peritoneal carcinomatosis on home parenteral nutrition. Nutrition2006;22:355‐60. ">Santarpia 2006</a>) measured nutritional status. <a href="./references#CD012812-bbs2-0003" title="BozzettiF , CozzaglioL , BiganzoliE , ChiavennaG , DeCiccoM , DonatiD , et al. Quality of life and length of survival in advanced cancer patients on home parenteral nutrition. Clinical Nutrition2002;21:281‐8. ">Bozzetti 2002</a> monitored nutritional status at the start of treatment until death; measuring weight, serum albumin, lymphocyte count and serum transferrin. <a href="./references#CD012812-bbs2-0007" title="FinocchiaroC , GervasioS , AgnelloE , AppianoS , BertettoO , CiuffredaL , et al. Multicentric study on home parenteral nutrition in advanced cancer patients. Rivista italiana di Nutrizione Parenterale ed Enterale2002;20:98‐107. ">Finocchiaro 2002</a> reported on nutritional status before PN and after two months in the 27 (of 70 participants) who survived longer than two months. They measured weight and patient‐generated‐subjective global assessment (PG‐SGA); PG‐SGA is measured as either A, B or C with A representing the best nutritional status and C the worst. <a href="./references#CD012812-bbs2-0009" title="KingLA , CarsonLF , KonstantinidesN , HouseMS , AdcockLL , PremKA , et al. Outcome assessment of home parenteral nutrition in patients with gynecologic malignancies: what have we learned in a decade of experience?. Gynecologic Oncology1993;51:377‐82. ">King 1993</a> measured nutritional status prior to HPN and at one week, one month, three months, six months and one year; as per protocol we report on measures at baseline, one month, three months and six months. <a href="./references#CD012812-bbs2-0009" title="KingLA , CarsonLF , KonstantinidesN , HouseMS , AdcockLL , PremKA , et al. Outcome assessment of home parenteral nutrition in patients with gynecologic malignancies: what have we learned in a decade of experience?. Gynecologic Oncology1993;51:377‐82. ">King 1993</a> measured weight, serum albumin and serum transferrin. <a href="./references#CD012812-bbs2-0012" title="SantarpiaL , AlfonsiL , PasanisiF , DeCaprioC , ScalfiL , ContaldoF . Predictive factors of survival in patients with peritoneal carcinomatosis on home parenteral nutrition. Nutrition2006;22:355‐60. ">Santarpia 2006</a> reported weight at baseline and one month in two tables for participants who lived more than 60 or 90 days. We report the data for 64 participants surviving for 60 or more days. </p> </section> <section id="CD012812-sec-0075"> <h6 class="title">Qualitative reports of symptoms</h6> <p>No studies had qualitative reports of symptoms.</p> </section> <section id="CD012812-sec-0076"> <h6 class="title">Adverse events</h6> <p>Nine studies gave information on adverse events (<a href="./references#CD012812-bbs2-0002" title="AugustDA , ThornD , FisherRL , WelchekCM . Home parenteral nutrition for patients with inoperable malignant bowel obstruction. Journal of Parenteral and Enteral Nutrition1991;15:323‐7. ">August 1991</a>; <a href="./references#CD012812-bbs2-0004" title="ChermeshI , MashiachT , AmitA , HaimN , PapierI , EferganR , et al. Home parenteral nutrition (HTPN) for incurable patients with cancer with gastrointestinal obstruction: do the benefits outweigh the risks?. Medical Oncology2011;28:83‐8. ">Chermesh 2011</a>; <a href="./references#CD012812-bbs2-0005" title="CotogniP , DeCarliL , PasseraR , AmerioML , AgnelloE , FaddaM , et al. Longitudinal study of quality of life in advanced cancer patients on home parenteral nutrition. Cancer Medicine2017;6:1799‐806. ">Cotogni 2017</a>; <a href="./references#CD012812-bbs2-0006" title="DuerksenDR , TingE , ThomsonP , McCurdyK , LinscerJ , Larsen‐CelharS , et al. Is there a role for TPN in terminally ill patients with bowel obstruction?. Nutrition2004;20:760‐3. ">Duerksen 2004</a>; <a href="./references#CD012812-bbs2-0007" title="FinocchiaroC , GervasioS , AgnelloE , AppianoS , BertettoO , CiuffredaL , et al. Multicentric study on home parenteral nutrition in advanced cancer patients. Rivista italiana di Nutrizione Parenterale ed Enterale2002;20:98‐107. ">Finocchiaro 2002</a>; <a href="./references#CD012812-bbs2-0009" title="KingLA , CarsonLF , KonstantinidesN , HouseMS , AdcockLL , PremKA , et al. Outcome assessment of home parenteral nutrition in patients with gynecologic malignancies: what have we learned in a decade of experience?. Gynecologic Oncology1993;51:377‐82. ">King 1993</a>; <a href="./references#CD012812-bbs2-0010" title="MercadanteS . Parenteral nutrition at home in advanced cancer patients. Journal of Pain and Symptom Management1995;10:476‐80. ">Mercadante 1995</a>; <a href="./references#CD012812-bbs2-0011" title="PironiL , RuggeriE , TannebergerS , GiordaniS , PannutiF , MiglioliM . Home artificial nutrition in advanced cancer. Journal of the Royal Society of Medicine1997;90(11):597‐603. ">Pironi 1997</a>; <a href="./references#CD012812-bbs2-0013" title="SooI , GramlichL . Use of parenteral nutrition in patients with advanced cancer. Applied Physiology, Nutrition, and Metabolism2008;33:102‐6. ">Soo 2008</a>). They included information about a variety of major and minor adverse events that participants encountered, but as per protocol, we report only on central venous catheter infection and hospitalisations due to PN complications. </p> </section> <section id="CD012812-sec-0077"> <h6 class="title">Health economic outcomes</h6> <p>Two of the studies considered cost (<a href="./references#CD012812-bbs2-0010" title="MercadanteS . Parenteral nutrition at home in advanced cancer patients. Journal of Pain and Symptom Management1995;10:476‐80. ">Mercadante 1995</a>; <a href="./references#CD012812-bbs2-0011" title="PironiL , RuggeriE , TannebergerS , GiordaniS , PannutiF , MiglioliM . Home artificial nutrition in advanced cancer. Journal of the Royal Society of Medicine1997;90(11):597‐603. ">Pironi 1997</a>). However, they did not consider cost in a health economic evaluation such as quality adjusted life years. </p> </section> </section> </section> <section id="CD012812-sec-0078"> <h4 class="title">Excluded studies</h4> <p>See <a href="#CD012812-sec-0078">Excluded studies</a> </p> <p>We provide details of 24 excluded studies. We listed studies as excluded if they were obtained in full text and were discussed by three review authors: AMS, JS and SB. The summary of reasons for exclusion included the following. </p> <p> <ul id="CD012812-list-0022"> <li> <p>The study did not address the aim of the review (<a href="./references#CD012812-bbs2-0015" title="BozzettiF , CotogniP , Lo VulloS , PironiL , GiardielloD , MarianiL . Development and validation of a nomogram to predict survival in incurable cachectic cancer patients on home parenteral nutrition. Annals of Oncology2015;26(11):2335‐40. ">Bozzetti 2015</a>; <a href="./references#CD012812-bbs2-0018" title="ChenCJ , ShihSC , WangHY , SunFJ , LuSC , ChuCH , et al. Clinical application of total parenteral nutrition in patients with peritoneal carcinomatosis. European Journal of Cancer Care2013;22:468‐73. ">Chen 2013</a>; <a href="./references#CD012812-bbs2-0020" title="DiverE , O'ConnorO , GarrettL , BorutaD , GoodmanA , DelCarmenM , et al. Modest benefit of total parenteral nutrition and chemotherapy after venting gastrostomy tube placement. Gynecologic Oncology2013;129:332‐5. ">Diver 2013</a>; <a href="./references#CD012812-bbs2-0036" title="VillaresJM , GomisPM , ValeroMA , Leon‐SanzM . Home parenteral nutrition in advanced cancer patients with intestinal obstruction or dysfunction. A single‐institution experience. Rivista Italiana di Nutrizione Parenterale ed Enterale2001;19:28‐31. ">Villares 2001</a>; <a href="./references#CD012812-bbs2-0037" title="VillaresJMM , GomisPM , ValeroMA , Leon‐SanzM . Home parenteral nutrition in patients with advanced cancer: experience of a single centre over ten years. Nutricion Hospitalaria2004;19:253‐8. ">Villares 2004</a>). </p> </li> <li> <p>Patients did not received HPN (<a href="./references#CD012812-bbs2-0016" title="BrardL , WeitzenS , Strubel‐LaganSL , SwamyN , GordinierME , MooreRG , et al. The effect of total parenteral nutrition on the survival of terminally ill ovarian cancer patients. Gynecologic Oncology2006;103:176‐80. ">Brard 2006</a>; <a href="./references#CD012812-bbs2-0017" title="ChakrabortyA , SelbyD , GardinerK , MyersJ , MoravanV , WrightF . Malignant bowel obstruction: natural history of a heterogeneous patient population followed prospectively over two years. Journal of Pain and Symptom Management2011;41:412‐20. ">Chakraborty 2011</a>; <a href="./references#CD012812-bbs2-0019" title="ChouhanJ , GuptaR , EnsorJ , RaghavK , FogelmanD , WolffRA , et al. Retrospective analysis of systemic chemotherapy and total parenteral nutrition for the treatment of malignant small bowel obstruction. Cancer Medicine2016;5:239‐47. ">Chouhan 2016</a>; <a href="./references#CD012812-bbs2-0021" title="FanBG . Parenteral nutrition prolongs the survival of patients associated with malignant gastrointestinal obstruction. Journal of Parenteral and Enteral Nutrition2007;31:508‐10. ">Fan 2007</a>; <a href="./references#CD012812-bbs2-0030" title="OhSY , JunHJ , ParkSJ , ParkIK , LimGJ , YuY , et al. A randomized phase II study to assess the effectiveness of fluid therapy or intensive nutritional support on survival in patients with advanced cancer who cannot be nourished via enteral route. Journal of Palliative Medicine2014;17:1266‐70. ">Oh 2014</a>; <a href="./references#CD012812-bbs2-0032" title="SzefelJ , KruszewskiWJ , SzajewskiM , CiesielskiM , SobczakE , CzerepkoM , et al. Medium‐chain triglycerides/long‐chain triglycerides versus long‐chain triglycerides in treatment of cancer patients with major body mass loss. Survival in patients with refractory cachexia. Przeglad Gastroenterologiczny2016;11:181‐6. ">Szefel 2016</a>; <a href="./references#CD012812-bbs2-0034" title="TuncaJC . Impact of cisplatin multiagent chemotherapy and total parenteral hyperalimentation on bowel obstruction caused by ovarian cancer. Gynecologic Oncology1981;12:219‐21. ">Tunca 1981</a>). </p> </li> <li> <p>The number of people with MBO was not specified or was lower than 70% (<a href="./references#CD012812-bbs2-0014" title="BozzettiF , SantarpiaL , PironiL , ThulP , KlekS , GavazziC , et al. The prognosis of incurable cachectic cancer patients on home parenteral nutrition: a multi‐centre observational study with prospective follow‐up of 414 patients. Annals of Oncology2014;25:487‐93. ">Bozzetti 2014</a>; <a href="./references#CD012812-bbs2-0023" title="GirkeJ , SeiptC , MarkowskiA , LuettigB , SchettlerA , MommaM , et al. Quality of life and nutrition condition of patients improve under home parenteral nutrition: An exploratory study. Nutrition in Clinical Practice2016;31:659‐65. ">Girke 2016</a>; <a href="./references#CD012812-bbs2-0026" title="HodaD , JatoiA , BurnesJ , LoprinziC , KellyD . Should patients with advanced, incurable cancers ever be sent home with total parenteral nutrition? A single institution's 20‐year experience. Cancer2005;103:863‐8. ">Hoda 2005</a>; <a href="./references#CD012812-bbs2-0028" title="MercadanteS , CaruselliA , VillariP , GirelliD , PrestiaG , GiarratanoA . Frequency and indications of parenteral nutrition in an acute palliative care unit. Nutrition and Cancer2015;67:1010‐3. ">Mercadante 2015</a>; <a href="./references#CD012812-bbs2-0033" title="TangE , DavisJ , SilbermanH . Bowel obstruction in cancer patients. Archives of Surgery1995;130:832‐6. ">Tang 1995</a>; <a href="./references#CD012812-bbs2-0035" title="VashiPG , DahlkS , PopielB , LammersfeldCA , Ireton‐JonesC , GuptaD . A longitudinal study investigating quality of life and nutritional outcomes in advanced cancer patients receiving home parenteral nutrition. BMC Cancer2014;14:593. ">Vashi 2014</a>). </p> </li> <li> <p>Only hydration was received by patients (<a href="./references#CD012812-bbs2-0022" title="GemloB , RaynerAA , LewisB , WongA , VieleCS , UngarettiJR , et al. Home support of patients with end‐stage malignant bowel obstruction using hydration and venting gastrostomy. The American Journal of Surgery1986;152:100‐4. ">Gemlo 1986</a>; <a href="./references#CD012812-bbs2-0027" title="MercadanteS . Bowel obstruction in home‐care cancer patients: 4 years experience. Support Care Cancer1995;3:190‐3. ">Mercadante 1995a</a>). </p> </li> <li> <p>Data were included in another study (<a href="./references#CD012812-bbs2-0031" title="PasanisiF , OrbanA , ScalfiL , AlfonsiL , SantarpiaL , ZurloE , et al. Predictors of survival in terminal‐cancer patients with irreversible bowel obstruction receiving home parenteral nutrition. Nutrition2001;17:581‐4. ">Pasanisi 2001</a>;<a href="./references#CD012812-bbs2-0025" title="GuptaR , ChouhanJS , EnsorJ , FogelmanDR , EpnerDE , WolffAR , et al. Role of concurrent systemic chemotherapy and total parental nutrition (TPN) for the treatment of malignant small bowel obstruction (SBO). Journal of Clinical Oncology2015;33:1. ">Gupta 2015</a>). </p> </li> <li> <p>Review article (<a href="./references#CD012812-bbs2-0029" title="NaghibiM , SmithTR , EliaM . A systematic review with meta‐analysis of survival, quality of life and cost‐effectiveness of home parenteral nutrition in patients with inoperable malignant bowel obstruction. Clinical Nutrition2015;34:825‐37. ">Naghibi 2015</a>). </p> </li> <li> <p>Unable to extract data from patients who received home parenteral nutrition <a href="./references#CD012812-bbs2-0024" title="GuerraEA , Cortes‐SalgadoA , Mateo‐LoboR , NatteroL , RiveiroJ , Vega‐PineroB , et al. Role of parenteral nutrition in oncologic patients with intestinal occlusion and peritoneal carcinomatosis. Nutricion Hospitalaria2015;32:1222‐7. ">Guerra 2015</a>. </p> </li> </ul> </p> </section> </section> <section id="CD012812-sec-0079"> <h3 class="title">Risk of bias in included studies</h3> <p>All the studies were case series or cohort studies; participants were not randomised to treatments, there was no group allocation concealment and no blinding of participants, personnel or assessors. Therefore, the risk of bias in all studies was high. </p> <section id="CD012812-sec-0080"> <h4 class="title">Allocation</h4> <p>Allocation bias was high in all studies. Participants were not randomised to treatments and there was no group allocation concealment. In most of the studies there was only one treatment group and no comparator (<a href="./references#CD012812-bbs2-0002" title="AugustDA , ThornD , FisherRL , WelchekCM . Home parenteral nutrition for patients with inoperable malignant bowel obstruction. Journal of Parenteral and Enteral Nutrition1991;15:323‐7. ">August 1991</a>; <a href="./references#CD012812-bbs2-0003" title="BozzettiF , CozzaglioL , BiganzoliE , ChiavennaG , DeCiccoM , DonatiD , et al. Quality of life and length of survival in advanced cancer patients on home parenteral nutrition. Clinical Nutrition2002;21:281‐8. ">Bozzetti 2002</a>; <a href="./references#CD012812-bbs2-0006" title="DuerksenDR , TingE , ThomsonP , McCurdyK , LinscerJ , Larsen‐CelharS , et al. Is there a role for TPN in terminally ill patients with bowel obstruction?. Nutrition2004;20:760‐3. ">Duerksen 2004</a>; <a href="./references#CD012812-bbs2-0007" title="FinocchiaroC , GervasioS , AgnelloE , AppianoS , BertettoO , CiuffredaL , et al. Multicentric study on home parenteral nutrition in advanced cancer patients. Rivista italiana di Nutrizione Parenterale ed Enterale2002;20:98‐107. ">Finocchiaro 2002</a>; <a href="./references#CD012812-bbs2-0008" title="KeaneN , FragkosK , PatelP , BertschF , MehtaJ , DiCaroS , et al. Performance status, prognostic scoring, and parenteral nutrition requirements predict survival in patients with advanced cancer receiving home parenteral nutrition. Nutrition and Cancer2018;70(1):73‐82. ">Keane 2018</a>; <a href="./references#CD012812-bbs2-0009" title="KingLA , CarsonLF , KonstantinidesN , HouseMS , AdcockLL , PremKA , et al. Outcome assessment of home parenteral nutrition in patients with gynecologic malignancies: what have we learned in a decade of experience?. Gynecologic Oncology1993;51:377‐82. ">King 1993</a>; <a href="./references#CD012812-bbs2-0010" title="MercadanteS . Parenteral nutrition at home in advanced cancer patients. Journal of Pain and Symptom Management1995;10:476‐80. ">Mercadante 1995</a>; <a href="./references#CD012812-bbs2-0011" title="PironiL , RuggeriE , TannebergerS , GiordaniS , PannutiF , MiglioliM . Home artificial nutrition in advanced cancer. Journal of the Royal Society of Medicine1997;90(11):597‐603. ">Pironi 1997</a>; <a href="./references#CD012812-bbs2-0012" title="SantarpiaL , AlfonsiL , PasanisiF , DeCaprioC , ScalfiL , ContaldoF . Predictive factors of survival in patients with peritoneal carcinomatosis on home parenteral nutrition. Nutrition2006;22:355‐60. ">Santarpia 2006</a>; <a href="./references#CD012812-bbs2-0013" title="SooI , GramlichL . Use of parenteral nutrition in patients with advanced cancer. Applied Physiology, Nutrition, and Metabolism2008;33:102‐6. ">Soo 2008</a>). Three studies had two groups (<a href="./references#CD012812-bbs2-0001" title="Abu‐RustumNR , BarakatRR , VenkatramanE , SpriggsD . Chemotherapy and total parenteral nutrition for advanced ovarian cancer with bowel obstruction. Gynecologic Oncology1997;64:493‐5. ">Abu‐Rustum 1997</a>; <a href="./references#CD012812-bbs2-0004" title="ChermeshI , MashiachT , AmitA , HaimN , PapierI , EferganR , et al. Home parenteral nutrition (HTPN) for incurable patients with cancer with gastrointestinal obstruction: do the benefits outweigh the risks?. Medical Oncology2011;28:83‐8. ">Chermesh 2011</a>; <a href="./references#CD012812-bbs2-0005" title="CotogniP , DeCarliL , PasseraR , AmerioML , AgnelloE , FaddaM , et al. Longitudinal study of quality of life in advanced cancer patients on home parenteral nutrition. Cancer Medicine2017;6:1799‐806. ">Cotogni 2017</a>); although <a href="./references#CD012812-bbs2-0004" title="ChermeshI , MashiachT , AmitA , HaimN , PapierI , EferganR , et al. Home parenteral nutrition (HTPN) for incurable patients with cancer with gastrointestinal obstruction: do the benefits outweigh the risks?. Medical Oncology2011;28:83‐8. ">Chermesh 2011</a> compared participants with MBO and those with benign disease and only MBO participants are included in this review. The decision for which treatments a participant received seems to have been clinically driven as no information is given about group allocation. </p> </section> <section id="CD012812-sec-0081"> <h4 class="title">Blinding</h4> <p>Performance and detection bias for all studies is high as there was no blinding of participants, healthcare professionals or assessors to treatment received. </p> </section> <section id="CD012812-sec-0082"> <h4 class="title">Incomplete outcome data</h4> <p>Attrition bias across most of the studies was low as all participants were accounted for in the outcomes measured (<a href="./references#CD012812-bbs2-0001" title="Abu‐RustumNR , BarakatRR , VenkatramanE , SpriggsD . Chemotherapy and total parenteral nutrition for advanced ovarian cancer with bowel obstruction. Gynecologic Oncology1997;64:493‐5. ">Abu‐Rustum 1997</a>; <a href="./references#CD012812-bbs2-0002" title="AugustDA , ThornD , FisherRL , WelchekCM . Home parenteral nutrition for patients with inoperable malignant bowel obstruction. Journal of Parenteral and Enteral Nutrition1991;15:323‐7. ">August 1991</a>; <a href="./references#CD012812-bbs2-0003" title="BozzettiF , CozzaglioL , BiganzoliE , ChiavennaG , DeCiccoM , DonatiD , et al. Quality of life and length of survival in advanced cancer patients on home parenteral nutrition. Clinical Nutrition2002;21:281‐8. ">Bozzetti 2002</a>; <a href="./references#CD012812-bbs2-0004" title="ChermeshI , MashiachT , AmitA , HaimN , PapierI , EferganR , et al. Home parenteral nutrition (HTPN) for incurable patients with cancer with gastrointestinal obstruction: do the benefits outweigh the risks?. Medical Oncology2011;28:83‐8. ">Chermesh 2011</a>; <a href="./references#CD012812-bbs2-0006" title="DuerksenDR , TingE , ThomsonP , McCurdyK , LinscerJ , Larsen‐CelharS , et al. Is there a role for TPN in terminally ill patients with bowel obstruction?. Nutrition2004;20:760‐3. ">Duerksen 2004</a>; <a href="./references#CD012812-bbs2-0008" title="KeaneN , FragkosK , PatelP , BertschF , MehtaJ , DiCaroS , et al. Performance status, prognostic scoring, and parenteral nutrition requirements predict survival in patients with advanced cancer receiving home parenteral nutrition. Nutrition and Cancer2018;70(1):73‐82. ">Keane 2018</a>; <a href="./references#CD012812-bbs2-0010" title="MercadanteS . Parenteral nutrition at home in advanced cancer patients. Journal of Pain and Symptom Management1995;10:476‐80. ">Mercadante 1995</a>; <a href="./references#CD012812-bbs2-0011" title="PironiL , RuggeriE , TannebergerS , GiordaniS , PannutiF , MiglioliM . Home artificial nutrition in advanced cancer. Journal of the Royal Society of Medicine1997;90(11):597‐603. ">Pironi 1997</a>; <a href="./references#CD012812-bbs2-0012" title="SantarpiaL , AlfonsiL , PasanisiF , DeCaprioC , ScalfiL , ContaldoF . Predictive factors of survival in patients with peritoneal carcinomatosis on home parenteral nutrition. Nutrition2006;22:355‐60. ">Santarpia 2006</a>; <a href="./references#CD012812-bbs2-0013" title="SooI , GramlichL . Use of parenteral nutrition in patients with advanced cancer. Applied Physiology, Nutrition, and Metabolism2008;33:102‐6. ">Soo 2008</a>). In four studies there was a high attrition rate in the measurement of quality of life or nutritional status due to patient death (<a href="./references#CD012812-bbs2-0005" title="CotogniP , DeCarliL , PasseraR , AmerioML , AgnelloE , FaddaM , et al. Longitudinal study of quality of life in advanced cancer patients on home parenteral nutrition. Cancer Medicine2017;6:1799‐806. ">Cotogni 2017</a>; <a href="./references#CD012812-bbs2-0007" title="FinocchiaroC , GervasioS , AgnelloE , AppianoS , BertettoO , CiuffredaL , et al. Multicentric study on home parenteral nutrition in advanced cancer patients. Rivista italiana di Nutrizione Parenterale ed Enterale2002;20:98‐107. ">Finocchiaro 2002</a>; <a href="./references#CD012812-bbs2-0009" title="KingLA , CarsonLF , KonstantinidesN , HouseMS , AdcockLL , PremKA , et al. Outcome assessment of home parenteral nutrition in patients with gynecologic malignancies: what have we learned in a decade of experience?. Gynecologic Oncology1993;51:377‐82. ">King 1993</a>; <a href="./references#CD012812-bbs2-0012" title="SantarpiaL , AlfonsiL , PasanisiF , DeCaprioC , ScalfiL , ContaldoF . Predictive factors of survival in patients with peritoneal carcinomatosis on home parenteral nutrition. Nutrition2006;22:355‐60. ">Santarpia 2006</a>). In <a href="./references#CD012812-bbs2-0005" title="CotogniP , DeCarliL , PasseraR , AmerioML , AgnelloE , FaddaM , et al. Longitudinal study of quality of life in advanced cancer patients on home parenteral nutrition. Cancer Medicine2017;6:1799‐806. ">Cotogni 2017</a>, quality of life was measured at four months in less than half the participants. <a href="./references#CD012812-bbs2-0007" title="FinocchiaroC , GervasioS , AgnelloE , AppianoS , BertettoO , CiuffredaL , et al. Multicentric study on home parenteral nutrition in advanced cancer patients. Rivista italiana di Nutrizione Parenterale ed Enterale2002;20:98‐107. ">Finocchiaro 2002</a> only measured quality of life and nutritional status in 27 of 70 participants who had PN for longer than four months. In <a href="./references#CD012812-bbs2-0009" title="KingLA , CarsonLF , KonstantinidesN , HouseMS , AdcockLL , PremKA , et al. Outcome assessment of home parenteral nutrition in patients with gynecologic malignancies: what have we learned in a decade of experience?. Gynecologic Oncology1993;51:377‐82. ">King 1993</a>, there was a high attrition rate in measurement of nutritional status with only 18 out of 61 participants measured at three months. <a href="./references#CD012812-bbs2-0012" title="SantarpiaL , AlfonsiL , PasanisiF , DeCaprioC , ScalfiL , ContaldoF . Predictive factors of survival in patients with peritoneal carcinomatosis on home parenteral nutrition. Nutrition2006;22:355‐60. ">Santarpia 2006</a> measured nutritional status at one month in those surviving more than 60 days in 64 of 152 participants. </p> </section> <section id="CD012812-sec-0083"> <h4 class="title">Selective reporting</h4> <p>It was unclear if selective reporting was present as we were unable to locate protocols for the studies. </p> </section> <section id="CD012812-sec-0084"> <h4 class="title">Other potential sources of bias</h4> <p>There did not appear to be any other sources of bias present.</p> <p>The risk of bias in the included studies is summarised in <a href="#CD012812-fig-0002">Figure 2</a> and displayed graphically in <a href="#CD012812-fig-0003">Figure 3</a> </p> <div class="figure" id="CD012812-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study." data-id="CD012812-fig-0002" src="/cdsr/doi/10.1002/14651858.CD012812.pub2/media/CDSR/CD012812/image_n/nCD012812-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <div class="figure" id="CD012812-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD012812-fig-0003" src="/cdsr/doi/10.1002/14651858.CD012812.pub2/media/CDSR/CD012812/image_n/nCD012812-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> </section> </section> <section id="CD012812-sec-0085"> <h3 class="title" id="CD012812-sec-0085">Effects of interventions</h3> <p>See: <a href="./full#CD012812-tbl-0001"><b>Summary of findings for the main comparison</b> Parenteral nutrition (PN) for inoperable malignant bowel obstruction (MBO)</a> </p> <section id="CD012812-sec-0086"> <h4 class="title">Primary outcomes</h4> <section id="CD012812-sec-0087"> <h5 class="title">Survival</h5> <p>Survival was measured in all of the studies; see <a href="#CD012812-fig-0004">Figure 4</a>. Seven of the studies (<a href="./references#CD012812-bbs2-0002" title="AugustDA , ThornD , FisherRL , WelchekCM . Home parenteral nutrition for patients with inoperable malignant bowel obstruction. Journal of Parenteral and Enteral Nutrition1991;15:323‐7. ">August 1991</a>; <a href="./references#CD012812-bbs2-0004" title="ChermeshI , MashiachT , AmitA , HaimN , PapierI , EferganR , et al. Home parenteral nutrition (HTPN) for incurable patients with cancer with gastrointestinal obstruction: do the benefits outweigh the risks?. Medical Oncology2011;28:83‐8. ">Chermesh 2011</a>; <a href="./references#CD012812-bbs2-0005" title="CotogniP , DeCarliL , PasseraR , AmerioML , AgnelloE , FaddaM , et al. Longitudinal study of quality of life in advanced cancer patients on home parenteral nutrition. Cancer Medicine2017;6:1799‐806. ">Cotogni 2017</a>; <a href="./references#CD012812-bbs2-0006" title="DuerksenDR , TingE , ThomsonP , McCurdyK , LinscerJ , Larsen‐CelharS , et al. Is there a role for TPN in terminally ill patients with bowel obstruction?. Nutrition2004;20:760‐3. ">Duerksen 2004</a>; <a href="./references#CD012812-bbs2-0008" title="KeaneN , FragkosK , PatelP , BertschF , MehtaJ , DiCaroS , et al. Performance status, prognostic scoring, and parenteral nutrition requirements predict survival in patients with advanced cancer receiving home parenteral nutrition. Nutrition and Cancer2018;70(1):73‐82. ">Keane 2018</a>; <a href="./references#CD012812-bbs2-0010" title="MercadanteS . Parenteral nutrition at home in advanced cancer patients. Journal of Pain and Symptom Management1995;10:476‐80. ">Mercadante 1995</a>; <a href="./references#CD012812-bbs2-0012" title="SantarpiaL , AlfonsiL , PasanisiF , DeCaprioC , ScalfiL , ContaldoF . Predictive factors of survival in patients with peritoneal carcinomatosis on home parenteral nutrition. Nutrition2006;22:355‐60. ">Santarpia 2006</a>) gave survival at different time points, as can be seen in <a href="#CD012812-tbl-0002">Table 1</a>. However, we are uncertain whether HPN improves survival in MBO patients as the evidence was very low certainty. </p> <div class="figure" id="CD012812-fig-0004"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 4</div> </div> <hr class="top"/><img alt="Mean survival and standard deviations calculated from median and range (Hozo 2005) for all studies apart from Keane 2018; Pironi 1997; Soo 2008 which presented mean survival" data-id="CD012812-fig-0004" src="/cdsr/doi/10.1002/14651858.CD012812.pub2/media/CDSR/CD012812/image_n/nCD012812-AFig-FIG04.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Mean survival and standard deviations calculated from median and range (<a href="./references#CD012812-bbs2-0063" title="HozoS , DjulbegovicB , HozoI . Estimating the mean and variance from the median, range, and the size of a sample. BMC Medical Research Methodology2005;5:13. ">Hozo 2005</a>) for all studies apart from <a href="./references#CD012812-bbs2-0008" title="KeaneN , FragkosK , PatelP , BertschF , MehtaJ , DiCaroS , et al. Performance status, prognostic scoring, and parenteral nutrition requirements predict survival in patients with advanced cancer receiving home parenteral nutrition. Nutrition and Cancer2018;70(1):73‐82. ">Keane 2018</a>; <a href="./references#CD012812-bbs2-0011" title="PironiL , RuggeriE , TannebergerS , GiordaniS , PannutiF , MiglioliM . Home artificial nutrition in advanced cancer. Journal of the Royal Society of Medicine1997;90(11):597‐603. ">Pironi 1997</a>; <a href="./references#CD012812-bbs2-0013" title="SooI , GramlichL . Use of parenteral nutrition in patients with advanced cancer. Applied Physiology, Nutrition, and Metabolism2008;33:102‐6. ">Soo 2008</a> which presented mean survival </p> </div> </div> </div> <div class="table" id="CD012812-tbl-0002"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Length of Survival</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Numbers in study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N surviving 1 month</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N surviving &gt; 1‐3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N surviving &gt; 3‐6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N surviving ≥ 6 months</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012812-bbs2-0002" title="AugustDA , ThornD , FisherRL , WelchekCM . Home parenteral nutrition for patients with inoperable malignant bowel obstruction. Journal of Parenteral and Enteral Nutrition1991;15:323‐7. ">August 1991</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>14</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012812-bbs2-0004" title="ChermeshI , MashiachT , AmitA , HaimN , PapierI , EferganR , et al. Home parenteral nutrition (HTPN) for incurable patients with cancer with gastrointestinal obstruction: do the benefits outweigh the risks?. Medical Oncology2011;28:83‐8. ">Chermesh 2011</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>68</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>23</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>14</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012812-bbs2-0005" title="CotogniP , DeCarliL , PasseraR , AmerioML , AgnelloE , FaddaM , et al. Longitudinal study of quality of life in advanced cancer patients on home parenteral nutrition. Cancer Medicine2017;6:1799‐806. ">Cotogni 2017</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>111</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>74<sup>a</sup> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>38</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24<sup>b</sup> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012812-bbs2-0006" title="DuerksenDR , TingE , ThomsonP , McCurdyK , LinscerJ , Larsen‐CelharS , et al. Is there a role for TPN in terminally ill patients with bowel obstruction?. Nutrition2004;20:760‐3. ">Duerksen 2004</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012812-bbs2-0008" title="KeaneN , FragkosK , PatelP , BertschF , MehtaJ , DiCaroS , et al. Performance status, prognostic scoring, and parenteral nutrition requirements predict survival in patients with advanced cancer receiving home parenteral nutrition. Nutrition and Cancer2018;70(1):73‐82. ">Keane 2018</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>107</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>53<sup>a</sup> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>19</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>19</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012812-bbs2-0010" title="MercadanteS . Parenteral nutrition at home in advanced cancer patients. Journal of Pain and Symptom Management1995;10:476‐80. ">Mercadante 1995</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012812-bbs2-0012" title="SantarpiaL , AlfonsiL , PasanisiF , DeCaprioC , ScalfiL , ContaldoF . Predictive factors of survival in patients with peritoneal carcinomatosis on home parenteral nutrition. Nutrition2006;22:355‐60. ">Santarpia 2006</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>152</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>96</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>62</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>37</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>37</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p><sup>N = Numbers</sup> </p> <p><sup>a</sup>Survival was measured from 0 to 3 months in these studies. </p> <p><sup>b</sup>Number surviving at 9 months </p> </div> </div> <p>In six of the studies, all of the participants had MBO (<a href="./references#CD012812-bbs2-0001" title="Abu‐RustumNR , BarakatRR , VenkatramanE , SpriggsD . Chemotherapy and total parenteral nutrition for advanced ovarian cancer with bowel obstruction. Gynecologic Oncology1997;64:493‐5. ">Abu‐Rustum 1997</a>; <a href="./references#CD012812-bbs2-0002" title="AugustDA , ThornD , FisherRL , WelchekCM . Home parenteral nutrition for patients with inoperable malignant bowel obstruction. Journal of Parenteral and Enteral Nutrition1991;15:323‐7. ">August 1991</a>; <a href="./references#CD012812-bbs2-0004" title="ChermeshI , MashiachT , AmitA , HaimN , PapierI , EferganR , et al. Home parenteral nutrition (HTPN) for incurable patients with cancer with gastrointestinal obstruction: do the benefits outweigh the risks?. Medical Oncology2011;28:83‐8. ">Chermesh 2011</a>; <a href="./references#CD012812-bbs2-0006" title="DuerksenDR , TingE , ThomsonP , McCurdyK , LinscerJ , Larsen‐CelharS , et al. Is there a role for TPN in terminally ill patients with bowel obstruction?. Nutrition2004;20:760‐3. ">Duerksen 2004</a>; <a href="./references#CD012812-bbs2-0010" title="MercadanteS . Parenteral nutrition at home in advanced cancer patients. Journal of Pain and Symptom Management1995;10:476‐80. ">Mercadante 1995</a>; <a href="./references#CD012812-bbs2-0012" title="SantarpiaL , AlfonsiL , PasanisiF , DeCaprioC , ScalfiL , ContaldoF . Predictive factors of survival in patients with peritoneal carcinomatosis on home parenteral nutrition. Nutrition2006;22:355‐60. ">Santarpia 2006</a>). The median survival of participants across the studies was 15 days to 155 days with a range of three days to 1278 days. </p> <p>However, in seven of the studies the percentage of participants with MBO ranged from 70% to 89% (<a href="./references#CD012812-bbs2-0003" title="BozzettiF , CozzaglioL , BiganzoliE , ChiavennaG , DeCiccoM , DonatiD , et al. Quality of life and length of survival in advanced cancer patients on home parenteral nutrition. Clinical Nutrition2002;21:281‐8. ">Bozzetti 2002</a>; <a href="./references#CD012812-bbs2-0005" title="CotogniP , DeCarliL , PasseraR , AmerioML , AgnelloE , FaddaM , et al. Longitudinal study of quality of life in advanced cancer patients on home parenteral nutrition. Cancer Medicine2017;6:1799‐806. ">Cotogni 2017</a>; <a href="./references#CD012812-bbs2-0007" title="FinocchiaroC , GervasioS , AgnelloE , AppianoS , BertettoO , CiuffredaL , et al. Multicentric study on home parenteral nutrition in advanced cancer patients. Rivista italiana di Nutrizione Parenterale ed Enterale2002;20:98‐107. ">Finocchiaro 2002</a>; <a href="./references#CD012812-bbs2-0008" title="KeaneN , FragkosK , PatelP , BertschF , MehtaJ , DiCaroS , et al. Performance status, prognostic scoring, and parenteral nutrition requirements predict survival in patients with advanced cancer receiving home parenteral nutrition. Nutrition and Cancer2018;70(1):73‐82. ">Keane 2018</a>; <a href="./references#CD012812-bbs2-0009" title="KingLA , CarsonLF , KonstantinidesN , HouseMS , AdcockLL , PremKA , et al. Outcome assessment of home parenteral nutrition in patients with gynecologic malignancies: what have we learned in a decade of experience?. Gynecologic Oncology1993;51:377‐82. ">King 1993</a>; <a href="./references#CD012812-bbs2-0011" title="PironiL , RuggeriE , TannebergerS , GiordaniS , PannutiF , MiglioliM . Home artificial nutrition in advanced cancer. Journal of the Royal Society of Medicine1997;90(11):597‐603. ">Pironi 1997</a>; <a href="./references#CD012812-bbs2-0013" title="SooI , GramlichL . Use of parenteral nutrition in patients with advanced cancer. Applied Physiology, Nutrition, and Metabolism2008;33:102‐6. ">Soo 2008</a>); the other participants in the group were given PN for other reasons such as poor oral intake. The median survivals intervals were two to four months with a range of 0.07 to 26 months. <a href="./references#CD012812-bbs2-0008" title="KeaneN , FragkosK , PatelP , BertschF , MehtaJ , DiCaroS , et al. Performance status, prognostic scoring, and parenteral nutrition requirements predict survival in patients with advanced cancer receiving home parenteral nutrition. Nutrition and Cancer2018;70(1):73‐82. ">Keane 2018</a>, <a href="./references#CD012812-bbs2-0011" title="PironiL , RuggeriE , TannebergerS , GiordaniS , PannutiF , MiglioliM . Home artificial nutrition in advanced cancer. Journal of the Royal Society of Medicine1997;90(11):597‐603. ">Pironi 1997</a> and <a href="./references#CD012812-bbs2-0013" title="SooI , GramlichL . Use of parenteral nutrition in patients with advanced cancer. Applied Physiology, Nutrition, and Metabolism2008;33:102‐6. ">Soo 2008</a> calculated survival as arithmetic means rather than medians and found a mean survival of 12 (SD 8) weeks and five months (range 0.25 to 33), respectively. <a href="./references#CD012812-bbs2-0008" title="KeaneN , FragkosK , PatelP , BertschF , MehtaJ , DiCaroS , et al. Performance status, prognostic scoring, and parenteral nutrition requirements predict survival in patients with advanced cancer receiving home parenteral nutrition. Nutrition and Cancer2018;70(1):73‐82. ">Keane 2018</a> reported both median survival, 14 weeks (interquartile range (IQR) 5 to 34), and mean survival 31 weeks (95% CI 21 to 40). <a href="./references#CD012812-bbs2-0007" title="FinocchiaroC , GervasioS , AgnelloE , AppianoS , BertettoO , CiuffredaL , et al. Multicentric study on home parenteral nutrition in advanced cancer patients. Rivista italiana di Nutrizione Parenterale ed Enterale2002;20:98‐107. ">Finocchiaro 2002</a> did not report mean or median survival, but at the end of the 14‐month study period 41 out of 70 participants had died. </p> <p>There were no patients lost to follow up from any of the studies. In five studies (<a href="./references#CD012812-bbs2-0001" title="Abu‐RustumNR , BarakatRR , VenkatramanE , SpriggsD . Chemotherapy and total parenteral nutrition for advanced ovarian cancer with bowel obstruction. Gynecologic Oncology1997;64:493‐5. ">Abu‐Rustum 1997</a>; <a href="./references#CD012812-bbs2-0002" title="AugustDA , ThornD , FisherRL , WelchekCM . Home parenteral nutrition for patients with inoperable malignant bowel obstruction. Journal of Parenteral and Enteral Nutrition1991;15:323‐7. ">August 1991</a>; <a href="./references#CD012812-bbs2-0006" title="DuerksenDR , TingE , ThomsonP , McCurdyK , LinscerJ , Larsen‐CelharS , et al. Is there a role for TPN in terminally ill patients with bowel obstruction?. Nutrition2004;20:760‐3. ">Duerksen 2004</a>; <a href="./references#CD012812-bbs2-0010" title="MercadanteS . Parenteral nutrition at home in advanced cancer patients. Journal of Pain and Symptom Management1995;10:476‐80. ">Mercadante 1995</a>; <a href="./references#CD012812-bbs2-0012" title="SantarpiaL , AlfonsiL , PasanisiF , DeCaprioC , ScalfiL , ContaldoF . Predictive factors of survival in patients with peritoneal carcinomatosis on home parenteral nutrition. Nutrition2006;22:355‐60. ">Santarpia 2006</a>), all patients had died by the end of the study period. Five studies clearly stated the number of patients alive at the end of the study (<a href="./references#CD012812-bbs2-0004" title="ChermeshI , MashiachT , AmitA , HaimN , PapierI , EferganR , et al. Home parenteral nutrition (HTPN) for incurable patients with cancer with gastrointestinal obstruction: do the benefits outweigh the risks?. Medical Oncology2011;28:83‐8. ">Chermesh 2011</a>; <a href="./references#CD012812-bbs2-0005" title="CotogniP , DeCarliL , PasseraR , AmerioML , AgnelloE , FaddaM , et al. Longitudinal study of quality of life in advanced cancer patients on home parenteral nutrition. Cancer Medicine2017;6:1799‐806. ">Cotogni 2017</a>; <a href="./references#CD012812-bbs2-0009" title="KingLA , CarsonLF , KonstantinidesN , HouseMS , AdcockLL , PremKA , et al. Outcome assessment of home parenteral nutrition in patients with gynecologic malignancies: what have we learned in a decade of experience?. Gynecologic Oncology1993;51:377‐82. ">King 1993</a>; <a href="./references#CD012812-bbs2-0011" title="PironiL , RuggeriE , TannebergerS , GiordaniS , PannutiF , MiglioliM . Home artificial nutrition in advanced cancer. Journal of the Royal Society of Medicine1997;90(11):597‐603. ">Pironi 1997</a>; <a href="./references#CD012812-bbs2-0013" title="SooI , GramlichL . Use of parenteral nutrition in patients with advanced cancer. Applied Physiology, Nutrition, and Metabolism2008;33:102‐6. ">Soo 2008</a>); the numbers alive ranged from one to 13 patients, which was between 3% to 12% of the study populations. In <a href="./references#CD012812-bbs2-0003" title="BozzettiF , CozzaglioL , BiganzoliE , ChiavennaG , DeCiccoM , DonatiD , et al. Quality of life and length of survival in advanced cancer patients on home parenteral nutrition. Clinical Nutrition2002;21:281‐8. ">Bozzetti 2002</a>; <a href="./references#CD012812-bbs2-0007" title="FinocchiaroC , GervasioS , AgnelloE , AppianoS , BertettoO , CiuffredaL , et al. Multicentric study on home parenteral nutrition in advanced cancer patients. Rivista italiana di Nutrizione Parenterale ed Enterale2002;20:98‐107. ">Finocchiaro 2002</a> and <a href="./references#CD012812-bbs2-0008" title="KeaneN , FragkosK , PatelP , BertschF , MehtaJ , DiCaroS , et al. Performance status, prognostic scoring, and parenteral nutrition requirements predict survival in patients with advanced cancer receiving home parenteral nutrition. Nutrition and Cancer2018;70(1):73‐82. ">Keane 2018</a>, it was unclear how many patients were still alive at the end of the study period as all had patients censored from the analysis; for example if patients resumed oral intake or refused HPN. </p> <p>In addition to investigating overall survival, <a href="./references#CD012812-bbs2-0001" title="Abu‐RustumNR , BarakatRR , VenkatramanE , SpriggsD . Chemotherapy and total parenteral nutrition for advanced ovarian cancer with bowel obstruction. Gynecologic Oncology1997;64:493‐5. ">Abu‐Rustum 1997</a> investigated survival in participants treated with chemotherapy and PN and participants treated with chemotherapy alone; median survival was 89 days and 71 days, respectively. In contrast, <a href="./references#CD012812-bbs2-0005" title="CotogniP , DeCarliL , PasseraR , AmerioML , AgnelloE , FaddaM , et al. Longitudinal study of quality of life in advanced cancer patients on home parenteral nutrition. Cancer Medicine2017;6:1799‐806. ">Cotogni 2017</a> measured survival in 72 participants receiving PN and treatment (chemotherapy, radiotherapy or both) and in 39 participants receiving only PN; after three months, 54 (75%) participants with treatment survived compared to 20 (51%) participants with no treatment; after six months, 10 (26%) participants with no treatment survived compared to 28 (39%) participants having treatment. </p> <p>Two of the studies described survival statistics according to the different primary cancer diagnoses (<a href="./references#CD012812-bbs2-0002" title="AugustDA , ThornD , FisherRL , WelchekCM . Home parenteral nutrition for patients with inoperable malignant bowel obstruction. Journal of Parenteral and Enteral Nutrition1991;15:323‐7. ">August 1991</a>; <a href="./references#CD012812-bbs2-0006" title="DuerksenDR , TingE , ThomsonP , McCurdyK , LinscerJ , Larsen‐CelharS , et al. Is there a role for TPN in terminally ill patients with bowel obstruction?. Nutrition2004;20:760‐3. ">Duerksen 2004</a>); see <a href="#CD012812-tbl-0003">Table 2</a>. Ovarian cancer had the shortest median survival and gastric cancer had the longest. </p> <div class="table" id="CD012812-tbl-0003"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Survival for different cancer diagnoses</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p>Survival ‐ median (range) in days</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Ovarian cancer n = 9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Endometrial cancer n = 1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Gastrointestinal cancer n = 3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Colon cancer</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Gastric cancer n = 2</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012812-bbs2-0002" title="AugustDA , ThornD , FisherRL , WelchekCM . Home parenteral nutrition for patients with inoperable malignant bowel obstruction. Journal of Parenteral and Enteral Nutrition1991;15:323‐7. ">August 1991</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>39 (10 to 77)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>51</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>159 (106 to 208)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>89 (5 to 168)<sup>a</sup> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012812-bbs2-0006" title="DuerksenDR , TingE , ThomsonP , McCurdyK , LinscerJ , Larsen‐CelharS , et al. Is there a role for TPN in terminally ill patients with bowel obstruction?. Nutrition2004;20:760‐3. ">Duerksen 2004</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>155 (72 to 433)<sup>b</sup> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>258 (84 to 431)</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p><sup>a</sup> n = 4 </p> <p><sup>b</sup> n = 3 </p> </div> </div> </section> <section id="CD012812-sec-0088"> <h5 class="title">Quality of life</h5> <p>Quality of life was measured by four studies (measured in 268 participants) (<a href="./references#CD012812-bbs2-0003" title="BozzettiF , CozzaglioL , BiganzoliE , ChiavennaG , DeCiccoM , DonatiD , et al. Quality of life and length of survival in advanced cancer patients on home parenteral nutrition. Clinical Nutrition2002;21:281‐8. ">Bozzetti 2002</a>; <a href="./references#CD012812-bbs2-0005" title="CotogniP , DeCarliL , PasseraR , AmerioML , AgnelloE , FaddaM , et al. Longitudinal study of quality of life in advanced cancer patients on home parenteral nutrition. Cancer Medicine2017;6:1799‐806. ">Cotogni 2017</a>; <a href="./references#CD012812-bbs2-0007" title="FinocchiaroC , GervasioS , AgnelloE , AppianoS , BertettoO , CiuffredaL , et al. Multicentric study on home parenteral nutrition in advanced cancer patients. Rivista italiana di Nutrizione Parenterale ed Enterale2002;20:98‐107. ">Finocchiaro 2002</a>; <a href="./references#CD012812-bbs2-0009" title="KingLA , CarsonLF , KonstantinidesN , HouseMS , AdcockLL , PremKA , et al. Outcome assessment of home parenteral nutrition in patients with gynecologic malignancies: what have we learned in a decade of experience?. Gynecologic Oncology1993;51:377‐82. ">King 1993</a>). We are uncertain whether HPN improves quality of life in MBO patients as the evidence was very low certainty. The studies using a validated measure (<a href="./references#CD012812-bbs2-0003" title="BozzettiF , CozzaglioL , BiganzoliE , ChiavennaG , DeCiccoM , DonatiD , et al. Quality of life and length of survival in advanced cancer patients on home parenteral nutrition. Clinical Nutrition2002;21:281‐8. ">Bozzetti 2002</a>; <a href="./references#CD012812-bbs2-0005" title="CotogniP , DeCarliL , PasseraR , AmerioML , AgnelloE , FaddaM , et al. Longitudinal study of quality of life in advanced cancer patients on home parenteral nutrition. Cancer Medicine2017;6:1799‐806. ">Cotogni 2017</a>; <a href="./references#CD012812-bbs2-0007" title="FinocchiaroC , GervasioS , AgnelloE , AppianoS , BertettoO , CiuffredaL , et al. Multicentric study on home parenteral nutrition in advanced cancer patients. Rivista italiana di Nutrizione Parenterale ed Enterale2002;20:98‐107. ">Finocchiaro 2002</a>) presented a mixed picture. <a href="./references#CD012812-bbs2-0005" title="CotogniP , DeCarliL , PasseraR , AmerioML , AgnelloE , FaddaM , et al. Longitudinal study of quality of life in advanced cancer patients on home parenteral nutrition. Cancer Medicine2017;6:1799‐806. ">Cotogni 2017</a> found an improvement over three months for global quality of life. Two studies (<a href="./references#CD012812-bbs2-0003" title="BozzettiF , CozzaglioL , BiganzoliE , ChiavennaG , DeCiccoM , DonatiD , et al. Quality of life and length of survival in advanced cancer patients on home parenteral nutrition. Clinical Nutrition2002;21:281‐8. ">Bozzetti 2002</a>; <a href="./references#CD012812-bbs2-0007" title="FinocchiaroC , GervasioS , AgnelloE , AppianoS , BertettoO , CiuffredaL , et al. Multicentric study on home parenteral nutrition in advanced cancer patients. Rivista italiana di Nutrizione Parenterale ed Enterale2002;20:98‐107. ">Finocchiaro 2002</a>), reported around half of participants showed no change, a quarter to a fifth deteriorated and a quarter to a third improved. </p> <p>More information about quality of life for the three studies with validated measures (<a href="./references#CD012812-bbs2-0003" title="BozzettiF , CozzaglioL , BiganzoliE , ChiavennaG , DeCiccoM , DonatiD , et al. Quality of life and length of survival in advanced cancer patients on home parenteral nutrition. Clinical Nutrition2002;21:281‐8. ">Bozzetti 2002</a>; <a href="./references#CD012812-bbs2-0005" title="CotogniP , DeCarliL , PasseraR , AmerioML , AgnelloE , FaddaM , et al. Longitudinal study of quality of life in advanced cancer patients on home parenteral nutrition. Cancer Medicine2017;6:1799‐806. ">Cotogni 2017</a>; <a href="./references#CD012812-bbs2-0007" title="FinocchiaroC , GervasioS , AgnelloE , AppianoS , BertettoO , CiuffredaL , et al. Multicentric study on home parenteral nutrition in advanced cancer patients. Rivista italiana di Nutrizione Parenterale ed Enterale2002;20:98‐107. ">Finocchiaro 2002</a>) is given in <a href="#CD012812-tbl-0004">Table 3</a> </p> <div class="table" id="CD012812-tbl-0004"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Quality of life</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Numbers of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Timepoint</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Quality of lIfe measure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Score</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012812-bbs2-0003" title="BozzettiF , CozzaglioL , BiganzoliE , ChiavennaG , DeCiccoM , DonatiD , et al. Quality of life and length of survival in advanced cancer patients on home parenteral nutrition. Clinical Nutrition2002;21:281‐8. ">Bozzetti 2002</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>69<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Baseline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Rotterdam Symptom Checklist</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Well‐being assessment (n)<sup>c</sup><br/> Very well 3<br/> Well 55<br/> Not well 38<br/> Ill 0<br/> Missing 4 </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>64</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1 Month</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Rotterdam Symptom Checklist</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Well‐being assessment change from baseline (n)<br/> Increased 15<br/> No change 32<br/> Decreased 17 </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012812-bbs2-0005" title="CotogniP , DeCarliL , PasseraR , AmerioML , AgnelloE , FaddaM , et al. Longitudinal study of quality of life in advanced cancer patients on home parenteral nutrition. Cancer Medicine2017;6:1799‐806. ">Cotogni 2017</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>111<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Baseline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>EORTC<sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean (SD) Global QoL<sup>d</sup> 52 (17) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>97</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1 Month</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>EORTC</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean (SD) Global QoL 58 (17)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>76</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2 Months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>EORTC</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean (SD) Global QoL 66 (17)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>54</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3 Months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>EORTC</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean (SD) Global QoL 71 (14)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012812-bbs2-0007" title="FinocchiaroC , GervasioS , AgnelloE , AppianoS , BertettoO , CiuffredaL , et al. Multicentric study on home parenteral nutrition in advanced cancer patients. Rivista italiana di Nutrizione Parenterale ed Enterale2002;20:98‐107. ">Finocchiaro 2002</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>70<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Baseline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Therapy impact questionnaire</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Values not given</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>27</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2 Months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Therapy impact questionnaire</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Change from baseline<br/> Deterioration 20.5%<br/> Stationary 48%<br/> Improving 31.5% </p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p><sup>a</sup>Total number in the study </p> <p><sup>b</sup>EORTC = European Organization for Research and Treatment of Cancer Quality of life Questionnaire Core 30 </p> <p><sup>c</sup> Number </p> <p><sup>d</sup>Quality of life </p> </div> </div> </section> </section> <section id="CD012812-sec-0089"> <h4 class="title">Secondary outcomes</h4> <section id="CD012812-sec-0090"> <h5 class="title">Measurement of gastrointestinal symptoms</h5> <p>Two studies (measured in 88 participants) (<a href="./references#CD012812-bbs2-0007" title="FinocchiaroC , GervasioS , AgnelloE , AppianoS , BertettoO , CiuffredaL , et al. Multicentric study on home parenteral nutrition in advanced cancer patients. Rivista italiana di Nutrizione Parenterale ed Enterale2002;20:98‐107. ">Finocchiaro 2002</a>; <a href="./references#CD012812-bbs2-0009" title="KingLA , CarsonLF , KonstantinidesN , HouseMS , AdcockLL , PremKA , et al. Outcome assessment of home parenteral nutrition in patients with gynecologic malignancies: what have we learned in a decade of experience?. Gynecologic Oncology1993;51:377‐82. ">King 1993</a>) measured gastrointestinal symptoms and found some participants symptoms improved, others deteriorated and some had no change; see <a href="#CD012812-tbl-0005">Table 4</a>. We are uncertain whether HPN improves gastrointestinal symptoms in MBO patients as the evidence was very low certainty. </p> <div class="table" id="CD012812-tbl-0005"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 4.</span> <span class="table-title">Gastrointestinal symptoms</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Numbers in study</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Numbers gastrointestinal symptoms measured</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Time point</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Measure</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Nausea<sup>a</sup> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Vomiting</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Gastrointestinal discomfort</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Diarrhoea</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012812-bbs2-0009" title="KingLA , CarsonLF , KonstantinidesN , HouseMS , AdcockLL , PremKA , et al. Outcome assessment of home parenteral nutrition in patients with gynecologic malignancies: what have we learned in a decade of experience?. Gynecologic Oncology1993;51:377‐82. ">King 1993</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>61</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>61</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Baseline</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unvalidated<sup>b</sup> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.2</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.8</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.0</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>61</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>During HPN</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.7</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.4</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.8</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012812-bbs2-0007" title="FinocchiaroC , GervasioS , AgnelloE , AppianoS , BertettoO , CiuffredaL , et al. Multicentric study on home parenteral nutrition in advanced cancer patients. Rivista italiana di Nutrizione Parenterale ed Enterale2002;20:98‐107. ">Finocchiaro 2002</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>71</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>27</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Baseline</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Therapy impact questionnaire</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Values not given</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Values not given</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>27</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2 months</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Therapy impact questionnaire</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Change from Baseline</p> <p>Deterioration 26%<br/> Stationary 42%<br/> Improving 32% </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Change from Baseline</p> <p>Deterioration 15%<br/> Stationary 57%<br/> Improving 28% </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p><sup>a</sup>Nausea and vomiting measured together </p> <p><sup>b</sup> 1 to 5 scale where 1 is usual or best and 5 is worse or never </p> </div> </div> </section> <section id="CD012812-sec-0091"> <h5 class="title">Measurement of nutritional status</h5> <p>Four studies (measured in 221 participants) (<a href="./references#CD012812-bbs2-0003" title="BozzettiF , CozzaglioL , BiganzoliE , ChiavennaG , DeCiccoM , DonatiD , et al. Quality of life and length of survival in advanced cancer patients on home parenteral nutrition. Clinical Nutrition2002;21:281‐8. ">Bozzetti 2002</a>; <a href="./references#CD012812-bbs2-0007" title="FinocchiaroC , GervasioS , AgnelloE , AppianoS , BertettoO , CiuffredaL , et al. Multicentric study on home parenteral nutrition in advanced cancer patients. Rivista italiana di Nutrizione Parenterale ed Enterale2002;20:98‐107. ">Finocchiaro 2002</a>; <a href="./references#CD012812-bbs2-0009" title="KingLA , CarsonLF , KonstantinidesN , HouseMS , AdcockLL , PremKA , et al. Outcome assessment of home parenteral nutrition in patients with gynecologic malignancies: what have we learned in a decade of experience?. Gynecologic Oncology1993;51:377‐82. ">King 1993</a>; <a href="./references#CD012812-bbs2-0012" title="SantarpiaL , AlfonsiL , PasanisiF , DeCaprioC , ScalfiL , ContaldoF . Predictive factors of survival in patients with peritoneal carcinomatosis on home parenteral nutrition. Nutrition2006;22:355‐60. ">Santarpia 2006</a>), measured nutritional status and found that it was maintained. However, we are uncertain of the impact of HPN on nutritional status as the evidence was very low certainty. </p> <p>More information about nutritional status is given in <a href="#CD012812-tbl-0006">Table 5</a> </p> <div class="table" id="CD012812-tbl-0006"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 5.</span> <span class="table-title">Nutritional status</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Numbers nutritional status measured</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Timepoint</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Weight (kg)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Albumin (g/dl)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Transferin (mg/dL)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Lymphocytes</p> <p>(x 10<sup>9</sup>/L) </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cholesterol (mg/dL)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Haemoglobin (g/dL)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>PG‐SGA score (%)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012812-bbs2-0003" title="BozzettiF , CozzaglioL , BiganzoliE , ChiavennaG , DeCiccoM , DonatiD , et al. Quality of life and length of survival in advanced cancer patients on home parenteral nutrition. Clinical Nutrition2002;21:281‐8. ">Bozzetti 2002</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>69</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Baseline</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median 52.5 (35.5 to 77.5)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median 3.3 (2.2 to 4.8)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median 189 (26 to 420)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median 1.15 (0.15 to 3.05)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>69</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Before death</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median 54.0 (36 to 78)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median 3.2 (2.2 to 4.7</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median 180 (65 to 414)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median 1.2</p> <p>(0.24 to 3.65)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012812-bbs2-0007" title="FinocchiaroC , GervasioS , AgnelloE , AppianoS , BertettoO , CiuffredaL , et al. Multicentric study on home parenteral nutrition in advanced cancer patients. Rivista italiana di Nutrizione Parenterale ed Enterale2002;20:98‐107. ">Finocchiaro 2002</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>27<sup>a</sup> (of 70) </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Baseline</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>51 (37 to 76)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.15 (1.2 to 4)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>B ‐ 33%</p> <p>C ‐ 67%</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>27</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2 months</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>52.2 (40 to 71)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.14 (1.7 to 4.5)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A ‐ 15%</p> <p>B ‐ 37%</p> <p>C ‐ 48%</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012812-bbs2-0009" title="KingLA , CarsonLF , KonstantinidesN , HouseMS , AdcockLL , PremKA , et al. Outcome assessment of home parenteral nutrition in patients with gynecologic malignancies: what have we learned in a decade of experience?. Gynecologic Oncology1993;51:377‐82. ">King 1993</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>61</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Baseline</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean 54.5 (13.7)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean 2.5 (0.6)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean 149 (48)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>50</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1 month</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean 57.2 (12.4)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean 2.4 (0.6)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean 149 (60.2)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>18</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3 months</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean 57.7 (11.2)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean 2.9 (0.6)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean 195 (62.2)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 months</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean 59.8 (11.7)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean 3.1 (0.7)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean 225.4 (77)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012812-bbs2-0012" title="SantarpiaL , AlfonsiL , PasanisiF , DeCaprioC , ScalfiL , ContaldoF . Predictive factors of survival in patients with peritoneal carcinomatosis on home parenteral nutrition. Nutrition2006;22:355‐60. ">Santarpia 2006</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>64<sup>a</sup> (of 152) </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Baseline</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean 51.7 (10.3)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean 3.3 (0.6)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean 1.48 (0.72)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean 154 (46)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean 11.0 (1.9)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>64</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1 month</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean 53.2 (10.3)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean 3.4 (0.5)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean 1.46 (0.67)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean 150 (38)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean 10.5 (1.9)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p><sup>a</sup>Baseline values given for those patients who had nutritional status measured later. </p> </div> </div> </section> <section id="CD012812-sec-0092"> <h5 class="title">Qualitative reports of symptoms</h5> <p>No studies contained qualitative descriptions of symptoms.</p> </section> <section id="CD012812-sec-0093"> <h5 class="title">Adverse events</h5> <p>Nine studies (371 participants) gave information on adverse events (<a href="./references#CD012812-bbs2-0002" title="AugustDA , ThornD , FisherRL , WelchekCM . Home parenteral nutrition for patients with inoperable malignant bowel obstruction. Journal of Parenteral and Enteral Nutrition1991;15:323‐7. ">August 1991</a>; <a href="./references#CD012812-bbs2-0004" title="ChermeshI , MashiachT , AmitA , HaimN , PapierI , EferganR , et al. Home parenteral nutrition (HTPN) for incurable patients with cancer with gastrointestinal obstruction: do the benefits outweigh the risks?. Medical Oncology2011;28:83‐8. ">Chermesh 2011</a>; <a href="./references#CD012812-bbs2-0005" title="CotogniP , DeCarliL , PasseraR , AmerioML , AgnelloE , FaddaM , et al. Longitudinal study of quality of life in advanced cancer patients on home parenteral nutrition. Cancer Medicine2017;6:1799‐806. ">Cotogni 2017</a>; <a href="./references#CD012812-bbs2-0006" title="DuerksenDR , TingE , ThomsonP , McCurdyK , LinscerJ , Larsen‐CelharS , et al. Is there a role for TPN in terminally ill patients with bowel obstruction?. Nutrition2004;20:760‐3. ">Duerksen 2004</a>; <a href="./references#CD012812-bbs2-0007" title="FinocchiaroC , GervasioS , AgnelloE , AppianoS , BertettoO , CiuffredaL , et al. Multicentric study on home parenteral nutrition in advanced cancer patients. Rivista italiana di Nutrizione Parenterale ed Enterale2002;20:98‐107. ">Finocchiaro 2002</a>; <a href="./references#CD012812-bbs2-0009" title="KingLA , CarsonLF , KonstantinidesN , HouseMS , AdcockLL , PremKA , et al. Outcome assessment of home parenteral nutrition in patients with gynecologic malignancies: what have we learned in a decade of experience?. Gynecologic Oncology1993;51:377‐82. ">King 1993</a>; <a href="./references#CD012812-bbs2-0010" title="MercadanteS . Parenteral nutrition at home in advanced cancer patients. Journal of Pain and Symptom Management1995;10:476‐80. ">Mercadante 1995</a>; <a href="./references#CD012812-bbs2-0011" title="PironiL , RuggeriE , TannebergerS , GiordaniS , PannutiF , MiglioliM . Home artificial nutrition in advanced cancer. Journal of the Royal Society of Medicine1997;90(11):597‐603. ">Pironi 1997</a>; <a href="./references#CD012812-bbs2-0013" title="SooI , GramlichL . Use of parenteral nutrition in patients with advanced cancer. Applied Physiology, Nutrition, and Metabolism2008;33:102‐6. ">Soo 2008</a>); see <a href="#CD012812-tbl-0007">Table 6</a> for more details. Eight studies (<a href="./references#CD012812-bbs2-0002" title="AugustDA , ThornD , FisherRL , WelchekCM . Home parenteral nutrition for patients with inoperable malignant bowel obstruction. Journal of Parenteral and Enteral Nutrition1991;15:323‐7. ">August 1991</a>; <a href="./references#CD012812-bbs2-0004" title="ChermeshI , MashiachT , AmitA , HaimN , PapierI , EferganR , et al. Home parenteral nutrition (HTPN) for incurable patients with cancer with gastrointestinal obstruction: do the benefits outweigh the risks?. Medical Oncology2011;28:83‐8. ">Chermesh 2011</a>; <a href="./references#CD012812-bbs2-0006" title="DuerksenDR , TingE , ThomsonP , McCurdyK , LinscerJ , Larsen‐CelharS , et al. Is there a role for TPN in terminally ill patients with bowel obstruction?. Nutrition2004;20:760‐3. ">Duerksen 2004</a>; <a href="./references#CD012812-bbs2-0007" title="FinocchiaroC , GervasioS , AgnelloE , AppianoS , BertettoO , CiuffredaL , et al. Multicentric study on home parenteral nutrition in advanced cancer patients. Rivista italiana di Nutrizione Parenterale ed Enterale2002;20:98‐107. ">Finocchiaro 2002</a>; <a href="./references#CD012812-bbs2-0009" title="KingLA , CarsonLF , KonstantinidesN , HouseMS , AdcockLL , PremKA , et al. Outcome assessment of home parenteral nutrition in patients with gynecologic malignancies: what have we learned in a decade of experience?. Gynecologic Oncology1993;51:377‐82. ">King 1993</a>; <a href="./references#CD012812-bbs2-0010" title="MercadanteS . Parenteral nutrition at home in advanced cancer patients. Journal of Pain and Symptom Management1995;10:476‐80. ">Mercadante 1995</a>; <a href="./references#CD012812-bbs2-0011" title="PironiL , RuggeriE , TannebergerS , GiordaniS , PannutiF , MiglioliM . Home artificial nutrition in advanced cancer. Journal of the Royal Society of Medicine1997;90(11):597‐603. ">Pironi 1997</a>; <a href="./references#CD012812-bbs2-0013" title="SooI , GramlichL . Use of parenteral nutrition in patients with advanced cancer. Applied Physiology, Nutrition, and Metabolism2008;33:102‐6. ">Soo 2008</a>) reported the number of participants with adverse events and 32 of 280 participants had a central venous catheter infection or were hospitalised for PN complications, which equated to between 6% and 21% of participants across the studies. <a href="./references#CD012812-bbs2-0005" title="CotogniP , DeCarliL , PasseraR , AmerioML , AgnelloE , FaddaM , et al. Longitudinal study of quality of life in advanced cancer patients on home parenteral nutrition. Cancer Medicine2017;6:1799‐806. ">Cotogni 2017</a> reported complications in the standardised way and found 0.33 catheter‐related bloodstream infections per 1000 catheter days. However, this reporting differed from the other studies and it is unclear how many participants this relates to. Although not specified in all studies, it was assumed that any patients with central venous catheter infections were hospitalised. The Common Terminology Criteria for Adverse Events considers any hospitalisation as a grade three or severe complication (<a href="./references#CD012812-bbs2-0078" title="US Department of Health and Human Services. Common terminology criteria for adverse events. National Cancer Institute2017; Vol. v5. ">US Department of Health and Human Services, 2017</a>). </p> <div class="table" id="CD012812-tbl-0007"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 6.</span> <span class="table-title">Adverse events</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Number of participants in study</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Number with adverse events</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Number of catheter‐related bloodstream infections per 1000 catheter days</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012812-bbs2-0002" title="AugustDA , ThornD , FisherRL , WelchekCM . Home parenteral nutrition for patients with inoperable malignant bowel obstruction. Journal of Parenteral and Enteral Nutrition1991;15:323‐7. ">August 1991</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012812-bbs2-0004" title="ChermeshI , MashiachT , AmitA , HaimN , PapierI , EferganR , et al. Home parenteral nutrition (HTPN) for incurable patients with cancer with gastrointestinal obstruction: do the benefits outweigh the risks?. Medical Oncology2011;28:83‐8. ">Chermesh 2011</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>28</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012812-bbs2-0006" title="DuerksenDR , TingE , ThomsonP , McCurdyK , LinscerJ , Larsen‐CelharS , et al. Is there a role for TPN in terminally ill patients with bowel obstruction?. Nutrition2004;20:760‐3. ">Duerksen 2004</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012812-bbs2-0007" title="FinocchiaroC , GervasioS , AgnelloE , AppianoS , BertettoO , CiuffredaL , et al. Multicentric study on home parenteral nutrition in advanced cancer patients. Rivista italiana di Nutrizione Parenterale ed Enterale2002;20:98‐107. ">Finocchiaro 2002</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>70</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012812-bbs2-0009" title="KingLA , CarsonLF , KonstantinidesN , HouseMS , AdcockLL , PremKA , et al. Outcome assessment of home parenteral nutrition in patients with gynecologic malignancies: what have we learned in a decade of experience?. Gynecologic Oncology1993;51:377‐82. ">King 1993</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>61</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012812-bbs2-0011" title="PironiL , RuggeriE , TannebergerS , GiordaniS , PannutiF , MiglioliM . Home artificial nutrition in advanced cancer. Journal of the Royal Society of Medicine1997;90(11):597‐603. ">Pironi 1997</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>28<sup>a</sup> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012812-bbs2-0010" title="MercadanteS . Parenteral nutrition at home in advanced cancer patients. Journal of Pain and Symptom Management1995;10:476‐80. ">Mercadante 1995</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012812-bbs2-0013" title="SooI , GramlichL . Use of parenteral nutrition in patients with advanced cancer. Applied Physiology, Nutrition, and Metabolism2008;33:102‐6. ">Soo 2008</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>38</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012812-bbs2-0005" title="CotogniP , DeCarliL , PasseraR , AmerioML , AgnelloE , FaddaM , et al. Longitudinal study of quality of life in advanced cancer patients on home parenteral nutrition. Cancer Medicine2017;6:1799‐806. ">Cotogni 2017</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>111</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.33</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Total</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>371</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>32</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> </tbody> </table> <div class="table-footnote"> <p><sup>a</sup>Adverse events only reported in 28 patients who died. The whole population was 29 </p> </div> </div> <p>The other studies did not report adverse events. It was not clear whether this was because participants did not suffer from any or they were not reported. </p> </section> <section id="CD012812-sec-0094"> <h5 class="title">Health economic outcomes</h5> <p>Two studies (42 participants) considered cost (<a href="./references#CD012812-bbs2-0010" title="MercadanteS . Parenteral nutrition at home in advanced cancer patients. Journal of Pain and Symptom Management1995;10:476‐80. ">Mercadante 1995</a>; <a href="./references#CD012812-bbs2-0011" title="PironiL , RuggeriE , TannebergerS , GiordaniS , PannutiF , MiglioliM . Home artificial nutrition in advanced cancer. Journal of the Royal Society of Medicine1997;90(11):597‐603. ">Pironi 1997</a>). <a href="./references#CD012812-bbs2-0010" title="MercadanteS . Parenteral nutrition at home in advanced cancer patients. Journal of Pain and Symptom Management1995;10:476‐80. ">Mercadante 1995</a> considered the cost of providing PN solution, which in 1995 was $80 daily. However, this figure does not include pharmacist time or other healthcare costs. <a href="./references#CD012812-bbs2-0011" title="PironiL , RuggeriE , TannebergerS , GiordaniS , PannutiF , MiglioliM . Home artificial nutrition in advanced cancer. Journal of the Royal Society of Medicine1997;90(11):597‐603. ">Pironi 1997</a> found that in from 1 July 1995 to 30 June 1996, the cost of the nutrition support team was approximately 14.2 European Currency Units for each patient per day and 61 European Currency Units for solutions, lines and dressing kits. </p> <p>For an overview of the findings, see <a href="./full#CD012812-tbl-0001">summary of findings Table for the main comparison</a>. </p> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD012812-sec-0095" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD012812-sec-0095"></div> <section id="CD012812-sec-0096"> <h3 class="title" id="CD012812-sec-0096">Summary of main results</h3> <p>This review included 721 participants from 13 studies (<a href="./references#CD012812-bbs2-0001" title="Abu‐RustumNR , BarakatRR , VenkatramanE , SpriggsD . Chemotherapy and total parenteral nutrition for advanced ovarian cancer with bowel obstruction. Gynecologic Oncology1997;64:493‐5. ">Abu‐Rustum 1997</a>; <a href="./references#CD012812-bbs2-0002" title="AugustDA , ThornD , FisherRL , WelchekCM . Home parenteral nutrition for patients with inoperable malignant bowel obstruction. Journal of Parenteral and Enteral Nutrition1991;15:323‐7. ">August 1991</a>; <a href="./references#CD012812-bbs2-0003" title="BozzettiF , CozzaglioL , BiganzoliE , ChiavennaG , DeCiccoM , DonatiD , et al. Quality of life and length of survival in advanced cancer patients on home parenteral nutrition. Clinical Nutrition2002;21:281‐8. ">Bozzetti 2002</a>; <a href="./references#CD012812-bbs2-0004" title="ChermeshI , MashiachT , AmitA , HaimN , PapierI , EferganR , et al. Home parenteral nutrition (HTPN) for incurable patients with cancer with gastrointestinal obstruction: do the benefits outweigh the risks?. Medical Oncology2011;28:83‐8. ">Chermesh 2011</a>; <a href="./references#CD012812-bbs2-0005" title="CotogniP , DeCarliL , PasseraR , AmerioML , AgnelloE , FaddaM , et al. Longitudinal study of quality of life in advanced cancer patients on home parenteral nutrition. Cancer Medicine2017;6:1799‐806. ">Cotogni 2017</a>; <a href="./references#CD012812-bbs2-0006" title="DuerksenDR , TingE , ThomsonP , McCurdyK , LinscerJ , Larsen‐CelharS , et al. Is there a role for TPN in terminally ill patients with bowel obstruction?. Nutrition2004;20:760‐3. ">Duerksen 2004</a>; <a href="./references#CD012812-bbs2-0007" title="FinocchiaroC , GervasioS , AgnelloE , AppianoS , BertettoO , CiuffredaL , et al. Multicentric study on home parenteral nutrition in advanced cancer patients. Rivista italiana di Nutrizione Parenterale ed Enterale2002;20:98‐107. ">Finocchiaro 2002</a>; <a href="./references#CD012812-bbs2-0008" title="KeaneN , FragkosK , PatelP , BertschF , MehtaJ , DiCaroS , et al. Performance status, prognostic scoring, and parenteral nutrition requirements predict survival in patients with advanced cancer receiving home parenteral nutrition. Nutrition and Cancer2018;70(1):73‐82. ">Keane 2018</a>; <a href="./references#CD012812-bbs2-0009" title="KingLA , CarsonLF , KonstantinidesN , HouseMS , AdcockLL , PremKA , et al. Outcome assessment of home parenteral nutrition in patients with gynecologic malignancies: what have we learned in a decade of experience?. Gynecologic Oncology1993;51:377‐82. ">King 1993</a>; <a href="./references#CD012812-bbs2-0010" title="MercadanteS . Parenteral nutrition at home in advanced cancer patients. Journal of Pain and Symptom Management1995;10:476‐80. ">Mercadante 1995</a>; <a href="./references#CD012812-bbs2-0011" title="PironiL , RuggeriE , TannebergerS , GiordaniS , PannutiF , MiglioliM . Home artificial nutrition in advanced cancer. Journal of the Royal Society of Medicine1997;90(11):597‐603. ">Pironi 1997</a>; <a href="./references#CD012812-bbs2-0012" title="SantarpiaL , AlfonsiL , PasanisiF , DeCaprioC , ScalfiL , ContaldoF . Predictive factors of survival in patients with peritoneal carcinomatosis on home parenteral nutrition. Nutrition2006;22:355‐60. ">Santarpia 2006</a>; <a href="./references#CD012812-bbs2-0013" title="SooI , GramlichL . Use of parenteral nutrition in patients with advanced cancer. Applied Physiology, Nutrition, and Metabolism2008;33:102‐6. ">Soo 2008</a>). No randomised controlled trials were identified and 10 studies had a single arm without a comparator group (<a href="./references#CD012812-bbs2-0002" title="AugustDA , ThornD , FisherRL , WelchekCM . Home parenteral nutrition for patients with inoperable malignant bowel obstruction. Journal of Parenteral and Enteral Nutrition1991;15:323‐7. ">August 1991</a>; <a href="./references#CD012812-bbs2-0003" title="BozzettiF , CozzaglioL , BiganzoliE , ChiavennaG , DeCiccoM , DonatiD , et al. Quality of life and length of survival in advanced cancer patients on home parenteral nutrition. Clinical Nutrition2002;21:281‐8. ">Bozzetti 2002</a>; <a href="./references#CD012812-bbs2-0006" title="DuerksenDR , TingE , ThomsonP , McCurdyK , LinscerJ , Larsen‐CelharS , et al. Is there a role for TPN in terminally ill patients with bowel obstruction?. Nutrition2004;20:760‐3. ">Duerksen 2004</a>; <a href="./references#CD012812-bbs2-0007" title="FinocchiaroC , GervasioS , AgnelloE , AppianoS , BertettoO , CiuffredaL , et al. Multicentric study on home parenteral nutrition in advanced cancer patients. Rivista italiana di Nutrizione Parenterale ed Enterale2002;20:98‐107. ">Finocchiaro 2002</a>; <a href="./references#CD012812-bbs2-0008" title="KeaneN , FragkosK , PatelP , BertschF , MehtaJ , DiCaroS , et al. Performance status, prognostic scoring, and parenteral nutrition requirements predict survival in patients with advanced cancer receiving home parenteral nutrition. Nutrition and Cancer2018;70(1):73‐82. ">Keane 2018</a>; <a href="./references#CD012812-bbs2-0009" title="KingLA , CarsonLF , KonstantinidesN , HouseMS , AdcockLL , PremKA , et al. Outcome assessment of home parenteral nutrition in patients with gynecologic malignancies: what have we learned in a decade of experience?. Gynecologic Oncology1993;51:377‐82. ">King 1993</a>; <a href="./references#CD012812-bbs2-0010" title="MercadanteS . Parenteral nutrition at home in advanced cancer patients. Journal of Pain and Symptom Management1995;10:476‐80. ">Mercadante 1995</a>; <a href="./references#CD012812-bbs2-0011" title="PironiL , RuggeriE , TannebergerS , GiordaniS , PannutiF , MiglioliM . Home artificial nutrition in advanced cancer. Journal of the Royal Society of Medicine1997;90(11):597‐603. ">Pironi 1997</a>; <a href="./references#CD012812-bbs2-0012" title="SantarpiaL , AlfonsiL , PasanisiF , DeCaprioC , ScalfiL , ContaldoF . Predictive factors of survival in patients with peritoneal carcinomatosis on home parenteral nutrition. Nutrition2006;22:355‐60. ">Santarpia 2006</a>; <a href="./references#CD012812-bbs2-0013" title="SooI , GramlichL . Use of parenteral nutrition in patients with advanced cancer. Applied Physiology, Nutrition, and Metabolism2008;33:102‐6. ">Soo 2008</a>). However, conducting randomised controlled trials in this area is ethically difficult as patients who are not eating would be allocated to being fed on a random basis. </p> <section id="CD012812-sec-0097"> <h4 class="title">Survival</h4> <p>We are very uncertain about the impact of parenteral nutrition (PN on survival of patients with malignant bowel obstruction (MBO) as the certainty of the evidence was very low. Survival was reported in all of the studies and 636 or 88% of participants were dead at the end of the study and included in the survival analysis (<a href="./references#CD012812-bbs2-0001" title="Abu‐RustumNR , BarakatRR , VenkatramanE , SpriggsD . Chemotherapy and total parenteral nutrition for advanced ovarian cancer with bowel obstruction. Gynecologic Oncology1997;64:493‐5. ">Abu‐Rustum 1997</a>; <a href="./references#CD012812-bbs2-0002" title="AugustDA , ThornD , FisherRL , WelchekCM . Home parenteral nutrition for patients with inoperable malignant bowel obstruction. Journal of Parenteral and Enteral Nutrition1991;15:323‐7. ">August 1991</a>; <a href="./references#CD012812-bbs2-0003" title="BozzettiF , CozzaglioL , BiganzoliE , ChiavennaG , DeCiccoM , DonatiD , et al. Quality of life and length of survival in advanced cancer patients on home parenteral nutrition. Clinical Nutrition2002;21:281‐8. ">Bozzetti 2002</a>; <a href="./references#CD012812-bbs2-0004" title="ChermeshI , MashiachT , AmitA , HaimN , PapierI , EferganR , et al. Home parenteral nutrition (HTPN) for incurable patients with cancer with gastrointestinal obstruction: do the benefits outweigh the risks?. Medical Oncology2011;28:83‐8. ">Chermesh 2011</a>; <a href="./references#CD012812-bbs2-0005" title="CotogniP , DeCarliL , PasseraR , AmerioML , AgnelloE , FaddaM , et al. Longitudinal study of quality of life in advanced cancer patients on home parenteral nutrition. Cancer Medicine2017;6:1799‐806. ">Cotogni 2017</a>; <a href="./references#CD012812-bbs2-0006" title="DuerksenDR , TingE , ThomsonP , McCurdyK , LinscerJ , Larsen‐CelharS , et al. Is there a role for TPN in terminally ill patients with bowel obstruction?. Nutrition2004;20:760‐3. ">Duerksen 2004</a>; <a href="./references#CD012812-bbs2-0007" title="FinocchiaroC , GervasioS , AgnelloE , AppianoS , BertettoO , CiuffredaL , et al. Multicentric study on home parenteral nutrition in advanced cancer patients. Rivista italiana di Nutrizione Parenterale ed Enterale2002;20:98‐107. ">Finocchiaro 2002</a>; <a href="./references#CD012812-bbs2-0008" title="KeaneN , FragkosK , PatelP , BertschF , MehtaJ , DiCaroS , et al. Performance status, prognostic scoring, and parenteral nutrition requirements predict survival in patients with advanced cancer receiving home parenteral nutrition. Nutrition and Cancer2018;70(1):73‐82. ">Keane 2018</a>; <a href="./references#CD012812-bbs2-0009" title="KingLA , CarsonLF , KonstantinidesN , HouseMS , AdcockLL , PremKA , et al. Outcome assessment of home parenteral nutrition in patients with gynecologic malignancies: what have we learned in a decade of experience?. Gynecologic Oncology1993;51:377‐82. ">King 1993</a>; <a href="./references#CD012812-bbs2-0010" title="MercadanteS . Parenteral nutrition at home in advanced cancer patients. Journal of Pain and Symptom Management1995;10:476‐80. ">Mercadante 1995</a>; <a href="./references#CD012812-bbs2-0011" title="PironiL , RuggeriE , TannebergerS , GiordaniS , PannutiF , MiglioliM . Home artificial nutrition in advanced cancer. Journal of the Royal Society of Medicine1997;90(11):597‐603. ">Pironi 1997</a>; <a href="./references#CD012812-bbs2-0012" title="SantarpiaL , AlfonsiL , PasanisiF , DeCaprioC , ScalfiL , ContaldoF . Predictive factors of survival in patients with peritoneal carcinomatosis on home parenteral nutrition. Nutrition2006;22:355‐60. ">Santarpia 2006</a>; <a href="./references#CD012812-bbs2-0013" title="SooI , GramlichL . Use of parenteral nutrition in patients with advanced cancer. Applied Physiology, Nutrition, and Metabolism2008;33:102‐6. ">Soo 2008</a>). There was a wide variation of survival intervals reported in the studies, with median survival periods of 15 to 155 days (range three to 1278 days) and mean survival intervals of 85 to 164 days (range eight to 1004 days). Unfortunately, due to heterogeneity of cancer diagnosis and the differing start points for measuring survival it was not possible to combine the study results. Although, the hospital discharge date was most often used as the start point for measuring survival, this is relatively arbitrary and influenced by many non‐disease‐related factors making comparisons across hospitals and different health systems difficult. </p> </section> <section id="CD012812-sec-0098"> <h4 class="title">Quality of life</h4> <p>We are very uncertain about the impact of PN on quality of life of patients with MBO as the certainty of the evidence was very low. Results for quality of life were equivocal. Three studies used validated questionnaires (<a href="./references#CD012812-bbs2-0003" title="BozzettiF , CozzaglioL , BiganzoliE , ChiavennaG , DeCiccoM , DonatiD , et al. Quality of life and length of survival in advanced cancer patients on home parenteral nutrition. Clinical Nutrition2002;21:281‐8. ">Bozzetti 2002</a>; <a href="./references#CD012812-bbs2-0005" title="CotogniP , DeCarliL , PasseraR , AmerioML , AgnelloE , FaddaM , et al. Longitudinal study of quality of life in advanced cancer patients on home parenteral nutrition. Cancer Medicine2017;6:1799‐806. ">Cotogni 2017</a>; <a href="./references#CD012812-bbs2-0007" title="FinocchiaroC , GervasioS , AgnelloE , AppianoS , BertettoO , CiuffredaL , et al. Multicentric study on home parenteral nutrition in advanced cancer patients. Rivista italiana di Nutrizione Parenterale ed Enterale2002;20:98‐107. ">Finocchiaro 2002</a>). <a href="./references#CD012812-bbs2-0005" title="CotogniP , DeCarliL , PasseraR , AmerioML , AgnelloE , FaddaM , et al. Longitudinal study of quality of life in advanced cancer patients on home parenteral nutrition. Cancer Medicine2017;6:1799‐806. ">Cotogni 2017</a> found an improvement over three months for global quality of life. <a href="./references#CD012812-bbs2-0003" title="BozzettiF , CozzaglioL , BiganzoliE , ChiavennaG , DeCiccoM , DonatiD , et al. Quality of life and length of survival in advanced cancer patients on home parenteral nutrition. Clinical Nutrition2002;21:281‐8. ">Bozzetti 2002</a> and <a href="./references#CD012812-bbs2-0007" title="FinocchiaroC , GervasioS , AgnelloE , AppianoS , BertettoO , CiuffredaL , et al. Multicentric study on home parenteral nutrition in advanced cancer patients. Rivista italiana di Nutrizione Parenterale ed Enterale2002;20:98‐107. ">Finocchiaro 2002</a> had a mixed picture showing both improvements for some patients and deterioration for others </p> </section> <section id="CD012812-sec-0099"> <h4 class="title">Adverse events</h4> <p>We are very uncertain about the impact of PN on adverse events of patients with MBO as the certainty of the evidence was very low. Adverse events were reported in nine studies (<a href="./references#CD012812-bbs2-0002" title="AugustDA , ThornD , FisherRL , WelchekCM . Home parenteral nutrition for patients with inoperable malignant bowel obstruction. Journal of Parenteral and Enteral Nutrition1991;15:323‐7. ">August 1991</a>; <a href="./references#CD012812-bbs2-0004" title="ChermeshI , MashiachT , AmitA , HaimN , PapierI , EferganR , et al. Home parenteral nutrition (HTPN) for incurable patients with cancer with gastrointestinal obstruction: do the benefits outweigh the risks?. Medical Oncology2011;28:83‐8. ">Chermesh 2011</a>; <a href="./references#CD012812-bbs2-0005" title="CotogniP , DeCarliL , PasseraR , AmerioML , AgnelloE , FaddaM , et al. Longitudinal study of quality of life in advanced cancer patients on home parenteral nutrition. Cancer Medicine2017;6:1799‐806. ">Cotogni 2017</a>; <a href="./references#CD012812-bbs2-0006" title="DuerksenDR , TingE , ThomsonP , McCurdyK , LinscerJ , Larsen‐CelharS , et al. Is there a role for TPN in terminally ill patients with bowel obstruction?. Nutrition2004;20:760‐3. ">Duerksen 2004</a>; <a href="./references#CD012812-bbs2-0007" title="FinocchiaroC , GervasioS , AgnelloE , AppianoS , BertettoO , CiuffredaL , et al. Multicentric study on home parenteral nutrition in advanced cancer patients. Rivista italiana di Nutrizione Parenterale ed Enterale2002;20:98‐107. ">Finocchiaro 2002</a>; <a href="./references#CD012812-bbs2-0009" title="KingLA , CarsonLF , KonstantinidesN , HouseMS , AdcockLL , PremKA , et al. Outcome assessment of home parenteral nutrition in patients with gynecologic malignancies: what have we learned in a decade of experience?. Gynecologic Oncology1993;51:377‐82. ">King 1993</a>; <a href="./references#CD012812-bbs2-0010" title="MercadanteS . Parenteral nutrition at home in advanced cancer patients. Journal of Pain and Symptom Management1995;10:476‐80. ">Mercadante 1995</a>; <a href="./references#CD012812-bbs2-0011" title="PironiL , RuggeriE , TannebergerS , GiordaniS , PannutiF , MiglioliM . Home artificial nutrition in advanced cancer. Journal of the Royal Society of Medicine1997;90(11):597‐603. ">Pironi 1997</a>; <a href="./references#CD012812-bbs2-0013" title="SooI , GramlichL . Use of parenteral nutrition in patients with advanced cancer. Applied Physiology, Nutrition, and Metabolism2008;33:102‐6. ">Soo 2008</a>). For eight studies, data for individual participants could be extracted, and 32 of 260 (12%) participants developed a central venous catheter infection or were hospitalised for PN complications (<a href="./references#CD012812-bbs2-0002" title="AugustDA , ThornD , FisherRL , WelchekCM . Home parenteral nutrition for patients with inoperable malignant bowel obstruction. Journal of Parenteral and Enteral Nutrition1991;15:323‐7. ">August 1991</a>; <a href="./references#CD012812-bbs2-0004" title="ChermeshI , MashiachT , AmitA , HaimN , PapierI , EferganR , et al. Home parenteral nutrition (HTPN) for incurable patients with cancer with gastrointestinal obstruction: do the benefits outweigh the risks?. Medical Oncology2011;28:83‐8. ">Chermesh 2011</a>; <a href="./references#CD012812-bbs2-0006" title="DuerksenDR , TingE , ThomsonP , McCurdyK , LinscerJ , Larsen‐CelharS , et al. Is there a role for TPN in terminally ill patients with bowel obstruction?. Nutrition2004;20:760‐3. ">Duerksen 2004</a>; <a href="./references#CD012812-bbs2-0007" title="FinocchiaroC , GervasioS , AgnelloE , AppianoS , BertettoO , CiuffredaL , et al. Multicentric study on home parenteral nutrition in advanced cancer patients. Rivista italiana di Nutrizione Parenterale ed Enterale2002;20:98‐107. ">Finocchiaro 2002</a>; <a href="./references#CD012812-bbs2-0009" title="KingLA , CarsonLF , KonstantinidesN , HouseMS , AdcockLL , PremKA , et al. Outcome assessment of home parenteral nutrition in patients with gynecologic malignancies: what have we learned in a decade of experience?. Gynecologic Oncology1993;51:377‐82. ">King 1993</a>; <a href="./references#CD012812-bbs2-0010" title="MercadanteS . Parenteral nutrition at home in advanced cancer patients. Journal of Pain and Symptom Management1995;10:476‐80. ">Mercadante 1995</a>; <a href="./references#CD012812-bbs2-0011" title="PironiL , RuggeriE , TannebergerS , GiordaniS , PannutiF , MiglioliM . Home artificial nutrition in advanced cancer. Journal of the Royal Society of Medicine1997;90(11):597‐603. ">Pironi 1997</a>; <a href="./references#CD012812-bbs2-0013" title="SooI , GramlichL . Use of parenteral nutrition in patients with advanced cancer. Applied Physiology, Nutrition, and Metabolism2008;33:102‐6. ">Soo 2008</a>). </p> </section> </section> <section id="CD012812-sec-0100"> <h3 class="title" id="CD012812-sec-0100">Overall completeness and applicability of evidence</h3> <p>The applicability and generalisability of the evidence for parenteral nutrition in MBO is limited due to lack of adequate and comparative data across the studies. </p> <p>All of the studies reported survival data in some way, but there were flaws in the estimates in terms of start point. </p> <p>Quality of life was only measured in four studies and sequential measurements were limited due to participant mortality. </p> <p>Adverse events were only reported in nine of the 13 studies. It was unclear whether no adverse events occurred in the other studies or whether they were just not reported. </p> </section> <section id="CD012812-sec-0101"> <h3 class="title" id="CD012812-sec-0101">Quality of the evidence</h3> <p>Overall, the certainty of evidence was very low, derived mainly from observational studies without a comparator. </p> </section> <section id="CD012812-sec-0102"> <h3 class="title" id="CD012812-sec-0102">Potential biases in the review process</h3> <p>The main bias is that evidence comes from case series and cohort studies. There was no randomisation to treatment groups and no blinding of participants or healthcare professionals. The measurement of survival in 10 of the included studies was unclear or flawed in that a process measure (discharge date) was used to define the start point for measuring survival (<a href="./references#CD012812-bbs2-0002" title="AugustDA , ThornD , FisherRL , WelchekCM . Home parenteral nutrition for patients with inoperable malignant bowel obstruction. Journal of Parenteral and Enteral Nutrition1991;15:323‐7. ">August 1991</a>; <a href="./references#CD012812-bbs2-0003" title="BozzettiF , CozzaglioL , BiganzoliE , ChiavennaG , DeCiccoM , DonatiD , et al. Quality of life and length of survival in advanced cancer patients on home parenteral nutrition. Clinical Nutrition2002;21:281‐8. ">Bozzetti 2002</a>; <a href="./references#CD012812-bbs2-0004" title="ChermeshI , MashiachT , AmitA , HaimN , PapierI , EferganR , et al. Home parenteral nutrition (HTPN) for incurable patients with cancer with gastrointestinal obstruction: do the benefits outweigh the risks?. Medical Oncology2011;28:83‐8. ">Chermesh 2011</a>; <a href="./references#CD012812-bbs2-0005" title="CotogniP , DeCarliL , PasseraR , AmerioML , AgnelloE , FaddaM , et al. Longitudinal study of quality of life in advanced cancer patients on home parenteral nutrition. Cancer Medicine2017;6:1799‐806. ">Cotogni 2017</a>; <a href="./references#CD012812-bbs2-0007" title="FinocchiaroC , GervasioS , AgnelloE , AppianoS , BertettoO , CiuffredaL , et al. Multicentric study on home parenteral nutrition in advanced cancer patients. Rivista italiana di Nutrizione Parenterale ed Enterale2002;20:98‐107. ">Finocchiaro 2002</a>; <a href="./references#CD012812-bbs2-0008" title="KeaneN , FragkosK , PatelP , BertschF , MehtaJ , DiCaroS , et al. Performance status, prognostic scoring, and parenteral nutrition requirements predict survival in patients with advanced cancer receiving home parenteral nutrition. Nutrition and Cancer2018;70(1):73‐82. ">Keane 2018</a>; <a href="./references#CD012812-bbs2-0009" title="KingLA , CarsonLF , KonstantinidesN , HouseMS , AdcockLL , PremKA , et al. Outcome assessment of home parenteral nutrition in patients with gynecologic malignancies: what have we learned in a decade of experience?. Gynecologic Oncology1993;51:377‐82. ">King 1993</a>; <a href="./references#CD012812-bbs2-0011" title="PironiL , RuggeriE , TannebergerS , GiordaniS , PannutiF , MiglioliM . Home artificial nutrition in advanced cancer. Journal of the Royal Society of Medicine1997;90(11):597‐603. ">Pironi 1997</a>; <a href="./references#CD012812-bbs2-0012" title="SantarpiaL , AlfonsiL , PasanisiF , DeCaprioC , ScalfiL , ContaldoF . Predictive factors of survival in patients with peritoneal carcinomatosis on home parenteral nutrition. Nutrition2006;22:355‐60. ">Santarpia 2006</a>; <a href="./references#CD012812-bbs2-0013" title="SooI , GramlichL . Use of parenteral nutrition in patients with advanced cancer. Applied Physiology, Nutrition, and Metabolism2008;33:102‐6. ">Soo 2008</a>). </p> </section> <section id="CD012812-sec-0103"> <h3 class="title" id="CD012812-sec-0103">Agreements and disagreements with other studies or reviews</h3> <p><a href="./references#CD012812-bbs2-0029" title="NaghibiM , SmithTR , EliaM . A systematic review with meta‐analysis of survival, quality of life and cost‐effectiveness of home parenteral nutrition in patients with inoperable malignant bowel obstruction. Clinical Nutrition2015;34:825‐37. ">Naghibi 2015</a> conducted a systematic review of people with MBO having PN. They included 12 studies where more than 80% of the participants had MBO. the study authors reported a survival time of 83 days (median) and 116 days (mean). Unlike <a href="./references#CD012812-bbs2-0029" title="NaghibiM , SmithTR , EliaM . A systematic review with meta‐analysis of survival, quality of life and cost‐effectiveness of home parenteral nutrition in patients with inoperable malignant bowel obstruction. Clinical Nutrition2015;34:825‐37. ">Naghibi 2015</a>, we did not perform a meta‐analysis of the survival time due to the variety of cancer diagnoses, differing definitions of survival time and flawed definition of survival period. However, there was a range median survivals across the studies 15 to 155 days (range three to 1278 days), which is comparable to that reported by <a href="./references#CD012812-bbs2-0029" title="NaghibiM , SmithTR , EliaM . A systematic review with meta‐analysis of survival, quality of life and cost‐effectiveness of home parenteral nutrition in patients with inoperable malignant bowel obstruction. Clinical Nutrition2015;34:825‐37. ">Naghibi 2015</a> (median survivals were 15 to 140 days with a range of three to 1004 days). Similar to our findings, <a href="./references#CD012812-bbs2-0029" title="NaghibiM , SmithTR , EliaM . A systematic review with meta‐analysis of survival, quality of life and cost‐effectiveness of home parenteral nutrition in patients with inoperable malignant bowel obstruction. Clinical Nutrition2015;34:825‐37. ">Naghibi 2015</a> found limited data on quality of life and suggested that further research into quality of life in these participants is required. </p> <p><a href="./references#CD012812-bbs2-0029" title="NaghibiM , SmithTR , EliaM . A systematic review with meta‐analysis of survival, quality of life and cost‐effectiveness of home parenteral nutrition in patients with inoperable malignant bowel obstruction. Clinical Nutrition2015;34:825‐37. ">Naghibi 2015</a> also conducted base‐case economic modelling for HPN in palliative malignancy and found an incremental cost‐effectiveness ratio of £176, 587 per quality adjusted life year. None of the studies in this review conducted quality adjusted life year cost analysis of HPN. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD012812-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012812.pub2/media/CDSR/CD012812/urn:x-wiley:14651858:media:CD012812:CD012812-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012812.pub2/media/CDSR/CD012812/image_t/tCD012812-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD012812-fig-0001" src="/cdsr/doi/10.1002/14651858.CD012812.pub2/media/CDSR/CD012812/image_n/nCD012812-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012812.pub2/full#CD012812-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012812.pub2/media/CDSR/CD012812/image_n/nCD012812-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012812-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012812.pub2/media/CDSR/CD012812/urn:x-wiley:14651858:media:CD012812:CD012812-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012812.pub2/media/CDSR/CD012812/image_t/tCD012812-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study." data-id="CD012812-fig-0002" src="/cdsr/doi/10.1002/14651858.CD012812.pub2/media/CDSR/CD012812/image_n/nCD012812-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012812.pub2/full#CD012812-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012812.pub2/media/CDSR/CD012812/image_n/nCD012812-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012812-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012812.pub2/media/CDSR/CD012812/urn:x-wiley:14651858:media:CD012812:CD012812-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012812.pub2/media/CDSR/CD012812/image_t/tCD012812-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD012812-fig-0003" src="/cdsr/doi/10.1002/14651858.CD012812.pub2/media/CDSR/CD012812/image_n/nCD012812-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012812.pub2/full#CD012812-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012812.pub2/media/CDSR/CD012812/image_n/nCD012812-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012812-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012812.pub2/media/CDSR/CD012812/urn:x-wiley:14651858:media:CD012812:CD012812-AFig-FIG04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012812.pub2/media/CDSR/CD012812/image_t/tCD012812-AFig-FIG04.png" target="_blank"><b></b></a></p> </div><img alt="Mean survival and standard deviations calculated from median and range (Hozo 2005) for all studies apart from Keane 2018; Pironi 1997; Soo 2008 which presented mean survival" data-id="CD012812-fig-0004" src="/cdsr/doi/10.1002/14651858.CD012812.pub2/media/CDSR/CD012812/image_n/nCD012812-AFig-FIG04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 4</div> <div class="figure-caption"> <p>Mean survival and standard deviations calculated from median and range (<a href="./references#CD012812-bbs2-0063" title="HozoS , DjulbegovicB , HozoI . Estimating the mean and variance from the median, range, and the size of a sample. BMC Medical Research Methodology2005;5:13. ">Hozo 2005</a>) for all studies apart from <a href="./references#CD012812-bbs2-0008" title="KeaneN , FragkosK , PatelP , BertschF , MehtaJ , DiCaroS , et al. Performance status, prognostic scoring, and parenteral nutrition requirements predict survival in patients with advanced cancer receiving home parenteral nutrition. Nutrition and Cancer2018;70(1):73‐82. ">Keane 2018</a>; <a href="./references#CD012812-bbs2-0011" title="PironiL , RuggeriE , TannebergerS , GiordaniS , PannutiF , MiglioliM . Home artificial nutrition in advanced cancer. Journal of the Royal Society of Medicine1997;90(11):597‐603. ">Pironi 1997</a>; <a href="./references#CD012812-bbs2-0013" title="SooI , GramlichL . Use of parenteral nutrition in patients with advanced cancer. Applied Physiology, Nutrition, and Metabolism2008;33:102‐6. ">Soo 2008</a> which presented mean survival </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012812.pub2/full#CD012812-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012812.pub2/media/CDSR/CD012812/image_n/nCD012812-AFig-FIG04.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD012812-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Parenteral nutrition (PN) for inoperable malignant bowel obstruction (MBO)</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p><b>Home parenteral nutrition for people with inoperable bowel cancer</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p><b>Patient or population:</b> people with advanced cancer with inoperable malignant bowel obstruction (MBO)<br/> <b>Setting:</b> outpatient/home care<br/> <b>Intervention:</b> parenteral nutrition (PN) </p> </td> </tr> <tr class="table-header separated"> <td align="center" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Impact</b> </p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="center" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> </tr> <tr class="separated"> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Length of Survival</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>We are uncertain whether PN improves survival for patients with MBO receiving PN. It was not possible to combine data due to heterogeneity of cancer diagnosis and differing starting points for measuring survival.There was a wide variation of survival lengths reported in the studies, with median survival periods of 15 to 155 days (range 3 to 1278 days) and mean survival intervals of 85 to 164 days (range 8 to 1004 days). </p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>721</p> <p>(13 observational studies)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> Very Low <sup>1 2</sup> </p> </td> </tr> <tr class="separated"> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Quality of life</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>We are very uncertain if PN proves quality of life for patients with MBO receiving PN. Three studies used validated questionnaires. One of these studies found an improvement over three months for global quality of life. Two studies had a mixed picture; one measuring well‐being at one month and one overall quality of life at two months. Around half of participants showed no change, a quarter to a fifth deteriorated and a quarter to a third improved. </p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>188</p> <p>(3 observational studies)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> Very Low <sup>1 2</sup> </p> </td> </tr> <tr class="separated"> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adverse events</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>We are very uncertain about the impact of PN on adverse events of patients in MBO as the quality of the evidence was very low. There is limited evidence about adverse events. Although nine studies reported this outcome, data for individual patients could be extracted from eight studies and 32/260 (12%) patients developed a central venous catheter infection or were hospitalised for PN complications. </p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>280</p> <p>(9 observational studies)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> Very Low <sup>1 2</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate certainty:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low certainty:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low certainty:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="4"> <div class="table-footnote"> <p><sup>1</sup> The studies were down graded by three points as all of the studies were observational so patients were not allocated treatments at random and healthcare professionals and patients were not blinded to treatment received. Therefore, the studies are at very high risk of bias. </p> <p><sup>2</sup> Narrative synthesis conducted estimates not precise </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Parenteral nutrition (PN) for inoperable malignant bowel obstruction (MBO)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012812.pub2/full#CD012812-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD012812-tbl-0002"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Length of Survival</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Numbers in study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N surviving 1 month</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N surviving &gt; 1‐3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N surviving &gt; 3‐6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N surviving ≥ 6 months</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012812-bbs2-0002" title="AugustDA , ThornD , FisherRL , WelchekCM . Home parenteral nutrition for patients with inoperable malignant bowel obstruction. Journal of Parenteral and Enteral Nutrition1991;15:323‐7. ">August 1991</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>14</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012812-bbs2-0004" title="ChermeshI , MashiachT , AmitA , HaimN , PapierI , EferganR , et al. Home parenteral nutrition (HTPN) for incurable patients with cancer with gastrointestinal obstruction: do the benefits outweigh the risks?. Medical Oncology2011;28:83‐8. ">Chermesh 2011</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>68</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>23</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>14</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012812-bbs2-0005" title="CotogniP , DeCarliL , PasseraR , AmerioML , AgnelloE , FaddaM , et al. Longitudinal study of quality of life in advanced cancer patients on home parenteral nutrition. Cancer Medicine2017;6:1799‐806. ">Cotogni 2017</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>111</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>74<sup>a</sup> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>38</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24<sup>b</sup> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012812-bbs2-0006" title="DuerksenDR , TingE , ThomsonP , McCurdyK , LinscerJ , Larsen‐CelharS , et al. Is there a role for TPN in terminally ill patients with bowel obstruction?. Nutrition2004;20:760‐3. ">Duerksen 2004</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012812-bbs2-0008" title="KeaneN , FragkosK , PatelP , BertschF , MehtaJ , DiCaroS , et al. Performance status, prognostic scoring, and parenteral nutrition requirements predict survival in patients with advanced cancer receiving home parenteral nutrition. Nutrition and Cancer2018;70(1):73‐82. ">Keane 2018</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>107</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>53<sup>a</sup> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>19</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>19</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012812-bbs2-0010" title="MercadanteS . Parenteral nutrition at home in advanced cancer patients. Journal of Pain and Symptom Management1995;10:476‐80. ">Mercadante 1995</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012812-bbs2-0012" title="SantarpiaL , AlfonsiL , PasanisiF , DeCaprioC , ScalfiL , ContaldoF . Predictive factors of survival in patients with peritoneal carcinomatosis on home parenteral nutrition. Nutrition2006;22:355‐60. ">Santarpia 2006</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>152</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>96</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>62</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>37</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>37</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>N = Numbers</sup> </p> <p><sup>a</sup>Survival was measured from 0 to 3 months in these studies. </p> <p><sup>b</sup>Number surviving at 9 months </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Length of Survival</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012812.pub2/full#CD012812-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD012812-tbl-0003"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Survival for different cancer diagnoses</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p>Survival ‐ median (range) in days</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Ovarian cancer n = 9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Endometrial cancer n = 1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Gastrointestinal cancer n = 3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Colon cancer</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Gastric cancer n = 2</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012812-bbs2-0002" title="AugustDA , ThornD , FisherRL , WelchekCM . Home parenteral nutrition for patients with inoperable malignant bowel obstruction. Journal of Parenteral and Enteral Nutrition1991;15:323‐7. ">August 1991</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>39 (10 to 77)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>51</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>159 (106 to 208)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>89 (5 to 168)<sup>a</sup> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012812-bbs2-0006" title="DuerksenDR , TingE , ThomsonP , McCurdyK , LinscerJ , Larsen‐CelharS , et al. Is there a role for TPN in terminally ill patients with bowel obstruction?. Nutrition2004;20:760‐3. ">Duerksen 2004</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>155 (72 to 433)<sup>b</sup> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>258 (84 to 431)</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>a</sup> n = 4 </p> <p><sup>b</sup> n = 3 </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Survival for different cancer diagnoses</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012812.pub2/full#CD012812-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD012812-tbl-0004"> <div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Quality of life</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Numbers of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Timepoint</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Quality of lIfe measure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Score</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012812-bbs2-0003" title="BozzettiF , CozzaglioL , BiganzoliE , ChiavennaG , DeCiccoM , DonatiD , et al. Quality of life and length of survival in advanced cancer patients on home parenteral nutrition. Clinical Nutrition2002;21:281‐8. ">Bozzetti 2002</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>69<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Baseline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Rotterdam Symptom Checklist</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Well‐being assessment (n)<sup>c</sup><br/> Very well 3<br/> Well 55<br/> Not well 38<br/> Ill 0<br/> Missing 4 </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>64</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1 Month</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Rotterdam Symptom Checklist</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Well‐being assessment change from baseline (n)<br/> Increased 15<br/> No change 32<br/> Decreased 17 </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012812-bbs2-0005" title="CotogniP , DeCarliL , PasseraR , AmerioML , AgnelloE , FaddaM , et al. Longitudinal study of quality of life in advanced cancer patients on home parenteral nutrition. Cancer Medicine2017;6:1799‐806. ">Cotogni 2017</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>111<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Baseline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>EORTC<sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean (SD) Global QoL<sup>d</sup> 52 (17) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>97</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1 Month</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>EORTC</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean (SD) Global QoL 58 (17)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>76</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2 Months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>EORTC</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean (SD) Global QoL 66 (17)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>54</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3 Months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>EORTC</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean (SD) Global QoL 71 (14)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012812-bbs2-0007" title="FinocchiaroC , GervasioS , AgnelloE , AppianoS , BertettoO , CiuffredaL , et al. Multicentric study on home parenteral nutrition in advanced cancer patients. Rivista italiana di Nutrizione Parenterale ed Enterale2002;20:98‐107. ">Finocchiaro 2002</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>70<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Baseline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Therapy impact questionnaire</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Values not given</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>27</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2 Months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Therapy impact questionnaire</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Change from baseline<br/> Deterioration 20.5%<br/> Stationary 48%<br/> Improving 31.5% </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="5"> <div class="table-footnote"> <p><sup>a</sup>Total number in the study </p> <p><sup>b</sup>EORTC = European Organization for Research and Treatment of Cancer Quality of life Questionnaire Core 30 </p> <p><sup>c</sup> Number </p> <p><sup>d</sup>Quality of life </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Quality of life</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012812.pub2/full#CD012812-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD012812-tbl-0005"> <div class="table-heading"><span class="table-label">Table 4.</span> <span class="table-title">Gastrointestinal symptoms</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Numbers in study</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Numbers gastrointestinal symptoms measured</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Time point</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Measure</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Nausea<sup>a</sup> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Vomiting</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Gastrointestinal discomfort</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Diarrhoea</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012812-bbs2-0009" title="KingLA , CarsonLF , KonstantinidesN , HouseMS , AdcockLL , PremKA , et al. Outcome assessment of home parenteral nutrition in patients with gynecologic malignancies: what have we learned in a decade of experience?. Gynecologic Oncology1993;51:377‐82. ">King 1993</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>61</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>61</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Baseline</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unvalidated<sup>b</sup> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.2</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.8</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.0</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>61</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>During HPN</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.7</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.4</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.8</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012812-bbs2-0007" title="FinocchiaroC , GervasioS , AgnelloE , AppianoS , BertettoO , CiuffredaL , et al. Multicentric study on home parenteral nutrition in advanced cancer patients. Rivista italiana di Nutrizione Parenterale ed Enterale2002;20:98‐107. ">Finocchiaro 2002</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>71</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>27</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Baseline</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Therapy impact questionnaire</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Values not given</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Values not given</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>27</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2 months</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Therapy impact questionnaire</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Change from Baseline</p> <p>Deterioration 26%<br/> Stationary 42%<br/> Improving 32% </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Change from Baseline</p> <p>Deterioration 15%<br/> Stationary 57%<br/> Improving 28% </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="9"> <div class="table-footnote"> <p><sup>a</sup>Nausea and vomiting measured together </p> <p><sup>b</sup> 1 to 5 scale where 1 is usual or best and 5 is worse or never </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 4.</span> <span class="table-title">Gastrointestinal symptoms</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012812.pub2/full#CD012812-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD012812-tbl-0006"> <div class="table-heading"><span class="table-label">Table 5.</span> <span class="table-title">Nutritional status</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Numbers nutritional status measured</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Timepoint</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Weight (kg)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Albumin (g/dl)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Transferin (mg/dL)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Lymphocytes</p> <p>(x 10<sup>9</sup>/L) </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cholesterol (mg/dL)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Haemoglobin (g/dL)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>PG‐SGA score (%)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012812-bbs2-0003" title="BozzettiF , CozzaglioL , BiganzoliE , ChiavennaG , DeCiccoM , DonatiD , et al. Quality of life and length of survival in advanced cancer patients on home parenteral nutrition. Clinical Nutrition2002;21:281‐8. ">Bozzetti 2002</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>69</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Baseline</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median 52.5 (35.5 to 77.5)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median 3.3 (2.2 to 4.8)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median 189 (26 to 420)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median 1.15 (0.15 to 3.05)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>69</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Before death</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median 54.0 (36 to 78)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median 3.2 (2.2 to 4.7</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median 180 (65 to 414)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median 1.2</p> <p>(0.24 to 3.65)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012812-bbs2-0007" title="FinocchiaroC , GervasioS , AgnelloE , AppianoS , BertettoO , CiuffredaL , et al. Multicentric study on home parenteral nutrition in advanced cancer patients. Rivista italiana di Nutrizione Parenterale ed Enterale2002;20:98‐107. ">Finocchiaro 2002</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>27<sup>a</sup> (of 70) </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Baseline</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>51 (37 to 76)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.15 (1.2 to 4)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>B ‐ 33%</p> <p>C ‐ 67%</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>27</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2 months</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>52.2 (40 to 71)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.14 (1.7 to 4.5)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A ‐ 15%</p> <p>B ‐ 37%</p> <p>C ‐ 48%</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012812-bbs2-0009" title="KingLA , CarsonLF , KonstantinidesN , HouseMS , AdcockLL , PremKA , et al. Outcome assessment of home parenteral nutrition in patients with gynecologic malignancies: what have we learned in a decade of experience?. Gynecologic Oncology1993;51:377‐82. ">King 1993</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>61</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Baseline</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean 54.5 (13.7)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean 2.5 (0.6)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean 149 (48)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>50</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1 month</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean 57.2 (12.4)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean 2.4 (0.6)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean 149 (60.2)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>18</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3 months</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean 57.7 (11.2)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean 2.9 (0.6)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean 195 (62.2)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 months</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean 59.8 (11.7)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean 3.1 (0.7)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean 225.4 (77)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012812-bbs2-0012" title="SantarpiaL , AlfonsiL , PasanisiF , DeCaprioC , ScalfiL , ContaldoF . Predictive factors of survival in patients with peritoneal carcinomatosis on home parenteral nutrition. Nutrition2006;22:355‐60. ">Santarpia 2006</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>64<sup>a</sup> (of 152) </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Baseline</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean 51.7 (10.3)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean 3.3 (0.6)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean 1.48 (0.72)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean 154 (46)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean 11.0 (1.9)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>64</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1 month</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean 53.2 (10.3)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean 3.4 (0.5)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean 1.46 (0.67)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean 150 (38)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean 10.5 (1.9)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="10"> <div class="table-footnote"> <p><sup>a</sup>Baseline values given for those patients who had nutritional status measured later. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 5.</span> <span class="table-title">Nutritional status</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012812.pub2/full#CD012812-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD012812-tbl-0007"> <div class="table-heading"><span class="table-label">Table 6.</span> <span class="table-title">Adverse events</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Number of participants in study</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Number with adverse events</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Number of catheter‐related bloodstream infections per 1000 catheter days</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012812-bbs2-0002" title="AugustDA , ThornD , FisherRL , WelchekCM . Home parenteral nutrition for patients with inoperable malignant bowel obstruction. Journal of Parenteral and Enteral Nutrition1991;15:323‐7. ">August 1991</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012812-bbs2-0004" title="ChermeshI , MashiachT , AmitA , HaimN , PapierI , EferganR , et al. Home parenteral nutrition (HTPN) for incurable patients with cancer with gastrointestinal obstruction: do the benefits outweigh the risks?. Medical Oncology2011;28:83‐8. ">Chermesh 2011</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>28</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012812-bbs2-0006" title="DuerksenDR , TingE , ThomsonP , McCurdyK , LinscerJ , Larsen‐CelharS , et al. Is there a role for TPN in terminally ill patients with bowel obstruction?. Nutrition2004;20:760‐3. ">Duerksen 2004</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012812-bbs2-0007" title="FinocchiaroC , GervasioS , AgnelloE , AppianoS , BertettoO , CiuffredaL , et al. Multicentric study on home parenteral nutrition in advanced cancer patients. Rivista italiana di Nutrizione Parenterale ed Enterale2002;20:98‐107. ">Finocchiaro 2002</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>70</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012812-bbs2-0009" title="KingLA , CarsonLF , KonstantinidesN , HouseMS , AdcockLL , PremKA , et al. Outcome assessment of home parenteral nutrition in patients with gynecologic malignancies: what have we learned in a decade of experience?. Gynecologic Oncology1993;51:377‐82. ">King 1993</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>61</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012812-bbs2-0011" title="PironiL , RuggeriE , TannebergerS , GiordaniS , PannutiF , MiglioliM . Home artificial nutrition in advanced cancer. Journal of the Royal Society of Medicine1997;90(11):597‐603. ">Pironi 1997</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>28<sup>a</sup> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012812-bbs2-0010" title="MercadanteS . Parenteral nutrition at home in advanced cancer patients. Journal of Pain and Symptom Management1995;10:476‐80. ">Mercadante 1995</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012812-bbs2-0013" title="SooI , GramlichL . Use of parenteral nutrition in patients with advanced cancer. Applied Physiology, Nutrition, and Metabolism2008;33:102‐6. ">Soo 2008</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>38</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012812-bbs2-0005" title="CotogniP , DeCarliL , PasseraR , AmerioML , AgnelloE , FaddaM , et al. Longitudinal study of quality of life in advanced cancer patients on home parenteral nutrition. Cancer Medicine2017;6:1799‐806. ">Cotogni 2017</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>111</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.33</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Total</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>371</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>32</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> </tbody> <tfoot> <tr> <td colspan="4"> <div class="table-footnote"> <p><sup>a</sup>Adverse events only reported in 28 patients who died. The whole population was 29 </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 6.</span> <span class="table-title">Adverse events</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012812.pub2/full#CD012812-tbl-0007">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD012812.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD012812-note-0002">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD012812-note-0006">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD012812-note-0017">فارسی</a> </li> <li class="section-language"> <a class="" href="ja#CD012812-note-0005">日本語</a> </li> <li class="section-language"> <a class="" href="ms#CD012812-note-0004">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="ru#CD012812-note-0003">Русский</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD012812-note-0001">简体中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738735355000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738735355000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012812\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012812\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012812\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD012812\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012812\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012812\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012812\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012812\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012812\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD012812\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012812\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012812\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012812\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD012812\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012812\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012812\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012812\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD012812\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=jU9oKp1Y&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD012812.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD012812.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD012812.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD012812.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD012812.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740714470545"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD012812.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"/> <span class="taglib-text hide-accessible">Sign In</span> </span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740714470549"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD012812.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918d6f7b2d069377',t:'MTc0MDcxNDQ3MS4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 